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1  
CHAPTER 1 
 
1.1 INTRODUCTION TO THE ISSUE 
The last several years have seen an increasing amount of new evidence that allowed a greater 
knowledge and understanding of how cognitive, emotional, behavioural and relational skills emerge 
and develop throughout the brain maturation, and highlighted some factors which may account for 
their presentation as mental health conditions or mental health problems.  
In the field of Intellectual Disability (ID) the most appropriate framework is provided by the 
neurodevelopmental perspective, because it permits not only to explain the relations across systems 
but also to justify the need of researchers and practitioners who work for the development of multi-
level and interdisciplinary approaches focused on the aetiological comprehension and interventions of 
mental health problems.  
The neurodevelopmental perspective integrates the principles of core developmental 
psychology/psychobiology theories and models with those derived by developmental and cognitive 
neuroscience, and localises positive and pathological adaptations in the transactional relations between 
the individual’s internal biological/psychological mechanisms and the external environment. 
It represents a dimensional approach, which viewing illnesses on a continuum with normality is more 
sensitive to the individual’s changes across development. Therefore, it offers many advantages for 
neuroscience and genomics in respect to the categorical approaches.  
One of the most important consequences of such neurodevelopmental perspective is the appreciation 
that what have been previously considered as distinctive disorder categories actually share some 
features, and may co-occur or become evident as a sequential comorbidity, or instead represent a 
different age-adjusted presentation of the underlying brain mechanisms. The hypothesis regarding 
shared features between disorders has been supported by recent genome-wide association studies, 
showing that copy number variants of several syndromes as ID are also present in many autism-
spectrum disorders, as well in other major psychiatric disorders such as schizophrenia, bipolar 
disorder, and major depressive disorder. The recent findings revealing a genetic overlap for most of 
these disorders fostered the suggestion that they may constitute part of a unique group of disorders 
affecting the neurodevelopment (Owen, 2012). 
A developmental approach characterizes also the new Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5), and it is particularly evident in the new section dedicated to the 
‘Neurodevelopmental Disorders’ (American Psychiatric Association - APA, 2013), which replaced the 
‘Disorders usually first diagnosed in infancy, childhood, or adolescence’ section of DSM-IV-Text 
Revised (TR) (APA, 2000). In this section the disorders have been organized not taking into 
account necessarily the childhood or adolescence onset; instead, they have been clustered in a 
new meta-structure in consideration of the shared symptoms, shared genetic and environmental risk 
factors, shared neural substrates, common cognitive dysfunctions such as limitation of learning, 
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deficits in executive functions and impairments in communication and social skills. Moreover, the co-
occurrence of these conditions is now accepted.  
It is important to emphasize that this new group of conditions poses a challenge for clinicians and 
researchers, requiring more attention in the differential diagnosis and in the assessment for the 
presence of comorbidities. This is especially important in relation to ID, Autism Spectrum Disorders 
(ASD) and Schizophrenia Spectrum Disorders (SSD), in consideration of the co-occurrence of ASD 
and SSD in individuals with ID (Bertelli et al., 2015). 
In the last five years, the prevalence of autism increased greatly. Currently, the prevalence rate for 
ASD in adults is more than 1/100, whereas it was 0.5/1.000 in the 60s. Obviously, the reasons for such 
increase have posed some questions.   
It is possible that the greater awareness about the condition and the changes in the diagnostic criteria, 
in particular the introduction of a wide autistic spectrum with the DSM-5, may have played a role. 
Methodological differences among studies may provide further explanation (Wing and Potter, 2002; 
Fombonne, 2009; Matson & Kozlowski, 2011). 
Some environmental factors have been suggested to be the cause of such ASD increased prevalence, 
particularly the triple vaccine for measles, mumps and rubella (MMR). However, there is not enough 
evidence to confirm their etiopathogenetic role (Wing & Potter, 2002; Rutter, 2005); conversely, a 
stronger evidence supports the role of complex genetic factors in the emergence of the disorder. 
Findings by family studies (Tarpey et al., 2009; Shoubridge et al., 2010; Noor et al., 2010) showed the 
existence of early markers, and helped to define a broader autism phenotype in respect to the 
conceptualization suggested by Kanner (Kanner, 1973; Ching et al., 2010; Fisch et al., 2011; 
Georgiades et al., 2011). 
Among other factors considered to play a role in the increasing number of ASD diagnoses are the 
growing awareness and knowledge among the public, parents and professional workers, as well the 
development of specialist services (Wing & Potter, 2002; Fombonne, 2009; Matson & Kozlowski, 
2011). Since the 1960s, a growing interest in autism led to the development of parent voluntary 
associations, which demanded educational and treatment services for their offspring and fostered 
research in the area. The intensification of scientific interest in autism is evident in the higher number 
of published epidemiological studies on autism, there were only 23 in 1999, rising to 32 in 2003 
(Fombonne, 2003) and to 53 in 2009 (Fombonne, 2009). 
It is worth noting that in most of the countries where it was documented an increased prevalence of 
ASD it was also noticed a decrease in the number of ID diagnoses (Newschaffer et al., 2007; Baron-
Cohen et al., 2009; Lazoff, 2010). This finding presents some epidemiological, social and economic 
implications. Evidence shows that since the late 1970s, the number of specialized and educational 
institutes for people with Mental Retardation (MR) was gradually reduced whereas that of those 
addressed to the care of children and adults with autistic disorders has increased (Wing, 2001). It has 
been suggested that the greater availability of services can have determined a tendency among 
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professionals to make a diagnosis of autism, rather than another condition, because it allowed 
receiving more adequate support (Matson & Kozlowski, 2011). 
The great variability in ASD prevalence rates across studies has been also associated with the different 
methodologies for collecting data, such as the use of registries, hospital records, reports from 
community outpatient clinics and also retrospective reporting. The differences in such case finding 
and population sampling inevitably affect the prevalence estimates. Not to mention that information 
about age group and the rates of non-response are key elements for interpreting the prevalence rates of 
ASD (Posserud et al., 2010; Sun et al., 2013). 
Finally, the variance in prevalence estimates may be also a consequence of different assessment 
methods and diagnostic instruments used (Groen et al., 2007; Oosterling et al., 2009; Posserud et al., 
2010; Lord, 2011).  
The diagnosis of ASD is challenged by the high rate of comorbidity with ID/IDD (Intellectual 
Developmental Disorder) and SSD, requiring a more accurate assessment in order to disentangle the 
contribution of each disorder to the clinical presentation and the associated mental distress (Bradley & 
Bolton, 2006; Palucka et al., 2008; Bradley et al., 2011a,b). 
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1.2 AUTISM AND AUTISM SPECTRUM DISORDER  
 
1.2.1 DEFINITION AND DIAGNOSTIC CRITERIA: EVOLUTION AND CURRENT STATE  
There are three key features that characterize autism. These are: impaired ability to socialize, (e.g. 
reluctance to make eye-contact, lack of appropriate peer relationships, lack of emotional reciprocity), 
poor communication skills (e.g. delay in verbal responses, poor conversation skills, lack of pretend 
play), and restricted and repetitive behaviours or interests (e.g. repetitive motor movements, 
preoccupation with parts of objects) (Briegel et al., 2009; Matson et al., 2009a,b; Gillberg, 2010; 
Horovitz & Matson, 2010; Leung et al., 2010; Smith & Matson, 2010a,b,c). 
The term autism was coined by Eugen Bleuler to describe a kind of schizophrenia mainly 
characterised by individuals ‘inward turning’ into his/her own world and thereby losing contact with 
the outer world. Bleuler’s overall conceptualisation of schizophrenia is focused on the loss of 
interpretative and relational skills, as summarised in the 4A theory: inappropriate or flattened Affect, 
Ambivalence towards others, loosening of thought Associations, and Autism, which was defined as 
‘social withdrawal’ and ‘preference for living in a fantasy world’ rather than interacting appropriately 
with the social world (Bleuler, 1911; 1950).  
In 1944, Asperger used a similar term ‘Autistischen Psychopathen’, to describe some patients who 
were surprisingly similar to those described by Kanner. Asperger noted three significant differences: 
1) more fluent speech; 2) difficulty in carrying out large movements but not fine movements; 3) a 
different level of learning ability. He called his patients ‘abstract thinkers’, which, according to 
Kanner, have great problems with mechanical learning. Even with important common traits, two 
different clinical forms were determined - Kanner’s autism and Asperger’s syndrome. Subsequently, 
Asperger's syndrome became the term applied to the autistic people with a relatively high IQ 
(Intelligent Quotient; high-functioning autism). 
Lorna Wing, a British psychiatrist born in 1928, the mother of an autistic child and the founder of the 
National Autistic Society in the UK, distinguished three types of social interaction: 
• CONFIDENTIAL: individuals indifferent to other people, detached, characterized by the presence 
of motor stereotypes, good mechanical skills and visual-spatial abilities, and medium-severe 
cognitive impairments (autistic disorder). 
• PASSIVE: autistic disorder with fewer symptoms that are detected later in life. 
• STRANGE: people who are a bit ‘naïve’, but with good cognitive abilities (high-functioning 
autism). 
During the 1950s and 1960s, autism was considered an early manifestation of schizophrenia, which 
was thought of as an emotional disorder caused by pathological parent-child interaction.  
In the first two editions of the DSM, autism was classified under the terms ‘schizophrenic reaction, 
childhood type’ (APA, 1952) and ‘childhood schizophrenia’ (APA, 1968), respectively. 
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During the 1970s, the psychogenic paradigm was abandoned and the scientific community started 
thinking that autism is a biological disorder, and is not caused by cold parents. Autism was also no 
longer considered incompatible with MR. Even in the 1960s children showing several signs of autism, 
co-occurring MR, and childhood psychosis were described. 
In the 1960s and 1980s there was still a clear controversy over the definition of autism between the 
international nosographic systems. The International Classification of Diseases - Ninth Revision, ICD-
9 (WHO, 1980) considered autism a diagnostic subcategory of the childhood schizophrenia. The 
DSM-III (APA, 1980) introduced 6 diagnostic criteria for infantile autism including early onset within 
30 months of age, communication and language disorders, narrow interests and fear of change. For the 
first time the distinction between schizophrenia and autism was emphasized and the definition of 
Pervasive Developmental Disorder (PDD) was introduced. Five disorders comprised this diagnostic 
category and included infantile autism, residual infantile autism, childhood onset pervasive 
developmental disorder, residual childhood onset pervasive developmental disorder, and atypical 
autism. Bringing forward the concept of ‘syndrome’, possible symptoms including the bizarre 
movements, problems of affectivity, abnormal speech, hyper- or hyposensitivity, self-harming 
behaviours, anti-social behaviours, and lack of empathy were mentioned. 
The DSM-III-R (APA, 1987) provided a more complex definition and the diagnosis required that an 
individual had to exhibit at least 8 of these 16 criteria in the three areas of social interaction, 
communication/imagination and interest/activity. The age of onset was revised and shifted to ‘within 
the first 36 months of life’. A new diagnostic category under the term of PDD-Not Otherwise 
Specified (PDD-NOS) was introduced. PDD-NOS was defined by subthreshold symptoms, too mild to 
allow a diagnosis of real autism that should be considered if a child does not meet the diagnostic 
criteria for a specific PDD. Revisions made in the DSM-III-R included changing infantile autism to 
autistic disorder, while childhood onset pervasive developmental disorder and residual infantile autism 
were dropped. 
The DSM-IV (APA, 1994) further refined the diagnostic criteria and increased the number of PDD to  
five: autistic disorder, Asperger’s disorder, Rett’s disorder, childhood disintegrative disorder and 
PDD-NOS. The DSM-IV adds autism to the general chapter ‘global alterations of psychological 
development’ and particularly to ‘generalized developmental disorders’.  
In the DSM-IV-TR (2000) the diagnostic categories and criteria remained consistent from the earlier 
edition.  
According to the revision of the IV edition of DSM (DSM IV-TR) valid until May 2013, the diagnosis of autism 
requires the following criteria:  
A. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one each from (2) and (3): 
(1) qualitative impairment in social interaction, as manifested by at least two of the following: 
a) marked impairments in the use of multiple nonverbal behaviours such as eye-to-eye gaze, facial 
expression, body posture, and gestures to regulate social interaction 
b) failure to develop peer relationships appropriate to developmental level 
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c) a lack of spontaneous seeking to share enjoyment, interests, or achievements with other people, (e.g., by 
a lack of showing, bringing, or pointing out objects of interest)  
d) lack of social or emotional reciprocity  
(2) qualitative impairments in communication as manifested by at least one of the following: 
a. delay in, or total lack of, the development of spoken language (not accompanied by an attempt to 
compensate through alternative modes of communication such as gesture or mime) 
b. in individuals with adequate speech, marked impairment in the ability to initiate or sustain a 
conversation with others 
c. stereotyped and repetitive use of language or idiosyncratic language 
d. lack of varied, spontaneous make-believe play or social imitative play appropriate to developmental 
level 
(3) restricted repetitive and stereotyped patterns of behaviour, interests and activities, as manifested by at least 
two of the following: 
a. encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is 
abnormal either in intensity or focus 
b. apparently inflexible adherence to specific, non-functional routines or rituals 
c. stereotyped and repetitive motor mannerisms (e.g. hand or finger flapping or twisting, or complex 
whole-body movements) 
d. persistent preoccupation with parts of objects 
B. Delays or abnormal functioning in at least one of the following areas, with onset prior to age 3 years: 
(1) social interaction 
(2) language as used in social communication 
(3) symbolic or imaginative play 
C. The disturbance is not better accounted for by Rett’s Disorder or Childhood Disintegrative Disorder. 
Given the extreme variability in autistic symptoms, which has been widely described by clinicians and 
researchers during the past 15 years, the authors of the DSM-5 substantially revised the concept of 
autism and PDD. The DSM-5 combined four previously separate disorders into a single condition 
under the heading of ASD with different levels of symptom severity. The previous DSM-IV autistic 
disorder, Asperger’s disorder, childhood disintegrative disorder, and PDD-NOS (atypical autism) are 
not recognized anymore as single nosological entities, while the Rett’s disorder became an 
independent disorder, with a specific genetic etiopathogenesis. The diagnosis of ASD requires two 
core symptoms: a) deficits in social communication and social interaction and b) restricted repetitive 
behaviours, interests, and activities (Achkova & Manolova, 2014).  
The chronological criterion for the onset of symptoms has been widely modified from 36 months to 
‘early childhood’, with the possibility of other ages of onset in the situations in which deficits may not 
become fully manifest until social communication demands exceed limited capacities. 
Some researchers have criticized the DSM-IV-TR and DSM-5 approach, considering responsible for 
both the widening of diagnostic criteria and the progressive increase in prevalence rates of autism 
spectrum conditions (Wing et al., 2011). 
According to DSM-5 the ASD diagnostic criteria include: 
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A. Persistent deficits in social communication and social interaction across multiple contexts, as 
manifested by the following, currently or by history: 
1. Deficits in social-emotional reciprocity, ranging, for example, from abnormal social approach and 
failure of normal back-and-forth conversation; to reduced sharing of interests, emotions, or affect; to 
failure to initiate or respond to social interactions. 
2. Deficits in nonverbal communicative behaviours used for social interaction, ranging, for example, from 
poorly integrated verbal and nonverbal communication; to abnormalities in eye contact and body 
language or deficits in understanding and use of gestures; to a total lack of facial expressions and 
nonverbal communication. 
3. Deficits in developing, maintaining, and understand relationships, ranging, for example, from 
difficulties adjusting behaviour to suit various social contexts; to difficulties in sharing imaginative play 
or in making friends; to absence of interest in peers. 
B. Restricted, repetitive patterns of behaviour, interests, or activities, as manifested by at least two of the 
following, currently or by history: 
1. Stereotyped or repetitive motor movements, use of objects, or speech (e.g., simple motor stereotypes, 
lining up toys or flipping objects, echolalia, idiosyncratic phrases). 
2. Insistence on sameness, inflexible adherence to routines, or ritualized patterns of verbal or nonverbal 
behaviour (e.g., extreme distress at small changes, difficulties with transitions, rigid thinking patterns, 
greeting rituals). 
3. Highly restricted, fixated interests that are abnormal in intensity or focus  
4. Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment (e.g. 
apparent indifference to pain/temperature, adverse response to specific sounds or textures, excessive 
smelling or touching of objects, visual fascination with lights). 
C. Symptoms must be present in the early developmental period (but may not become fully manifest until 
social demands exceed limited capacities, or may be masked by learned strategies in later life). 
The DSM-5 defines three levels of severity based on the adaptive functioning: 
• Level 1: Requiring support  
• Level 2: Requiring substantial support  
• Level 3: Requiring very substantial support 
The disorder has been placed in a meta-syndromic or meta-structural grouping named 
‘Neurodevelopmental Disorders’ which includes: 
• Autism Spectrum Disorder 
• Intellectual Disability (Intellectual Developmental Disorder)  
• Communication disorders 
• Attention-Deficit/Hyperactivity Disorder 
• Specific Learning Disorder 
• Motor Disorders 
The neurodevelopmental disorders comprehend conditions with onset in childhood, typically early, 
often prior to entry to school, and are characterized by developmental deficits which produce 
impairments of the personal, social, academic, or occupational functioning. The range of 
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developmental deficits varies from very specific limitations in learning and executive functions to the 
global impairment of social skills or intelligence. The neurodevelopmental disorders frequently co-
occur together; for example people with autism often have ID.  
However, the debate on the final drafting of the autism core symptoms is still in vigour. Some authors 
suggest centring the diagnosis on repetitive behaviour and stereotypes, while others on sensorial 
sensitivity (Billstedt et al., 2007; Leekam et al., 2007; Happé & Ronald, 2008). 
 
1.2.2 EPIDEMIOLOGY 
In the last decade the prevalence of autism has increased considerably. In the 1960s the highest 
reported rate was 0.5/1.000, whereas it currently stands at 1–2/1.000 (Newschaffer et al., 2007). Also 
the recorded prevalence of ASD has increased dramatically and they are now considered the most 
common disorders in childhood, with a rate of 6/1.000 (Newschaffer et al., 2007; Fombonne, 2009). A 
2009 American report (Boseley, 2009) based on the 2007 Adult Psychiatric Morbidity Survey by the 
National Health Service in the UK, estimated that the prevalence of ASD in adults was approximately 
1/100 (Brugha et al., 2011). A recent study (2011) conducted by Kim and colleagues at the University 
of Yale found that about 2.64% of South Korean children are affected by autism.  
The age of onset traditionally occurs early in the first years of life (Ozonoff et al., 2008). The male-to-
female sex ratio is approximately 3-4/1 (Newschaffer et al., 2007).  
 
1.3.3 ETIOPATHOGENESIS 
Definitive etiopathogenetic mechanisms of ASD have not yet been identified. Currently the 
international scientific community is inclined to consider a complexity of different causal elements 
including both environmental and biological factors, especially genetic ones. Their combination may 
induce structural and functional defects of the Central Nervous System (CNS) in the first years of life 
and may produce the characteristic phenotype of autism. The current theories suggest that autism 
disorder resulted from the disruption of normal brain development with subsequent effects on cerebral 
functioning related to the specific symptoms of ASD (Watts, 2008).  
 
Genetic factors 
Genetic mutations appear to be a major cause of autism. More than one gene may be implicated and 
several candidate genes have been located. Submicroscopic chromosomal abnormalities have been 
identified in almost 1/5 of cases (Shen et al., 2010; Schaaf & Zoghbi, 2011; Silver & Rapin, 2012), 
whereas ASD-linked mutations of many candidate genes have been identified. The heritability of 
autism showed that 82-92% of monozygotic and 1-10% of dizygotic twins develop ASD (Persico & 
Bourgeron, 2006). Furthermore, autistic symptoms are usually observed in many genetic syndromes, 
such as fragile X, tuberous sclerosis, phenylketonuria and congenital rubella (Freitag, 2006; Betancour 
et al., 2009). 
 9 
Among the genes associated with autism risk, many code for proteins involved in regulating proper 
synaptic connectivity and brain functioning (Folstein & Rosen-Sheidley, 2001; Persico & Bourgeron, 
2006).  
Recent methodological advances of human genetics increased knowledge on the biological processes 
of ontogenesis and allowed the discovery of new DNA variants in ASD including the Copy Number 
Variations (CNVs) (Marshall & Scherer, 2012). CNVs are defined by a polymorphism from 
spontaneous deletions to duplications involving one or more DNA nucleotide. In the last years many 
studies found robust association between CNVs and ASD, mediated by specific structural and 
functional alterations of the CNS (Watts, 2008).  
In 2004, to provide a better description of the ASD risk-associated genes, the Autism Genome Project 
(AGP) was launched. AGP is the world's largest research project on DNA mapping and included 
analysis of DNA samples from approximately 1.200 families. The AGP discovered the involvement of 
chromosome 11 in the pathogenesis of autism, along with the gene coding for the Neurexin 1 
(NRXN1), a protein involved in synapse formation and synaptic transmission. Also dysfunction of the 
Neuroligin (NLGN), a cell adhesion protein on the postsynaptic membrane that mediates the 
formation and maintenance of synapses, was implicated in ASD. Mutations of the NRXN1 and NLGN 
genes have been also associated with schizophrenia, and ID (Szatmari et al., 2007; Südhof, 2008).  
Additionally, one of the most studied genes was SHANK3 (SH3 and multiple ankyrin repeat domains 
3) located on chromosome 22 and coding for the protein with the same name, also known as ProSAP2 
(Proline-rich synapse-associated protein 2), which is involved in synapses formation and in dendritic 
spines maturation as well as in the connection of various neurotransmitters receptors, ionic channels 
and other membrane proteins to the actin cytoskeleton (Durand et al., 2012). 
 
Epigenetic mechanisms  
Although increased evidences indicate genetic factors as the main cause of autism, this does not seem 
to explain all the current etiopathogenetic instances. In fact, epigenetic mechanisms that alter gene 
expression and phenotype without changing the DNA sequences, seem play a key role in the 
etiopathogenetic mechanisms of ASD.  
DNA methylation is the most widely studied, and also environmental toxins exposures are known to 
influence epigenetic modifications prenatally and throughout life (LaSalle, 2011; Zhubi et al., 2014; 
Loke et al., 2015). 
Interestingly, Rett syndrome is an X-linked disorder characterized by ID, inability to perform motor 
functions and autistic-like behaviours. This syndrome seems to be caused by an epigenetic alteration 
in the gene encoding methyl-CpG binding protein 2 (MECP2), which binds to methylated regions and 
activates the deacetylation of histones, inducing DNA inactivation. Decreased MECP2 levels have 
also been found in the cerebral cortex of people with ASD (Woods et al., 2012). 
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Biological and environmental factors 
Environmental factors have been considered to contribute to autism or exacerbate its symptoms. 
Infections such as congenital rubella syndrome or cytomegalovirus may occur during pregnancy and 
increase the risk of autism (Libbey et al., 2005). The possible contribution of allergic or mother's 
immune response during the pregnancy was supported by findings of maternal antibodies reactive to 
foetal brain proteins, which also seems to indicate their ability to pass through the blood-brain barrier 
and affect the development of brain.  
Toxic substances, which act through their teratogen potential and cause birth defect, include 
pesticides, phthalates, alcohol and some drugs, such as terbutaline, thalidomide, misoprostol, and 
valproic acid (Gardener et al., 2009). Toxic metals such as antimony, arsenic, cadmium, chromium, 
lead, mercury, manganese, nickel, styrene, trichloroethylene, methylene chloride, vinyl chloride and 
particulate of diesel are associated with ASD. Also the prenatal exposure to high air pollution 
containing many toxins impact negatively on the neurological function seems doubles the chance of 
developing ASD (Roberts et al., 2013).  
Scientists have spent years debating whether the use of common antidepressants during pregnancy 
could increase the risk of ASD. Boukhris et al., (2015) has recently published several reports 
suggesting that suggests that maternal exposure to selective serotonin reuptake inhibitors during 
pregnancy is associated with an increased risk of autism, but this causal relationship does not seem 
supported by clear evidence (Croen et al., 2011; Antrade, 2014; El Marroun et al., 2014; Kepser & 
Homberg, 2014; Jones & McDonald, 2014; O’Dowd, 2014; Suri et al., 2014). 
On the contrary, metabolic problems that affect mothers during pregnancy, especially type 2 diabetes, 
was significantly associated with an increased risk of ASD. Also maternal obesity during pregnancy 
may also increase the risk of autism, although further study is needed (Krakowiak et al., 2012; Li et 
al., 2015).  
It has been hypothesized that high levels of amniotic testosterone could play a role in ASD. Prenatal 
testosterone levels seem to play an important role in brain development by influencing communication 
skills and empathy and emphasizing masculine characteristics (Auyeung et al., 2009; 2010). 
Autism is associated with some perinatal and obstetric conditions including low birth weight, 
abnormal gestation length and hypoxic-ischaemic insult at birth (Kolevzon, 2007).  
Furthermore a broad variety of postnatal contributors to autism have been proposed, including: 
autoimmune diseases (Ashwood & van de Water, 2004), leaky gut syndrome (Johnson, 2006), 
amygdala developmental failure (Schultz, 2005), vitamin D deficiency (Cannell, 2007), and heavy 
metal toxicity (Davidson et al. 2004). For the majority of those risk factors, there is no definitive 
evidence of a causal or co-causal role in the development of ASD. 
Some researches indicate that oxidative stress may cause autism in individuals who are genetically 
predisposed (Kern & Jones, 2006). One theory is that stress increase the secretion of Corticotrophin-
Releasing Hormone (CRH) which stimulate mast cells to release cytokines, increasing the blood-brain 
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barrier permeability and damaging the functional and structural integrity of Purkinje cells in the 
cerebellum (Chauhan & Chauhan, 2006). 
Recently, food substances containing gluten and casein have been implicated in ASD, but their 
pathogenic mechanism of brain damage has not yet been clarified (Mari-Bauset et al., 2014).  
Among these factors, childhood vaccinations, especially the Measles-Mumps-Rubella (MMR) 
vaccine, and the subsequent development of autism vaccines, have attracted considerable attention. 
First Andrew Wakefield, a British physician known for his fraudulent 1998 paper, suggested that 
MMR antibodies were significantly higher in the gut of autistic children, but this association was 
never backed up by extensive evidence based on a large sample of observations (Wilson et al., 2003; 
Chen et al., 2004; Afzal et al., 2006; Taylor et al., 2014). 
In 2013, Prof. Frank DeStefano and colleagues from the U.S.A. CDC (Centers for Disease Control and 
Prevention) conducted a study on over 1.000 children with and without autism. This study did not 
found any link between ASD and the antigens contained in the vaccine, which determine the 
activation of the immune system. 
Also the exposure to heavy metals was also suspected of increasing the risk of ASD. In particular the 
hypothesis involved the use of the mercury-based compound thiomersal, a childhood vaccinations 
preservative. There was an enormous debate, but once again, large-scale research showed that children 
vaccinated with products with and without mercury have the same risk of ASD occurrence. The 
stronger evidence is that the autism rate has remained unchanged since the 2002 when the thiomersal 
was completely removed from paediatrics vaccines (Roberts & Harford, 2002; Stratton, 2012). 
 
Neuroanatomical abnormalities and neurotransmitters system 
Functional Magnetic Resonance Imaging (fMRI) allows researchers to observe directly brain activities 
while subjects perform various perceptual, and cognitive tasks. Brain-imaging techniques like fMRI 
have shown altered functional patterns in several domains of thinking, such as social, cognitive, 
linguistic, and visuospatial processing in children and adults with ASD (Maximo et al., 2014). Autism 
appears to result from developmental factors that affect many or all functional brain systems. Today a 
very plausible hypothesis suggests that disrupted connectivity should be seen as part of the primary 
pathogenesis of ASD. Evidence showed both of local over-connectivity and of long-distance under-
connectivity that appear more severe in later-developing cortical regions (Minshew & Keller, 2010; 
Muller et al., 2011). The disconnection of the neural circuits could lead to deficits in complex 
information processing and integration (Mizuno et al., 2006; Turner et al., 2006; Courchesne et al., 
2001, 2007; Geschwind & Levitt, 2007; Noonan et al., 2009). Disconnection of the nervous structures 
would be realized at the level of histogenetic processes passing through the period of brain 
development which begins in the uterus and extends into childhood that include neurogenesis, 
neuronal migration, dendritic development, synaptogenesis, synaptic pruning and dendritic plasticity 
and myelination. Some researches reported an overall brain enlargement, while others suggested 
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abnormalities in several areas, including the frontal lobe, limbic system, temporal lobe, and corpus 
callosum (Stanfield et al., 2008; Lefebvre et al., 2015). It is probable that each of these 
neurodevelopmental processes may be involved in the disconnection mechanisms, which could extend 
to communications between cortical and subcortical areas and result in a considerable heterogeneity of 
ASD phenotypes.  
Many neuroanatomical studies focused on the cerebral structures and neural circuits crucial for the 
ASD symptoms: 
1) difficulty in social interactions has been related to dysfunctions in the orbitofrontal cortex, anterior 
cingulate cortex, fusiform gyrus, superior temporal sulcus, amygdala, mirror neurons, inferior frontal 
gyrus and posterior parietal cortex; 
2) deficits in language development and communication skills have been related to the dysfunction of 
the inferior frontal gyrus - Broca's area, superior temporal sulcus, supplementary motor area, basal 
ganglia, thalamus, and cerebellum pontine nuclei; 
3) repetitive behaviours, ritualized and restricted range of interests have been related to dysfunction of 
the orbitofrontal cortex, anterior cingulate cortex, basal ganglia, and thalamus. 
However, contradictory information was recorded on the total volume content. Studies observed 
increased (Minshew et al, 2005) or decreased total size, as well as smaller posterior subregions of the 
corpus callosum (Courchesne et al., 1993; Stanfield et al., 2008; Hardan et al., 2009). Other researches 
found microstructural abnormalities mainly concerning a reduction of Purkinje cells of the cerebellum 
(Bauman & Kemper, 2005). The cerebellum in the past was considered to be involved exclusively in 
motor function, while today it has been associated with broader functions including cognition and 
emotional regulation.  
The amygdala is involved in many significant processes of social cognition. Increased, reduced or 
normal amygdala volume has been described (Howard et al., 2000; Eigisti & Shapiro, 2003; 
Schumann et al., 2004; Stanfield et al., 2008).  
Despite the importance of communication and language deficits in autistic individuals, there are many 
studies that examined the neuroanatomical areas that perform these functions. The areas of language 
include: Broca’s area in the inferior frontal gyrus implicated in expressive language, Wernicke’s area 
in the temporal-parietal region implicated in receptive language and the superior temporal sulcus 
which play a role in both the processing of language and social attention. Lesions to the language 
centre resulted primarily in alterations of the normal pattern of asymmetry (De Fossé et al., 2004; 
Rojas et al., 2005; Redcay, 2008).  
Investigations into other brain regions that may be involved in autism are limited. Abnormalities of the 
thalamus (Hardan et al., 2006), hippocampus (Schumann et al., 2004; Nicolson et al., 2006; Dager et 
al., 2007), and basal ganglia (Hardan et al., 2003; Hollander et al., 2005) were found. In particular, 
studies highlighted that repetitive and ritualistic behaviours were associated with larger increases in 
caudate volume (Hollander et al., 2005). 
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Recent evidences provide a better understand of neurotransmitter mechanisms regulating social 
behaviour. Oxytocin and vasopressin neuropeptides play an important role in social cognition, 
affecting individual differences in social recognition, and parenting or affiliative behaviours. The 
processes of social cognition are also supported by reward circuitry, underpinned by the activation of 
the brain dopaminergic system. Reward processes play a role in the development of social skills, 
parenting and pairing, and also influence social interactions, which require trust or altruism. The effect 
of emotional regulation upon social behaviour is also mediated by norepinephrine and serotonin 
systems (Skuse & Gallagher, 2011).  
 
Electrocortical alterations 
Some neurophysiological investigations on individuals with ASD reported abnormal frequency range 
(30-80 Hz) in neuronal synchronizations related to alterations in sensory and cognitive functioning, 
especially in working memory and perceptual binding (Saunders et al., 2012).  
Networks of GABAergic interneurons are implicated in synchronizing cortical activity, and seem to 
play a fundamental role in cognitive functions, such as attention and sensory processing (Rubenstein 
& Merzenich, 2003; Endele et al., 2010). 
Imbalance between excitation, inhibition and increased excitatory-inhibitory (E-I) ratio is a common 
mechanism in ASD, which is responsible for learning and memory as well as cognitive, sensory and 
motor deficits, and seizures occurring in these disorders. E-I imbalance in ASD is due primarily to 
abnormal glutamatergic and GABAergic neurotransmission in key brain regions such as the neocortex, 
hippocampus, amygdala, and cerebellum (Uzunova et al., 2015).  
 
Mirror neurons 
It has also been proposed that deficiency of the mirror neuron system may underlie cognitive disorders 
in individuals with autism. Mirror neurons were first discovered by Giacomo Rizzolatti and his 
colleagues at the Department of Neuroscience of the University of Parma (Rizzolatti et al., 1996). 
Using electrodes implanted in the pre-motor cortex of the macaque monkey, the researchers observed 
that some groups of neurons were activated not only when animals were intent on certain actions, but 
also when watching someone else perform the same actions. Subsequent studies, carried out with non-
invasive techniques, demonstrated the existence of similar system in humans. Various areas in the 
brain contain mirror neurons such as those of language, and provide a physiological explanation of our 
ability to position ourselves in relation to others. When we observe another perform an action, our 
brain activates the same neurons that come into play when we perform that action, or alternatively the 
same neurons that came into play when we undertook similar actions in the past. In fact, it seems that 
the mirror system comes into action only when the subject observes a behaviour that he himself has 
previously performed. Even the recognition of emotions seems related to a group of neural circuits in 
which the same mirror feature was observed. Experimental studies on primary emotions show that 
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when one observes others' facial expressions of disgust or pain the same neural substrate connected to 
the first perception is activated. Furthermore, clinical trials confirm that the loss of ability to feel 
emotions caused by neurological damages may lead also to lose the ability to recognize and interpret 
another person's emotions. 
The discovery of mirror neurons may provide a biological explanation for at least some forms of 
autism, such as Asperger’s syndrome. In fact, experiments seem to indicate decreased functioning of 
these neurons in autistic children. Although this is just a hypothesis, it may help to understand why 
autistic people do not participate in the life of others, can not empathize with the world around them, 
and do not understand the meaning of the gestures or actions of others (Gallese & Goldman, 1998). 
 
Theory of mind 
Uta Frith and Simon Baron-Cohen identified a deficit in the Theory of Mind (ToM) as the base of the 
difficulties of people with ASD to interact with others and with the outside world. Baron-Cohen 
described the ToM as the ability to infer a complete range of mental states including beliefs, desires, 
intentions, imagination, emotions, etc. from observable behaviour. To have a theory of mind means to 
be able to attribute intentional (desires) or epistemic (beliefs) mental states to oneself and to others, 
and to predict the behaviour of oneself or others on the basis of individual ‘internal’ mental states 
which determine those behaviours (Baron-Cohen, 1991). 
The concept of theory of mind is closely related to the more general concept of metacognition. The 
ToM would be a specific aspect of a broader range of metacognitive skills acquired during ontogenetic 
development. Metacognition refers to a set of skills which makes it possible to recognize and attribute 
mental states to others starting with facial expressions, somatic states, behaviours and actions. 
Metacognition also makes it possible to estimate mental states and to use the resulting information to 
make decisions, to solve problems, and to master subjective suffering (Semerari et al., 2012).  
Deficits in metacognitive capacity were associated with damage to the prefrontal cortex, superior 
temporal sulcus, front part of the temporal lobes and amygdala. 
Some phenomenologists and psychopathologists have recently expressed many doubts that the ToM 
plays a causal role in ASD, and more generally in the processes of social cognition. Studies have 
found that many people with ASD and psychotic disorders consciously observe and imitate the 
behaviours of others. According to these researchers the process of the perception of others would be 
conscious, finalized, and would not require any theory or simulation. For people with ASD the 
practice of explicit mind-reading seems to be a compensatory strategy which ultimately fails, and may 
even exacerbate their deficit of intuitive and interactive social understanding. A lack of embodiment 
interaction represents a valid alternative (Froese et al., 2013a,b; Gallagher & Varga, 2015). 
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1.2.4 PROBLEMS ASSOCIATED WITH AUTISM AND AUTISM SPECTRUM DISORDER 
ASD is associated with a complex physical and especially psychic vulnerability based on biological, 
psychological and environmental factors. 
Several studies have found abnormal sensitivity to sensory stimulation in 90% of children (Leekam et 
al., 2007) and in more than 95% of adults with ASD (Billstedt et al., 2007). Therefore some authors 
suggest that sensory processing problems are more frequent than social interaction difficulties (Baum 
et al., 2015). 
 
Problem behaviours 
Problem behaviours (PBs or Challenging Behaviours) are common in people with ASD, with a 
prevalence of 44% (Mattila et al., 2010) which can reach up to 85% in ASD plus ID (McCarthy et al., 
2010). 
The expression Challenging Behaviour, used for the first time by Emerson in 1995, refers to some 
abnormal behaviour of a culturally intensity, frequency, and duration as to endanger the physical 
safety of the person himself and of others, or behaviours that severely limit or prevent access to 
ordinary services in the community. The term encompasses a series of negative behaviours with 
respect to the relationship between the individual agent and the surrounding environment. Common 
types of challenging behaviour include physical and verbal aggressiveness self-directed or directed to 
other people or objects, oppositional, provocative or impulsive behaviour, escapism, and screams. 
These behaviours often develop in childhood and persist over time. Frequently the same individual 
may show multiple forms of challenging behaviour. PBs vary in intensity and frequency and are 
evaluated for quality (e.g. seriousness of the consequences) and quantity (e.g. the number of times per 
week and/or the number of times per hour). 
Hyper-activity, aggression, self-injurious behaviour, irritability, and tendency to moodiness (Emerson 
et al., 2001a) are often observed in people with ASD. Challenging behaviour may also simply be a 
means of communication and occur most likely in individuals with communication impairment 
(McClean & Grey, 2007; Sigafoos, 2000). Research found a relationship between PBs, such as 
aggression, tantrums, destruction of property, and severity of communication deficit and socialization 
problems (Matson, 2009).  
The majority of PBs have a complex multifactorial aetiology including biological, psychological, 
social and developmental factors. Challenging behaviours can occur as symptoms of other psychiatric 
disorders or physical diseases, but no one particular behaviour can be associated with one specific 
disorder. 
In people with ASD the most frequent causes of PBs are:  
• confusion and fear produced by unusual situations or events 
• interference with routine or repetitive activities 
• inability to understand instructions or explanations 
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• lack of knowledge on how to behave in a way that is appropriate to the context 
• inability to communicate needs and emotions 
• sensorial hyperesthesia 
• specific phobias of situations or objects 
• stress related to the performance of tasks that are too difficult 
Determining whether PBs are the result of organic conditions, co-occurrent psychiatric disorders, 
environmental influences, or a combination of these, is difficult. Thus the assessments procedure 
should examine all risk factors, to assess appropriate treatment options and to provide support (Matson 
et al., 2011). 
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1.3 INTELLECTUAL DISABILITY (INTELLECTUAL DEVELOPMENTAL DISORDER) 
 
1.3.1 DEFINITION AND DIAGNOSTIC CRITERIA: EVOLUTION AND CURRENT STATE 
ID has a long history within the taxonomy of mental disorders and its conceptualization has always 
been controversial. In fact, ID is a complex condition, quite hard to define, that include impairments of 
intelligence, learning, adaptive behaviours, and abilities. ID also occurs early in life and tends to 
persist for the whole of a person's life. 
ID may be considered not as a disease but as a metasyndromic group of health conditions 
characterized by deficit in cognitive functioning prior to the acquisition of abilities through learning 
(Salvador-Carulla & Bertelli, 2008). The severity of impairment is characterized by significant ability 
restrictions or limitations in more activities and interferes with the individual normal functioning. 
Deficits in intellectual functioning tend to remain stable (APA, 2000); while improvements in adaptive 
behaviour can occur in which cases the diagnosis of ID may no longer be appropriate (APA, 2013). 
Diagnostic classification of ID is complex but appropriate clinical assessments contribute for the 
estimation of prevalence, health service provision, intervention, and outcomes. 
Before the early nineteenth century, societies differed in how or whether they conceptualized ID. Over 
the past 200 years, the terms used for this condition have included idiocy, deficiency, oligophrenia, 
mental deficiency, mental handicap, mental subnormality etc. Only recently, older terms such as 
mental retardation has been gradually replaced by intellectual disability in an attempt to get away 
from negative connotations and stigma. The words MR refer to an outdate belief in a general 
deterioration of mental functions, while ID describes a significantly reduced ability to achieve certain 
targets. The word ID refers to intelligence and in particular to a deficit of logical-deductive process 
with a reduced ability to learn new skills. 
The term MR is still used by the World Health Organization in the ICD-10 (WHO, 1992) codes, while 
the APA introduced the term ID although only in the most recent editions of the DSM. 
This ambiguity is also summarized by the position of MR in the different editions of the DSM. Firstly 
both the DSM I (1952) and II (1968) included MR in a section separately from other diagnoses. The 
DSM III (1980) incorporated MR in Axis I disorders with onset usually occurring in childhood and 
adolescence. Then the DSM III-R (1987) and DSM IV (1994) moved RM on Axis II along with the 
personality disorders and PDD, or just with personality disorders, respectively. 
By contrast, the American Association for Intellectual and Developmental Disorders (AAIDD) 
explicitly defines ID as a ‘disability’ and not as a ‘health condition’. Based on the disability 
perspective, the AAIDD focuses mainly on functioning, adaptive behaviour, and support needs 
consistent with the model proposed by the ICF. The 11th edition of the AAIDD classification manual 
was published in 2010 (Schalock et al., 2010). 
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In the major international diagnostic manuals (DSM-IV-TR and ICD-10), the key feature of MR is a 
general intellectual functioning which is significantly below average (criterion A) and which is 
accompanied by significant limitations in adaptive functioning in at least two of the following 
performance capabilities: communication, personal care, family life, social/interpersonal abilities, use 
of community resources, self-determination, scholastic skills, work, leisure, health, and safety 
(Criterion B). Onset must occur before the age of 18 years (Criterion C). 
The IQ defines general intellectual functioning or equivalent, obtained by assessment with one or 
more of the standardized, individually administered intelligence tests (e.g. The Wechsler Intelligence 
Scale (WAIS), Stanford–Binet Intelligence Scale, or the Kaufman Brief Intelligence Test). 
Significantly subaverage general intellectual functioning is defined by the APA (2000) as an IQ of 
approximately 70 or below (approximately 2 standard deviations below the mean). 
• Mild mental retardation: IQ level 50-55 to approximately 70 
• Moderate mental retardation: IQ level 35-40 to 50-55 
• Severe mental retardation: IQ level 20-25 to 35-40 
• Profound mental retardation: IQ level below 20 or 25. 
Borderline Intellectual Functioning (BIF) is a mild cognitive developmental condition distinguished 
from ID by less extensive and severe cognitive impairments. BIF is defined as IQ between one and 
two standard deviations from the population IQ mean that is diagnosed by IQ test score of 70-85. BIF 
was included in the DSM-IV but omitted from DSM-IV-TR and DSM-5; neither it is included in ICD 
10, and ICF (Hassiotis, 2015). 
The words mental retardation, still available in major international diagnostic manuals, refer to an 
outdate belief in a general deterioration of mental functions, while intellectual disability describes a 
significantly reduced ability to achieve certain targets. The word ID refers to intelligence and in 
particular to a deficit of logical-deductive reasoning and reduced ability to learn new skills. 
In the DSM-5 (2013) the term MR was officially replaced by ID (Intellectual Developmental 
Disorder). The term ‘intellectual disability’ corresponds to the term ‘intellectual development 
disorders’, which has been adopted in the ICD-11 draft. To emphasize an increasing convergence 
between the two classificatory systems this second term has been reported in brackets in the title of the 
chapter of the DSM-5.  
The new terms adopted by the DSM-5 refer to a disorder with onset in childhood, which includes 
intellectual and adaptive deficits in the areas of conceptualization, socialization, and practical skills.  
In order to make a diagnosis according to DSM-5, the following 3 criteria must be satisfied: 
A. Deficit of intellectual functions, such as reasoning, problem solving, planning, abstract thinking, 
judgment, academic learning or learning from experience, and confirmed by both individual clinical assessment 
and standardized intelligence testing. 
B. Deficits in adaptive functioning that failure to meet developmental and socio-cultural standards for 
personal independence and social responsibility. Without ongoing support, the adaptive deficits limit functioning 
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in one or more activities of daily life, such as communication, social participation, and independent living, across 
multiple environments, such as home, school, work, and community. 
C. Onset of intellectual and adaptive deficits during the developmental period. 
Although ID/IDD is usually a stable diagnosis, there can be significant variability in cognitive functioning and 
abilities across different clinical severity levels throughout the life cycle. Therefore, ID is considered a dynamic 
health condition, and it should be reassessed at key developmental stages, life transitions (e.g. at school entry 
age, puberty and early and later adulthood), and in case of traumatic events or other life events.  
In the DSM-5, the specific age limit of 18 years of age was considered arbitrary. While ID does not 
require a specific age, individual’s symptoms must begin during the developmental period and are 
diagnosed based on the severity of impairments in adaptive functioning (APA, 2013).  
The subaverage general intellectual functioning (Criterion A) is defined by an IQ score of 
approximately two standard deviations or more below the population mean. When extremely low 
(under 60) IQ measures are no longer valid.  
Therefore, the DSM-5 continues to distinguish four levels of severity (mild, moderate, severe, and 
very serious), but with different criteria from the DSM-IV and IV-TR. The range of deficits extends 
from very specific limitations of learning and control of executive functions to a global impairment of 
social skills or intelligence. 
A recent literature mapping indicates that in People with ID (PwID) the same IQ score may be 
associated with different cognitive profiles, which are also based on the underlying etiopathogenetic 
factors (Bertelli et al., 2014). For example, persons with Down’s syndrome usually manifest 
impairments in specific areas of language, long-term memory and motor performance while showing 
relative strengths in visuospatial construction (Edgin et al., 2010). 
The term adaptive behaviour refers to the individual’s ability to cope with and meet environmental 
demands for personal independence and responsibility (APA, 2013) according to the expectations of 
their chronological age and cultural group (Schalock et al., 2010).  
The DSM-5 defines the severity levels on the basis of adaptive functioning and not on IQ scores 
because it is the adaptive functioning in the areas of conceptualization, socialization, and practical 
skills that determine the level of support required to maintain an acceptable condition of life.  
Measurable indicators of adaptive functioning include the following:  
• Conceptual skills: language, reading and writing, using money, understanding and using concepts such 
as time, numbers or measures, and problem solving. 
• Social skills: creating and maintaining mutually satisfying social relationships, interactions with others, 
social engagement and participation, emotional competence, social problem solving, self-direction, 
responsibility, gullibility and naïveté, and self-esteem.  
• Practical skills: instrumental and basic activities of daily living, work/vocational skills, domestic skills, 
and personal hygiene. 
The debate on ID classification could have serious implications. Diagnostic categories are used 
throughout the world to specify which people are eligible for what health care, educational and social 
services. Therefore the location of ID as disability or health conditions would impact on health 
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statistics, health policy, and on the services available to this vulnerable population (Salvador-Carulla 
et al., 2011). 
 
1.3.2 EPIDEMIOLOGY 
The prevalence of ID is estimated between 1 and 3%, and the incidence is estimated to be around 
1.8% (Heikura et al., 2003; Harris, 2006). In developed countries like Finland or the Netherlands, the 
prevalence of ID is currently less than 1%, while it may rise to 4–5% in more deprived regions of the 
world (Durkin, 2002) and can reach up to 6% in some countries in Eastern Europe. Among the four 
different severity degrees, 85% have mild ID, 10% moderate, 4% severe, and 2% profound (King et 
al., 2009).  
Mild ID is present in 80 to 85% of the world’s population (Schalock et al., 2010), that could explain 
why many person with ID are not identified until they reach school age and start having difficulties 
acquiring and learning new skills.  
The prevalence of BIF is estimated between 12.3%; Hassiotis et al. (2008) found that on a sample of 
8.450 adults living as part of a family in UK, approximately one-eighth had BIF. 
The prevalence of ID is higher in males than female in both adults, and children/adolescents. Among 
adults the male-to-female ratio varied between 0.7 and 0.9 (Maulik et al., 2011).  
The lack of adequate and consistent epidemiological data was one of the main reasons for the 
exclusion of the last study conducted by the World Health Organization and the World Bank Burden 
of Disease. One consequence is that ID still occupies an important position among the ‘hidden 
problems’ of global health. Another consequence is that the gap between the offering of health 
services and the unmet needs of intellectually-disabled people has become incalculable (WHO, 2007).   
 
1.3.3 ETIOPATHOGENESIS 
IDs are a heterogeneous group caused by a different combination of specific causative factors, both 
genetic and environmental (Bertelli & Kishore, 2014). The cause is unknown for up to 60% of cases 
(Rauch et al., 2006). 
 
Prenatal causes 
 
Genetic factors 
A proportion of cases ranging from 17% to 50% are caused by a genetic disorder (Moeschler & 
Shevell, 2006; Rauch et al., 2006; Tzschach & Ropers, 2007; Kaufman et al., 2010), while non-
syndromic ID account for 30-50% of cases (Daily et al., 2000; Gonzáles et al., 2013). 
Conventionally, genetic forms of MR are divided into two major categories: syndromic MR 
characterized by associated clinical, radiological, metabolic or biological features, and non-syndromic 
forms in which cognitive impairment represents the only manifestation of the disease. Although this 
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distinction remains useful for clinical approach, recent studies and detailed clinical follow-up 
indicated that distinctions between syndromic and non-syndromic MR are disappearing, and some of 
the latter could be recognized as syndromic forms (Chelly & Mandel, 2001; Frints, et al 2002; Ropers 
& Hamel, 2005). 
Detailed analyses of database and literature searches reveals more than a thousand of genes can cause 
MR. Furthermore, more than 290 genes are involved in clinical phenotypes, metabolic, and 
neurological disorders associated with MR (Kahler & Fahey, 2003; Chelly et al., 2006; Levy, 2009). 
Trisomy 21 is the chromosome abnormality responsible for over 95% of Down's syndrome, which is 
the best-known genetic cause of MR (Patterson & Costa, 2005; Rauch et al., 2006).  
The most prevalent genetic conditions include Fragile X syndrome (Leonard & Wen, 2002), Turner 
syndrome, Klinefelter's syndrome (Money, 1993), neurofibromatosis (or von Recklinghausen's 
disease), phenylketonuria, Williams’s syndrome, and Prader-Willi syndrome. ID occur in other genetic 
syndromes like tuberous sclerosis, Huntington's disease (Mouridsen & Sorensen, 1995; Raznahan et 
al., 2007), mucopolysaccharidosis, alcaptonuria, and porphyria (Kahler & Fahey, 2003; Levy, 2009) 
The risk of transmission of recessive genes is greatly increased by consanguineous marriage. For a 
couple of first cousins, the chance of passing on chromosomal alterations is about 5 times higher than 
for couple that are not blood relatives (Ten Kate, 2012). 
Idiopathic ID supports the hypothesis that rare de novo point mutations can be significant causal 
factors of MR (de Ligt et al., 2012). Microarray studies, and exome sequencing techniques found 
CNVs in approximately 15% of PwID (Ropers & Hamel 2005; Pfundt & Veltman, 2012). 
Studies observed that recurrent CNVs involve the following genes: 1q21.1, 1q41-42, 2p15-q16.1, 
3q29, 7q11.23, 9q22.3, 12q14, 14q112, 15q13.3, 15q24, 16p11.2, 16p11.2-12.2, 16p13.1, 17p11.2, 
17q21.31, 19q13.11, 22q11.2, and Xq28 (Vissers et al., 2009; Morrow, 2010).  
Berkel and colleagues (2010) observed de novo CNVs of the SHANK2 gene in 184 individuals with 
ID, and in 396 individuals with ASD. CNVs of the NLGN4 gene and 16p11.2 were identified both in 
ID and ASD (Berkel et al. 2010; Cook & Scherer, 2008; Fernandez et al., 2010), while deletions of the 
1q21.1 region were detected also in schizophrenia (Stone et al., 2008). 
 
Epigenetic mechanisms 
Epigenetic regulation has been implicated in the causation of ID. Mutations in Methyl CpG binding 
protein 2 (MeCP2) and ATP-dependent helicase X-linked (ATRX) protein gene is already well 
established in Rett syndrome, Down's syndrome and some cases of X-linked (Dragich et al. 2000; 
Gibbons et al. 2009; Nan et al., 2007; Sanchez-Mut et al., 2012).  
However, in most cases such modifications are known to be affected by environmental factors before 
and after birth (Zahir & Brown, 2011).  
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Biological and environmental factors 
Prenatal causes of ID include congenital infections such as cytomegalovirus, toxoplasmosis, herpes, 
rubella, influenza and human immunodeficiency virus (Strømme & Hagberg, 2007). The human foetus 
seems unable to produce an effective immunological response in early pregnancy; the ability of 
children to produce antibodies increases significantly only between the sixth and twelve months of 
age. 
Exposure to pollutants, heavy metals, and harmful medications such as thalidomide, phenytoin and 
warfarin in early pregnancy; additive substances such as alcohol, nicotine and cocaine can also cause 
MR (Daily et al., 2000; Ke & Liu, 2012; Sithisarn et al., 2012; Behnke & Smith, 2013). 
Other prenatal risk factors are: maternal hypoglycaemia, diabetes and malnutrition (Mann et al., 2013; 
Groce et al., 2014). Evidences from experimental studies show that malnutrition in utero can impact 
on brain development process leading to reduce nervous cells, protein synthesis defect, and abnormal 
electrical activity (Nyaradi et al., 2013).  
 
Perinatal causes 
Perinatal causes involve complications in delivery, severe prematurity, very low birth weight, birth 
asphyxia, and birth trauma. Furthermore neonatal complications in the first 4 weeks of life included 
septicaemia, severe jaundice, and hypoglycaemia (Nosarti et al., 2004; Kolevzon et al., 2007). 
Low birth weight at term delivery can be due to genetic causes. In other cases poor nutritional 
contribution in uterus associated with placental insufficiency, or others damaging agents may occur. 
These children, born small for gestational age, show retardation in foetal growth and subsequent 
neurological complications that are different to those related to shorter gestation period. True pre-term 
births before 26 weeks of gestation and pre-term births after less than 36 weeks of gestation are those 
at greatest risk of developing neurological damage, which increases in inverse proportion to their 
degree of maturity and birth weight (<1500 grams) (Winter, et al., 2002; Marlow et al., 2005). 
Structural abnormalities of the CNS were more common among children born at lower limit of 
viability and birth weight, while learning disabilities affect almost exclusively children of lower 
socioeconomic status. This finding supports the theory that, independently to biological factors, 
adverse childhood events have a negative effect on cognitive performance (Ritchie et al., 2010).  
 
Postnatal causes 
During the postnatal period, which includes infancy and childhood, brain infections such as 
encephalitis, and bacterial meningitis are observed (Noyola et al., 2001). Furthermore, encephalic 
traumatism, chronic lead exposure, severe and prolonged malnutrition can lead to some kind of ID 
(Leonard & Wen, 2002; Anderson et al., 2005). Malnutrition is a common cause of lower cognitive 
abilities (Durkin et al., 2000). The effects of malnutrition on the development of ID are almost always 
concomitant with negative socio-environmental conditions. Studies reported a significant association 
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between ID and exposure to a wide range of environmental and psychosocial distress including 
infections, inadequate caregivers, low level of stimulation, and social deprivation (Leonard et al., 
2005; Emerson, 2007). 
 
Neuroanatomical abnormalities  
Structural abnormalities of the CNS are the result of a multitude of insults that are primarily prenatal 
in origin. Primary malformations such as neural tube defects, cerebral dysgenesis, and congenital 
hydrocephaly or hydranencephaly can all be associated with severe ID.  
PwID show extensive damage in the integrity of the brain's structures, and wide cerebral abnormalities 
are positive associated with greater cognitive dysfunction (Plomin & Kosslyn, 2001; McDaniel, 2005).  
Cortical grey matter volumes is related to cognitive performance such as planning, working memory, 
and attention. Studies found negative correlations between low IQ and reduced total volume of frontal 
grey matter (Reiss et al., 1996; Sowell et al., 2001), particularly in the orbitofrontal and medial frontal 
regions (Frangou et al., 2004).  
Also the integrity of white matter tracts, including the corpus callosum, cingulum, uncinate fasciculus, 
corticospinal tract and optic radiation, are damaged in people with MR (Yu et al., 2008).  
The corpus callosum is the major white matter tract that connects the right and left cerebral 
hemispheres. Studies found thinning or reduced size of the corpus callosum, particularly in anterior 
subregions (Njiokiktjien et al., 1994; Spencer et al., 2005). It is involved in the control of sustained 
attention and adaptive skills during complex cognitive tasks (Colom et al., 2006). Researchers found a 
significant left-greater-than-right asymmetry of the cingulum, which is associated with impairment of 
the executive functioning (Gong et al., 2005). Abnormalities of the uncinate fasciculus are related with 
deficit in verbal, visual memory, and executive performance (Levine et al., 1998), while the 
corticospinal tract plays a role in the control of discrete finger movements (Martin, 2005). 
The optic radiation or geniculo-calcarine tract transmits visual information. PwID seem to have a high 
prevalence of visual impairments (Warburg, 2001), which leads to sensorial problems, such as 
strabismus, loss of visual acuity, and amblyopia (Atkinson et al., 2001). 
 
1.3.4 PROBLEMS ASSOCIATED WITH INTELLECTUAL DISABILITY (INTELLECTUAL 
DEVELOPMENTAL DISORDER) 
The comorbidity with organic pathology in persons with ID is much higher than in the general 
population. The most frequent disorders are: epilepsy, gastro-oesophageal reflux disorder (GORD), 
constipation, visual impairments, hearing impairments, osteoporosis, respiratory infection, risk of 
aspiration and choking, and repeated accidents or falls. Diabetes is more than twice common in PwID 
as in the general population, and obesity is significantly associated with diabetes.  
Specific genetic conditions such as Down’s syndrome or William’s syndrome are associated with 
illnesses as thyroid disorders, and cardiovascular disease, which may arise at different stages of life. 
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Also antipsychotic medications seem to contribute to physical diseases (Jansen et al., 2004; Prasher & 
Janicki, 2008). 
Organic pathologies are often undetected and misinterpreted as apparent PBs, or psychiatric 
symptoms. Therefore, in the complex evaluation of PwID it is essential to consider all factors that can 
influence behaviour, and affect vulnerability and symptom presentation. 
 
Problem behaviours 
PBs are very common in adults with ID with a prevalence ranging from 5 to 60%, and a point 
prevalence of about 20%, depending on the exact definition of the terms used (Emerson et al., 1999; 
Smiley, 2005; Cooper et al., 2007c; Deb et al., 2008). 
The most common type of PBs in this population are: physically aggressive behaviour, verbally 
aggressive behaviour, screaming, destructive behaviour or aggression to property, self-injurious 
behaviour, overly-demanding behaviour, oppositional-defiant behaviour, and sexually inappropriate 
behaviour (Lowe et al., 2007; Smith & Matson, 2010b). Behavioural difficulties often persist, with 
relapse and remit, and the same individual may show multiple forms of challenging behaviour (Lowe 
et al., 2007). 
PBs result from the complex interaction between biological, psychological, social and developmental 
factors (Griffith & Gardner, 2002), whereas in some cases genetic causes underlie PBs and impacts 
directly on the phenotypic expression (O'Brien & Yule, 1995). 
Challenging behaviours can occur as symptoms of other psychiatric or physical disorders (Moss et al., 
2000; Emerson et al., 2001b; Kishore et al., 2005; Hemmings et al., 2006; Felce et al., 2009; De 
Winter et al., 2011), especially in individuals with more severe impairment (Felce et al., 2009). In this 
case, before making a diagnosis is required to clarify the temporal relationship to the onset of the PBs  
(Charlot, 2005). Hence a special focus is needed on assessment of challenging behaviours in ID, as 
they are a major cause of misdiagnosis, inadequate treatment, and service use in this population group. 
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1.4 SCHIZOPHRENIA AND SCHIZOPHRENIA SPECTRUM DISORDERS  
 
1.4.1 DEFINITION AND DIAGNOSTIC CRITERIA: EVOLUTION AND CURRENT STATE 
Schizophrenia is a complex psychiatric disorder with a chronic course characterized by the presence of 
some, but not necessarily all, of the following features: emotional blunting, cognitive impairment, 
social isolation, disorganized speech and behaviour, delusions, and hallucinations. 
Since its first conceptualisation the disorder has been one of the most studied and discussed 
psychiatric disorders. 
The concept of schizophrenia originates from the description by Emil Kraepelin (1856-1926), more 
than a century ago. Kraepelin, based on his observations of many clinical cases, believed that the 
illness occurred in young people and that it inevitably led to severe cognitive deterioration and altered 
pattern of behaviours. His observations led him to integrate different clinical pictures into a single 
nosological entity under the term of ‘dementia praecox’. Kraepelin combined hebephrenia, catatonia, 
which were previously described by Hecker and Kahlbaum respectively, and paranoid states into the 
concept of dementia praecox. 
Kraepelin’s concept of schizophrenia was significantly modified by Eugen Bleuler (1857-1939). He 
observed some clinical cases, which did not evolve into deterioration, that previously was considered 
as key feature by Kraepelin. Bleuler coined the term ‘schizophrenia’ to replace ‘dementia praecox’ 
and highlight that the deficit in integration of different psychic functions (personality, thought, 
memory and perception) was the distinctive feature (Altamura et al., 2014). The age of onset and 
course were considered less significant symptoms. Bleuler introduced a fundamental distinction 
between obligatory and accessory symptoms of schizophrenia diagnosis. The basic symptoms, which 
are known as the ‘4 A of Bleuler’ included thought and speech derailment (loosening of Associations), 
volitional indeterminacy (Ambivalence), Affective incongruence, and withdrawal from reality 
(Autism). The accessory symptoms included delusions and hallucinations, which are commonly 
classified as ‘positive’ symptoms (Jablensky, 2010; Tandon, 2012). 
The history of this disorder is complex and the concept of schizophrenia has undergone several 
revisions over the years. All the definitions of schizophrenia included three major clusters of features: 
the Kraepelinian stress on avolition, chronic course, and poor outcome (Kraepelin, 1971); the 
Bleulerian accent on negative symptoms and dissociative pathology (Bleuler, 1950); and the 
Schneiderian emphasis on positive symptoms (Schneider, 1959) (Tandon et al., 2013). 
Symptoms of schizophrenia were classified by Kurt Schneider (1887–1967) in 1938. ‘First-rank’ 
symptoms, considered by Schneider to be the most important indicators of schizophrenia, include the 
experience of thought alienation (e.g. thought insertion, thought withdrawal, thought broadcast), 
somatic passivity, delusional perception, and auditory hallucinations in the form of voices discussing, 
commentary, and repeating. ‘Second-rank’ symptoms are symptoms of schizophrenia but often occur 
with other mental disorders. They include perplexity, emotional blunting, depressive and euphoric 
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mood changes, sudden delusions (e.g. delusions of reference, paranoid delusion, persecutory 
delusion), and other disorders of perception. 
The accent on one or another of the major three perspectives has changed over time (Andreasen, 1989; 
Bruijnzeel & Tandon, 2011; Keller et al., 2011a). In the DSM-I and DSM-II the definition of 
schizophrenia reflected the Bleulerian view.  
In the 1970s the discrepancy between the international nosographic systems (DSM and ICD) was 
evident, leading to more diagnostic disagreement in USA and Europe (Kendell et al., 1971; Wing & 
Nixon, 1975). Additionally, over the course of the decades, a number of European and American 
clinicians proposed further subnosological distinctions within the widening phenotype of 
schizophrenia, including schizoaffective disorder, schizophreniform psychoses, paranoid non-paranoid 
schizophrenia, and schizoid personality. 
In the 1980s, The DSM-III attempted to define a more homogeneous disorder by requiring a triad of 
symptoms characterized by chronic course, poor functioning and Schneiderian first-rank symptoms. 
From DSM-III through DSM-III-R to DSM-IV, there were few changes of the criteria of 
schizophrenia with the elimination of the requirement that onset occur before age 45 and inclusion of 
negative symptoms.  
In the last 1980s the gap between the DSM-IV and the ICD-10 definitions of schizophrenia remained. 
Whereas the DSM-IV required a total duration of symptoms at least of 6 months and 
social/occupational dysfunctions, the ICD-10 required a minimum duration of 1 month and has no the 
requirement for social/occupational dysfunction. Furthermore, the ICD-10 lays greater focus on the 
Schneiderian first-rank symptoms than the DSM-IV. In contrast to the DSM, the ICD-10 also defines 
two additional subtypes - post-schizophrenic depression and schizophrenia simplex, where the latter 
was a type of schizophrenia with progressive development of negative symptoms and no history of 
psychotic episodes.  
In the last edition of the DSM (DSM-5; APA, 2013) the definition of schizophrenia remained 
essentially the same as that specified by the DSM-IV-TR, but the DSM-5 makes a number of changes. 
The DSM-5 added the word ‘spectrum’ to the title. This new term Schizophrenia Spectrum and other 
psychotic Disorders (SSD) implies that there are different degrees of the disorder. 
The six diagnostic criteria (A–F) of the DSM-IV-TR were retained and modest changes were made. In 
criterion A, the definition of negative symptoms was refined, and the requirement that at least one 
characteristic symptom must be delusion, hallucination, or disorganized speech was inserted.  
 According to the DSM-5 to meet the criteria for diagnosis of SSD, the patient must have experienced at least 2 
of the following symptoms (A), each present for a significant portion of time during a 1-month period (or less if 
successfully treated). At least 1 of the symptoms must be the presence of delusions, hallucinations, or 
disorganized speech: 
A. 1. Delusions. (Delusions can take a number of different forms: paranoid delusions or delusions of persecution, 
delusions of reference somatic delusions, delusions of grandeur) 
2. Hallucinations. (They can be: visual auditory tactile olfactory gustatory experiences) 
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3. Disorganized speech (e.g., frequent derailment or incoherence) 
4. Grossly disorganized or catatonic behavior. 
5. Negative symptoms (i.e., diminished emotional expression or avolition). Some of these include: lack of 
emotion, low energy, lack of interest, low motivation, affective flattening alogia, inappropriate social skills or 
lack of interest or ability to socialize with other people, and social isolation. 
B.  For a significant portion of the time since the onset of the disturbance, level of functioning in one or 
more major areas, such as work, interpersonal relationships, or self-care, is markedly below the level achieved 
prior to the onset (or when the onset is in childhood or adolescence, there is failure to achieve expected level of 
interpersonal, academic, or occupational functioning). 
C.  Continuous signs of the disturbance persist for at least 6 months. This 6-month period must include at 
least 1 month of symptoms (or less, if successfully treated) that meet Criterion A (e.g., active phase symptoms) 
and may include periods of prodromal or residual symptoms. During these prodromal or residual periods, the 
signs of the disturbances may be manifested by only negative symptoms or by two or more symptoms listed in 
Criterion A present in an attenuated form (e.g., odd beliefs, unusual perceptual experiences). 
D.  Schizoaffective disorder and depressive or bipolar disorder with psychotic features have been ruled out 
because either 1) no major depressive or manic episodes have occurred concurrently with the active-phase 
symptoms, or 2) if mood episodes have occurred during active-phase symptoms, they have been present for a 
minority of the total duration of the active and residual periods of the illness. 
E.  The disturbance is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a 
medication) or another medical condition. 
F.  If there is a history of autism spectrum disorder or a communication disorder of childhood onset, the 
additional diagnosis of schizophrenia is made only if prominent delusions or hallucinations, in addition to the 
other required symptoms of schizophrenia, are also present for at least 1 month (or less if successfully treated).  
Whereas the DSM-IV-TR included paranoid, disorganized, catatonic, undifferentiated and residual 
subtype of schizophrenia, the APA removed the schizophrenia subtypes from the DSM-5; they did not 
appear to be helpful for providing better-targeted treatment or predicting response to treatment. Also 
catatonia is no longer associated with schizophrenia (Heckers et al., 2009). Special treatment of 
bizarre delusions and Schneider's first-rank symptoms was also removed.  
The DSM-5 included a set of course specifiers that provide information on the cross-sectional state 
and longitudinal courses of SSD. The distinction of course specifiers according to their current state 
and its longitudinal progress allows the clinician to document both the current status and the previous 
course up to the present observation period (Tandon et al., 2013). 
However, the debate on the SSD diagnostic symptoms is still in vigour.  
Evidence shows that cognitive deficits are a significant psychopathological feature of SSD. The 
hypothesis of the presence of cognitive dysfunction in people with schizophrenia dates back to the 
constitution of modern psychiatry, when Kraepelin conceptualized the disorder as dementia praecox. 
This theory has received limited credit for a long time, although the clinicians have continued to 
recognize that in people with MR there is an increased vulnerability (psychosis of engagement). Only 
in the last twenty years, on the basis of the progressive affirmation of pathogenic models pertaining to 
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neurodevelopment, identification and treatment of cognitive deficits has been a subject of renewed 
interest. 
Although the inclusion of cognitive impairment in the diagnostic criteria of schizophrenia was 
considered (Keefe, 2008; Tandon & Maj, 2008), no change was made. In fact, cognitive deficit has not 
been considered sufficiently precise to distinguish between schizophrenia and other disorders (Depp et 
al., 2007; Reichenberg et al., 2008; Barch, 2009; Reichenberg, 2010). The cognitive symptoms of 
schizophrenia refer particularly to concentration and memory problems (Trivedi, 2006; Keefe & 
Harvey, 2012). These impairments can include disorganized thinking, slow thinking, difficulty 
understanding, poor concentration, poor memory, difficulty expressing thoughts, and difficulty 
integrating thoughts, feelings, and behaviour. On this subject, cognitive rehabilitation programs have 
generated consistent interest (Wykes & Spaulding, 2011; Barlati et al., 2012). 
 
1.4.2 EPIDEMIOLOGY 
Lifetime prevalence of schizophrenia is about 1%, varying from 0.5% to 1.5%. The incidence is 
approximately 1.5/10.000 (Owen et al., 2004; McGrath et al., 2008). The average age of onset is 
typically in late adolescence or early adulthood (Van Os & Kapur, 2009). A minority of patients has 
age of onset in middle or old age after 40-60 years (Howard et al., 2000). Furthermore childhood-onset 
schizophrenia is very rare and usually occurs after the age of 5 years (Kumra et al., 2001). 
Evidence suggests that schizophrenia is more common in men than in women and the male-to-female 
ratio varied between 1.3 and 1.4 (McGrath et al., 2004; Aleman et al., 2003). 
 
1.4.3 ETIOPATHOGENESIS 
Schizophrenia is a disorder with variable phenotypic expression that results from a complex set of 
interrelated causal factors, including genetic, as well as environmental contributions (Jablensky & 
Kalaydjieva, 2003; Mäki et al., 2005; Rapoport et al., 2005). 
 
Genetic factors 
Familial predisposition and genetic risk factors for SSD has been observed. Although over two-thirds 
of cases occur sporadically, having an affected family member is associated with an increased risk of 
developing schizophrenia. Twin studies have found the heritability of risk about of 65-80%. 
Researches have consistently estimated concordance rates of 41-65% in monozygotic and 28% in 
dizygotic twins (Cardno & Gottesman, 2000; Sullivan et al., 2003). The absence of a complete 
concordance in monozygotic twins, which share the entire gene pool, indicates that further factors 
other than genetic ones should be taken into account in the pathogenesis of disease. 
The risk increases with the degree of biological relatedness to the patient (Kendler & Diehl, 1993). 
Studies reported increased frequency of parental consanguinity among patients with schizophrenia. 
First cousins show a risk of 2% that their offspring developing schizophrenia, while the risk in the 
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general population is about 1%. The offspring of two schizophrenic parents show a risk of 50%, and 
the offspring of one schizophrenic parent show a risk of 13% (Jablensky, 2000; Tsuang, 2000; 
Gottesman & Erlenmeyer-Kimling, 2001).  
The first investigations on the molecular genetic of schizophrenia date back to the late 1980s. Since 
then, numerous studies have been conducted using both candidate genes for the coding of protein in 
neurotransmitter systems with possible roles in the pathogenesis of schizophrenia and systematic 
investigations into the entire human genome. Combinations of variations in multiple genes are 
associated with schizophrenia with a proportion of the transmitted genotypes remaining clinically 
unexpressed (Muir et al., 2006).  
Recently, large-scale studies have considerably advanced in terms of identifying risk genomic regions. 
Over 100 loci are now associated with schizophrenia as identified by Single Nucleotide 
Polymorphisms (SNPs) in genome-wide association studies. The Psychiatric Genetics Consortium 
(PGC) attempted to combine findings from the Genome-Wide Association Studies (GWAS) of 
schizophrenia. In 2014 this collaboration expanded the data into the largest meta-analysis on GWAS 
data (36.989 cases and 113.075 controls), indicating 108 schizophrenia-associated genetic loci, 83 of 
which have not been previously described (Ripke et al., 2014). 
Other studies have suggested that high risk-rare variants, which could be caused by de novo mutations 
and CNVs, are linked to increased risk for schizophrenia and other neurodevelopmental disorders 
(Malhotra & Sebat, 2012). Reviews have listed some genes including: NRG1 (neuroregulin 1), 
DTNBP1 (dysbindin), DRD1-4 (dopamine receptors D1–D4), NRXN1 (neurexins), COMT (catechol-
O-methyl-transferase) and GRM3 (metabotropic glutamate receptor) (Talkowski et al., 2008; St Clair, 
2009; Bassett et al., 2010; Magri et al., 2010; Girirajan et al., 2012; Kukshal et al., 2013).  
The pathogenic effects of these CNVs are not limited to schizophrenia; many increase risk for other 
disorders such as ID and ASD (Girirajan et al., 2012; Malhotra & Sebat, 2012). 
An updated meta-analysis on CNVs for schizophrenia published in 2015 expanded the number of 
CNVs implicated in schizophrenia, replicated previous findings for disruption of glutamatergic 
signalling, and has also offered the first genetic evidence for the involvement of GABAergic 
neurotransmission deficit (Pocklington et al., 2015). 
 
Neurotransmitters system 
In the second half of the twentieth century, dopamine (DA) dysfunction was considered to play a 
crucial role in the pathogenesis of schizophrenia. This was firstly due to studies on DA-releasing 
drugs, such as amphetamine, which induce psychosis and also to evidences that antipsychotic drugs 
block the dopaminergic D2 receptors (Carlsson, 1988; Howes & Kapur, 2009).  
Recently, studies showed that mutations in the gene coding for the serine/threonine protein kinase 
(AKT) which mediates the dopaminergic neurotransmission, plays an important role in the 
pathogenesis of schizophrenia (Arguello & Gogos, 2008; Zheng et al., 2012; Emamian, 2012).  
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Later researches suggest that excessive DA function cannot fully explained schizophrenia. Studies on 
cognitive impairments have led to consideration that other neurotransmitters, such as glutamate, may 
play a role (Javitt, 2010; Lau et al., 2013). Cognitive symptoms including attentional impairment and 
memory deficits may result from a decreased activity of the N-methyl d-aspartate (NMDA) receptor 
on GABA inhibitory interneurons in the prefrontal cortex (Kraguljac et al., 2012; Plitman et al., 2014).  
In a large-scale study conducted by the Consortium on the Genetics of Schizophrenia, the organization 
noted that NMDA receptor NR1, NR2A, and NR2B subunits polymorphisms are often associated with 
the diagnosis of schizophrenia. Through further research a relevant association with NMDA subunits 
alteration has been identified also for ASD (Endele et al., 2010; Hamdan et al., 2011; Saunders et al., 
2012). In addition, recent work for the SHANK3, NLGN1, NRXN1, FMRP1, MeCP2, DISC1, RELN 
on transgenic mice genes and rodents exposed in utero, respectively considered models of autism and 
autism risk, showed a reduced activity of the NMDA receptor signaling. Harmful mutations of NR1, 
NR2A, and NR2B have been identified through large-scale studies, also in PwID (Coyle, 2006; Insel, 
2010). Considering all of the data, these results indicate that a dysfunction of NMDA receptor 
signaling may represent a molecular substrate common to several neuropsychiatric disorders of 
development.  
Finally, serotonin system alterations also seem to contribute in the pathogenesis of schizophrenia 
through a dysfunction of the dopaminergic modulation (Abi-Dargham, 2007; Selvaraj et al., 2014). 
 
Epigenetic mechanisms  
Epigenetic regulators of gene expression including DNA cytosine methylation, posttranslational 
histone modifications, and chromosomal looping for promoter-enhancer interactions, seem to 
contribute to altered expression of genes related to synapse and metabolism in schizophrenia (Roth et 
al., 2009; Akbarian, 2014; Shorter & Miller, 2015). For example, in the prefrontal cortex of subjects 
with schizophrenia, abnormal DNA or histone methylation at sites of specific genes and promoters can 
lead to changes in RNA expression. These findings are of interest from a neurodevelopmental 
perspective because there is increasing evidence that epigenetic regulation of genes are highly 
involved during the first years of life.  
 
Biological factors  
Brain hypoxia before at or immediately after birth, low birth weight, and small head circumference are 
associated with an increased risk of developing schizophrenia. Furthermore, pregnancy bleeding, 
preeclampsia, diabetes, rhesus incompatibility, and delivery complications were also associated with 
schizophrenia (Cannon et al., 2002; Abel et al., 2010). 
Exposure to toxins and viral infections in utero, especially during the second trimester, or in childhood 
are significant risk factors for schizophrenia. Polio, varicella-zoster, rubella, herpes simplex virus, 
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influenza and Toxoplasma gondii have been correlated with the later development of schizophrenia 
(Venables et al., 2007; Boksa, 2008).   
Recent findings support the hypothesis that schizophrenia is associated with alterations of the 
tryptophane-kynurenine metabolic pathway due to activation of specific parts of the immune system 
(Müller et al., 2015). Therefore, the immune-mediated glutamatergic-dopaminergic dysregulation may 
lead to the clinical symptoms of schizophrenia disorder (Müller & Schwarz, 2006). 
 
Environmental factors 
Childhood experiences of social adversity, social exclusion, migration, and abuses have been 
suggested to contribute to schizophrenia (Boydell et al., 2004; Wicks et al. 2005).  
A study found that chronic adverse exposures may produce sensitization and hyper reactivity of the 
dopaminergic system at high levels (Pruessner et al., 2004). 
There is evidence that living in an urban area has repeatedly is a risk factor for developing 
schizophrenia (Krabbeddam, 2005), even after controlling for other factors such as drug use (van Os, 
2004). The likelihood of being diagnosed with the schizophrenia was found to increase with the 
number of years spent in an urban environment in childhood and adolescence (Pedersen et al., 2001). 
Various possible explanations have been hypothesized including infectious causes and social 
exclusion which interact with genetic vulnerability (Kelly et al., 2010).  
Strong evidence indicates that drugs such as cannabis, amphetamines, and hallucinogens may trigger 
psychotic relapse and precipitate schizophrenia in vulnerable individuals (Meltzer & Fatemi, 2000; 
Arsenault et al., 2004).  
 
Neuroanatomical abnormalities  
The most common findings on examination by computed tomography and Magnetic Resonance 
Imaging (MRI) in patients with schizophrenia have been enlarged size of the cerebral ventricles, white 
matter anisotropy, and decreased cerebral cortical volume especially in the temporal lobe, superior 
temporal gyrus, and insula (Honea et al., 2005; Bakhshi & Chance, 2015).  
Individuals who developed psychosis were found to have reduced grey matter volume in the right 
medial temporal, lateral temporal, inferior frontal cortex, and in the cingulate cortex, bilaterally 
(Pantelis, et al., 2003). Other neuroimaging studies confirm that cerebral structures including the 
cavum septi pellucidi, amygdaloid/hippocampal complex, basal ganglia, thalamus, and cerebellum 
play a role in the SSD symptoms (Shenton et al., 2001). 
Reduction in whole brain and gray matter volumes were associated with lower premorbid IQ and 
poorer performance on IQ test scores (Antonova, 2005). 
Patients with schizophrenia show a broad spectrum of cognitive dysfunctions and include problems in 
sustaining attention, performing executive functions, verbal and visuo-spatial working memory and 
language skills, each of which is associated with different brain structures (Riley et al., 2000). The 
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enlargement of the third ventricle seems to correlate with deficits in abstraction, language, and 
attention. Damage to the prefrontal cortex was associated with impaired executive functions (Orellana 
& Slachevsky, 2013). Abnormalities of the temporal lobe were related to cognitive deficits in 
processing speed and performance accuracy; damages to the hippocampus were associated with 
memory and executive function impairment, and anomalies of the parahippocampal gyrus were related 
to deficient abstraction ability (Antonova et al., 2004, 2005). 
 
Premorbid IQ 
Cognitive deficits affect the vast majority of schizophrenia patients, with prevalence estimates that 
averaged about 75-80% of the patient population and a quantification that was between 1 to 2 standard 
deviations below the mean of the average population (Woodberry et al., 2008; Morgan, 2008).  A 
meta-analysis conducted by Heinrichs and Zakzanis (1998) of 204 studies comparing a total of 7.420 
patients with schizophrenia and 5.865 healthy controls showed a deterioration of global cognitive 
functioning with a very significant effect size. Systematic reviews more recently have shown a similar 
deterioration in people with the first episode of the illness, in those never treated with antipsychotic 
drugs or those in remission of symptoms (Heaton et al., 2001; Bowie et al., 2006; Forbes et al., 2009; 
Mesholam-Gately et al., 2009). 
Schizophrenia has been consistently associated with a range of intellectual impairments, such as 
attention, language and memory deficit, some of which precede the onset of psychotic symptoms.  
The cognitive impairments that are most frequently encountered are: 
• Reduction of intelligence quotient (IQ), already observed in children who later develop the 
disease and more clearly with the onset of the disorder, to be able to present a substantially 
stable course; 
• Attention deficits, in particular the responsiveness to sensory stimuli; 
• Deficits in working memory; 
• Deficits in verbal memory, immediate and delayed; 
• Deficits in executive functioning, with particular difficulty in categorizing information and 
errors in preservation. 
Evidences suggest that the risk of schizophrenia increases by 3.7% for every point decrease in IQ 
(Khandaker et al., 2011). Greater premorbid IQ decrement, which affects both verbal and non-verbal 
cognitive abilities, has been associated with increased severity of illness and earlier onset of 
schizophrenia (Cornblatt et al., 2003).  
Premorbid low IQ indicates that impairment in intellectual ability may exist from early in life and is 
not just a consequence of the pathological process of disease. In fact, poor school performance in 
childhood can be considered as premorbid sign for the later development of schizophrenia (Isohanni et 
al., 2004). 
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1.4.4 PROBLEMS ASSOCIATED WITH SCHIZOPHRENIA AND SCHIZOPHRENIA 
SPECTRUM DISORDERS 
Schizophrenia is a serious brain disorder that distorts the way a person thinks, perceives reality, and 
relates to others, which led to have problems functioning in society, and in relationships.  
People with schizophrenia have a wide range of multiple-comorbid physical-health problems and are 
at high risk of premature mortality due to cardiovascular disease, diabetes, obesity and smoking-
related lung disease (Smith et al., 2013). Metabolic syndrome occurs frequently in schizophrenic 
patient, with prevalence two to three time higher than in the general population. Metabolic syndrome 
is a cluster of metabolic including obesity, hypertension, cardiovascular diseases, dyslipidemia, 
hyperuricemia, abnormalities of glucose homeostasis and diabetes mellitus (De Hert et al., 2009). 
Unhealthy lifestyles, restricted access to health care, social services or the side effects of antipsychotic 
drugs may contribute to its development (Ryan & Thakore, 2002). 
 
Problems behaviours 
The prevalence rates of violent behaviours in people with schizophrenia shows a wide variability 
ranging from 10 and 15% (Fazel et al., 2009). There was a common and widespread view that 
schizophrenic patients were violent. However, studies showed that these patients are not inclined to 
violence, but they often prefer stay alone and tend not to be disposed to social relations (Brüne et al., 
2011). The risk of violent behaviours increased when these patients are under the influence of alcohol 
or psychoactive substances. Furthermore, people with paranoid and psychotic symptoms, which can 
become worse if antipsychotic drugs are discontinued, may also be at higher risk for violent 
behaviours (Buchanan et al., 2002; Hodgins, 2008; Wehring & Carpenter, 2011). 
Suicide and suicide attempts amongst schizophrenics are 8.5 higher than in the general population. 
Estimates suggest that 10% of patients with schizophrenia complete suicide (Siris, 2001). Furthermore 
a high percentage, ranging between 20 and 50%, have a history of suicide attempts in the course of 
disease and in particular in the psychotic acute phase (Meltzer, 2006). Study shows that suicidal 
behaviours are also more likely to occur in people with early onset psychosis, alcohol abuse, substance 
dependence, feelings of loneliness, and low compliance to treatments (Mork et al., 2012).  
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1.5. PSYCHIATRIC COMORBIDITY  
 
1.5.1 GENERAL ISSUES 
In PwID, the prevalence of mental disorders is up to four times higher than in the general population 
(Cooper et al., 2007c). However, the opinion that psychiatric disorders could not occur in PwID has 
represented the view of the majority of the scientific community for a long time. Various explanations 
were given, including a lack of consensus on which problems in ID should be considered as mental 
health problems (Holland & Koot, 1998). The long-lasting denial of the presence of psychiatric 
disorders in PwID was a significant impediment to research on the specific phenomenological and 
psychopathological concepts, and to the development of effective assessment procedures. Thus, the 
nature of psychiatric disorders, and what causes them often remained unresolved. 
Noteworthy, the DSM-III and DSM-IV included MR on Axis II along with the personality disorders, 
while ‘major’ groups of diagnosis (depression, psychosis, etc.) were placed on Axis I. This choice had 
several implications. The placement of psychiatric disorders and MR on a separate axis may prevent 
the effect of ‘diagnostic overshadowing’ (Reiss et al., 1982), which is the difficulty to attribute the 
observed or referred dysfunctions to the basic condition of ID or to a comorbid psychiatric disorder 
(Reiss et al., 1982; Reiss & Syszko, 1983; Deb et al., 2001b; Jopp et al., 2001). This categorization 
could avoid the tendency of clinicians engaged in evaluations of MR to focus almost exclusively on 
intellectual and adaptive functioning, ignoring other important information on overall mental health. 
However this separation may result in the opposite effect, reducing the impact of MR on the 
psychopathology and clinical presentation.  
The assessment of psychiatric disorders in PwID requires appropriate modifications in respect to the 
general population, in order to adapt for cognitive impairments, language limitations, communication 
problems, sensory dysfunctions, skill difficulties, adaptation deficits, and physical disabilities that are 
frequently in this population. Moreover, some studies underline the interference of PBs in the 
psychiatric diagnostic evaluation (Reiss et al., 1982; Reiss & Syszko, 1983). All these difficulties 
creates diagnostic challenges for clinicians who did not receive any specific training to diagnose 
psychiatric disorders in PwID (Werner & Stawsky, 2012). The ‘diagnostic overshadowing’ represents 
the first problem. Furthermore, mainly in the most severe cases, some individuals may show 
‘cognitive distortion’ (Sovner & DesNoyers Hurley, 1986), which consists of difficulties in 
introspection capacity, in defining one’s own life experiences, and in communicating states of 
uneasiness or suffering (Cooper et al., 2003). PwID may have poor verbal expression capacities, may 
be passive, inclined to acquiescence and, for certain peculiarities in the experiential range, may show 
deviations from the norm according to the attribution of meaning to communicative contents 
(‘psychosocial masking’; Sovner, 1986). The developmental level, previous life experiences, cultural, 
and environmental influences impact on the presentation of symptoms, which often is atypical, 
chaotic, intermittent, fluctuating, masked, mixed, or poorly defined (Sovner, 1986; Bouras, 1999). 
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Furthermore, people with more severe ID tend to express their psychic suffering through behavioural 
changes, including the increase of severity or frequency of PBs that could indicate the onset of a co-
occurrent psychiatric disorder (‘baseline exaggeration’; Sovner, 1986; Sturmey, 1990; Moss et al., 
2000). In addiction, the symptomatology of psychiatric disorders in ID is often characterised by 
neurovegetative vulnerability; pains, organ dysfunction, and circadian rhythm disorders are frequently 
the main expression of emotional dysregulations (Costello & Bouras, 2006). 
Atypical clinical presentation, including maladaptive behaviours, lent support for ‘behavioural 
equivalent’ substitutes of standard criteria. The evaluation is always based on direct observation of 
behaviours and the person’s way of interacting with the outside world through the knowledge of 
precise meanings in the context of various environmental factors. However the majority of instruments 
that have been produced to date are only applicable to subjects with more mild cases of ID, have a 
suggestive value, are not very sensitive, or are time consuming (Bertelli et al., 2012). 
Several studies highlighted the difficulties in applying diagnostic criteria for psychiatric disorders, 
designed to be used with the general population, to persons with ID. These criteria may be applied 
without adaptation only to borderline or mild ID level (Clarke et al., 1994), while they cannot be used 
with more severe ID (Sovner, 1986; Cooper & Bailey, 2001). The diagnostic criteria of the current 
nosographical systems, including the DSM-IV-TR, DSM-5, and ICD-10, show some characteristics 
that may interfere with the reliability of the psychiatric diagnosis in PwID. Many of the diagnostic 
criteria require verbal descriptions, especially of emotional state that are difficult to understand and 
express for PwID. Furthermore, the standard diagnostic criteria are not developed for use with an 
informant (e.g. caregiver, and family), and require detailed information on the psychopathology that 
not applicable to PwID. Finally, PBs have yet to be categorized in any of the nosographical systems 
(Cooper et al., 2003). 
The Royal College of Psychiatrists (UK) and the National Association for Dual Diagnosis (USA) 
respectively have produced adaptations of the ICD-10 and DSM-IV-TR called Diagnostic Criteria for 
Learning Disability (DC-LD) (Royal College of Psychiatrists, 2001), and Diagnostic Manual - 
Intellectual Disability (DM-ID) (Fletcher et al., 2007). Additional consideration and researches have 
been conducted to produce a more reliable conversion in DC-LD 2. Furthermore, an update of the 
DM-ID for adaptation of the DSM-5 criteria is underway. 
 
1.5.1.1 PSYCHIATRIC COMORBIDITY IN AUTISM AND AUTISM SPECTRUM 
DISORDER  
Psychiatric comorbidities are common in ASD and frequently lead to further associated impairment. 
Diagnosis of co-occurrent psychiatric disorders is often challenging due to several difficulties 
including the core symptoms of ASD themselves, communication deficit, atypical presentation of 
psychiatric symptoms, and scarcity of standardised diagnostic tools (Chandrasekhar & Sikich, 2015). 
Furthermore, the clinical manifestations of ASD often overlap with the symptoms of other disorders; 
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thus, it can be difficult distinguishing between them (Matson & Sturmey, 2011; Underwood et al., 
2010, 2015). 
 
Mood Disorders 
Depression, along with anxiety, is the most common disorder in adults with ASD (Royal College of 
Psychiatrists, 2014). The difficulty in detecting depression in this population is due to problems in 
communicating and expressing feelings of sadness, hopelessness, low self-esteem, guilt, or suicidal 
ideation (Stewart et al., 2006). Furthermore, individuals with ASD often show flat or constricted 
affect, so that changes associated with the onset of depression may not be identified (Chandrasekhar & 
Sikich, 2015). Depression in people with ASD is characterised by a variety of symptoms, including 
decreased interest in favourite interests, worsening in self-care capabilities, and decline in personal 
hygiene (Lainhart & Folstein, 1994; Charlot et al., 2008). In other cases, stereotyped and repetitive 
behaviours may intensify (Ghaziuddin et al., 2002), and there may be worsening of PBs such as 
agitation, aggression, or self-injury (Lainhart & Folstein, 1994; Gotham et al., 2015). Also, 
neurovegetative symptoms as changes in sleeping patterns, appetite, and weight are common, 
especially in those with lower verbal abilities (Chandrasekhar & Sikich, 2015). 
 
Anxiety disorders 
Clinical significant anxiety is common in individuals with ASD and is related to increased 
psychosocial, and familial impairment (Nadeau et al., 2011).  
People with ASD and comorbid anxiety may show increased ritualistic behaviours and PBs (Davis et 
al., 2011). However, anxiety disorders can be difficult to diagnose in this group, due to difficulties in 
expressing worry and fear.  
Study found that individuals with ASD, especially high-functioning, are likely to suffer from social 
anxiety, which may contribute to the avoidance of social interaction typically seen in this population 
this population. An important difference between social anxiety disorder and ASD is the presence in 
this latter group of social awkwardness. (Bejerot et al., 2014). 
 
Obsessive-Compulsive Disorder 
Obsessive thoughts and stereotypical behaviours are commonly observed in ASD and overlap with 
OCD in the symptomatic profile (Ivarsson & Melin, 2008). So it can be difficult to distinguish 
symptoms that are related to a comorbid OCD, particularly in people with lower functioning levels. 
However, studies have indicated that repetitive thoughts and autistic behaviours differ from those of 
the OCD (Ruzzano et al., 2015; Cadman et al., 2015). In OCD, typical obsessive themes include 
worries about germs, harm coming to self or others, distinguishing right from wrong, and guilt about 
morals, or religiosity. Therefore, typical compulsions include ritualized washing, checking, ordering, 
apologizing, or mental rituals such as counting or praying. Whereas people with ASD, may perform 
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repetitive or ritualistic behaviours such as ordering, arranging, counting, or touching/tapping 
(McDougle et al; 1995). However, people with ASD are not likely to think about their rituals and may 
present with limited insight into the reason behind their ritualized behaviours. People with ASD are 
also less likely to be using their ritualized behaviours to neutralize fear or anxiety as would be true for 
OCD. Rather, ritualized behaviours and repetitive thoughts may satisfy other needs, such as modifying 
sensory input, knowing what is going to happen next in their daily routine, controlling and gaining 
reinforcement from the environment, or preserving routine and sameness in their daily lives. 
 
Psychotic disorders 
Transition into adulthood and exposure to stressful events are related to the onset of brief psychotic 
episodes in adults with ASD. Furthermore, psychotic symptoms are often signs of an underlying mood 
disorder or a schizoaffective disorder (Underwood et al., 2015). The overlap between autism and SSD 
is the subject of this thesis and will be discussed in detail in a subsequent section. 
 
Eating disorders 
Eating disorders are often reported among adults with ASD, particularly pica, food refusal, and food 
selection for colour, type or texture. Selective food refusal is also associated with food spitting, 
obsessions, and rituals in ASD (Gravestock, 2000; Gravestock, 2003). Autism and eating disorders, 
especially anorexia nervosa, have common features concerning cognitive style and behaviours 
(Rastam, 2008), such as the tendency to focus on details and the insistence on sameness (Gillberg et 
al., 2007).  
 
Post-Traumatic Stress Disorder  
Although negative life events, physical and sexual abuse are quite common in people with ASD 
studies are lacking. Traumatic events and clinical presentation of PTSD are difficult to detect in 
people with ASD especially for their difficulties in defining their inner psychic state (Mehtar & 
Mukaddes, 2011). Diagnosis of PTSD require an accurate assessment to understand cognitive 
interpretation, PBs, emotional disorders, and recognise signs of increased physiological arousal and 
sensory processing of the traumatic events, which might otherwise be misdiagnosed as exacerbation of 
ASD symptoms. 
 
 
1.5.1.2 PSYCHIATRIC COMORBIDITY IN INTELLECTUAL DISABILITY 
(INTELLECTUAL DEVELOPMENTAL DISORDER) 
PwID can experience the full range of mental disorders, and there is evidence that occur more 
commonly than observed in the general population. The psychiatric diagnosis, already complex in the 
general population, becomes even more difficult in a person with ID, especially in the more severe 
 38 
cases, where normal communication capacities are limited or absent. Psychiatric disorders are 
frequently underdiagnosed or misdiagnosed, and can markedly reduce cognitive and adaptive 
functioning. 
 
Mood disorders 
Depression is one of the most frequent psychiatric disorders in adults with ID. Research shows that 
PwID can suffer also from bipolar disorder, for which the incidence is higher than the general 
population. The main symptoms of mood disorders described in terms of observable behaviour include 
sadness, irritability, decreased social interaction, worsening of functioning levels, sleep disturbance, 
diurnal variation, and aggression (Hurley, 2008). Low appetite or other eating problems are two key 
signs in diagnosing depression, especially in people with more severe level of ID (Mayville et al., 
2005), while understanding complex concepts such as guilt, thoughts of death or suicide are difficult.  
Symptoms of mania include insomnia, increased activity, pressured speech, and psychomotor agitation 
(Vanstraelen & Tyrer, 2001; Matson et al., 2007). In addition to this usual presentation, atypical 
symptoms of mania are aggression and self-injurious behaviour (Hurley, 2008; Kendall & Owen, 
2015). 
 
Anxiety disorders 
All types of anxiety disorders can occur in PwID. Clinical features of anxiety include fearful 
anticipation, irritability, concentration and memory problems, repetitive worrying thoughts, increased 
drinking, hyperventilation, increased urinary frequency, anger, sweating, avoidance behaviour, 
agitation, and excessive motor activity (Cooray & Bakala, 2005). 
Studies found that PwID exhibit challenging behaviour such as aggression or self-injurious behaviour 
as a means of coping, especially in those with greater difficulty in communicating (Stavrakaki, 2002; 
Cooray & Bakala, 2005).  
 
Psychotic disorders 
The prevalence of psychotic symptoms in ID seems three times more frequent than in the general 
population (Ayub et al., 2015). Diagnosis of psychotic disorders is based on a complex assessment of 
subjective symptoms such as delusions and hallucinations. However PwID may exhibit strange 
behaviours to communicate unusual thoughts, especially in those with limited verbal skills.  
An additional complicating issue is that many of the same behaviours that might indicate psychosis 
can also interpreted as features of ID. If a person with ID says that his name has been mentioned in the 
radio, or television, does not be misinterpreted as a delusion of reference. PwID may also think that 
someone is trying to control their own actions, because they require support of others. In grandiose 
delusions, the content can be quite simple in this population - for example, they might think they can 
drive a car.  
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It is important to distinguish true ‘psychotic’ symptoms from ‘psychotic-like’ symptoms; in the latter 
case ‘fantasy thinking’ can be part of the symptomatology of ASD. Furthermore, some adults with ID 
may speak to themselves, an object, or an imaginary person. These behaviours could be indirect signs 
of hallucinations, but could also be symptoms of ID caused by underlying brain abnormalities (Deb et 
al., 2001a).  
 
Personality disorders 
Features of borderline personality disorder, such as self-injurious behaviour, impulsive behaviours and 
affective liability, often occur in PwID (Mavromatis, 2000). However, communication deficit and 
maladaptive behaviours can make a personality disorder very difficult to diagnose in this population, 
especially in those with more severe impairment (Wilson, 2001; Alexander & Cooray, 2003). Also the 
diagnostic criteria of dependent and anxious/avoidant personality disorders may be difficult to identify 
in this group (Alexander & Cooray, 2003). 
 
Eating Disorders 
Numerous and heterogeneous types of eating and feeding problems affect PwID (Gal, 2011). Common 
dysfunctions are pica (Hove, 2004), rumination/regurgitation, psychogenic vomiting (Gravestock, 
2000), food faddiness, and selective food refusal (Gravestock, 2000; Royal College of Psychiatrists, 
2001). 
 
Post Traumatic Stress Disorder 
PwID have been found to more likely to experience traumatic events, such as sexual and physical 
abuse (Focht-New et al., 2008). Fewer abilities in managing adverse life events, maladaptive coping 
strategies, and low social support make PwID more vulnerable to develop PTSD (Tomasulo & Razza, 
2007). Language deficit and impairment in identification or description of his experiences and 
emotional state make it difficult to identify PTSD in individuals with ID (Hall et al., 2014). Studies 
found that traumatic experience in this population often manifests itself in disorganized or agitated 
behaviour, while re-experiencing the trauma takes the form of behavioural acting out of traumatic 
experiences, self-injurious behaviour, nightmares without recognizable trauma-specific content that 
can appear as symptoms of psychosis (Fletcher et al., 2007; Mevissen & de Jongh, 2010).  
 
1.5.1.3 PSYCHIATRIC COMORBIDITY IN SCHIZOPHRENIA AND SCHIZOPHRENIA 
SPECTRUM DISORDERS 
Individuals with SSD show high rates of psychiatric comorbidity including anxiety, depression, OCD, 
and especially substance abuse (Buckley et al., 2009; 2015). 
 
 
 40 
Depression 
Depression can be difficult to identify in people with schizophrenia, because some negative symptoms 
such as anhedonia, abulia, alogia, amotivational state, avolition, and asociality can mimic depression 
features (Mulholland & Cooper, 2000). Study found that depressive symptoms in SSD are related to 
feelings of loss, distress and hopelessness (Bosanac & Castle, 2012).  
Depressive symptoms can occur throughout all phases of the illness, during the course of the disorder, 
in the post-psychotic interval, and may be also associated with the prodromal symptoms (Buckley et 
al., 2009). The post-psychotic depression is considered a psychological reaction to the episode that 
occurs only during the residual phase of schizophrenia. 
Research finding showed that depression in people with schizophrenia is associated with a poorer 
clinical outcome, including more psychotic relapses, suicidality and reduced quality of life (Sim et al., 
2004; Buckley et al., 2009; Tsai & Rosenheckc, 2013).  
 
Anxiety symptoms and anxiety disorders 
Anxiety symptoms are frequently observed among patients with schizophrenia and commonly occur 
along with other mental disorders. Anxiety may appear both spontaneously, in response to psychotic 
symptoms, and as common side effect of antipsychotic drug (Tibbo et al., 2003). People who suffer 
from severe anxiety seem to also have a significant vulnerability to substance use and also to suicidal 
ideations or suicidal behaviours (Fialko et al., 2006).  
Considering specific types of anxiety disorder, panic symptoms and panic attacks seem more common 
in people with paranoid ideation, and can present as part of the prodromal picture of psychosis 
(Labbate et al., 1999; Baylé et al., 2001). Social anxiety is a frequent but often unrecognized comorbid 
disorder in schizophrenia, and is associated with poor outcome (Pallanti et al., 2004).  
 
Obsessive Compulsive Disorder 
Comorbidity with OCD symptoms is commonly reported in those with schizophrenia. OCD can occur 
both in the context of disorder, associated with the prodromal symptoms and in the post-psychotic 
state during the course of chronic schizophrenia (Goodwin et al., 2003; Schirmbeck & Zink, 2013). 
OCD can be difficult to identify because the symptom of schizophrenia might overlap with the OC 
features, especially in cases of catatonic schizophrenia (Fink & Taylor, 2001; Fink, 2013). 
Study found that the most prevalent symptoms in people with schizophrenia and comorbid OCD were 
aggressive and contamination obsessions, followed by somatic and sexual obsessions; the most 
prevalent compulsions were cleaning and washing (Poyurovsky et al., 2003). The existence of a 
comorbid OCD is related to positive symptoms and especially to compulsions, that seem to be a 
phenomenon which is less delusion dependent (Eisen et al., 1997; Öngür & Goff, 2005). 
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Post Traumatic Stress Disorder 
Traumatic events often occur in people with schizophrenia, especially in childhood. In the latter case 
trauma is a risk factor for the onset of psychosis (Morgan & Fisher, 2006; Buckley et al., 2009). 
Schizophrenic patients are more likely to experience trauma than the general population due to illness-
related features, environmental factors, and comorbid substance use (Picken & Tarrier, 2011).  
PTSD seems to have a clear link with positive symptoms; studies found that PTSD comorbid with 
schizophrenia is most commonly associated with paranoia, and higher severity of delusions and 
hallucination (Resnick et al., 2003; Gearon et al., 2004).  
It is less clear whether the symptoms of PTSD are associated with increased (Duke et al., 2010) or 
decreased negative symptoms (Read et al., 2003; Strauss et al., 2009). 
Other researches found that PTSD in schizophrenia is associated with more severe psychopathology 
rather than with cognitive impairment and functional deterioration (Duke et al., 2010; Peleikis et al., 
2013). 
 
Substance abuse 
Alcohol and other drugs abuse are the most prevalent co-occurring disorders in people with 
schizophrenia. Caffeine, cannabis, alcohol, cocaine and especially tobacco, are the substance most 
commonly abused by this population (Winklbaur et al., 2006; Thoma & Daum, 2013).  
Substances producing sedative and relaxing effects are often used to self-medicate the symptoms of 
anxiety, while abuse stimulants to self-medicate negative symptoms. The self-therapeutic hypothesis 
suggests that smoking may improve attention and memory deficits often observed in those with SSD 
(Rezvani & Levin, 2001). 
Alcohol and substance use disorders are related to worse clinical outcomes, increased positive 
symptoms, higher rate of psychosis relapse, physical illnesses, and other mental health disorders 
(Krystal et al., 2006; Winklbaur et al., 2006; Buckley et al., 2009). In particular, cannabis abuse may 
trigger psychotic relapse and is associated with poorer treatment compliance (Volkow, 2009).  
 
1.5.2 PREVALENCE OF COMORBID PSYCHIATRIC DISORDERS 
1.5.2.1 PREVALENCE OF PSYCHIATRIC DISORDERS IN AUTISM AND AUTISM 
SPECTRUM DISORDER 
The prevalence rate of psychiatric disorders in adults with ASD ranges from 16% to 35% (Royal 
College of Psychiatrists, 2014). The prevalence of depression and anxiety in adults with ASD is 
estimated between 15%-42% and 7%-22%, respectively (Ghaziuddin et al., 2002; Matson & 
Cervantes, 2014). OCD prevalence rates ranged from 7% to 24%, and psychotic symptoms from 12% 
to 17% (Leyfer et al., 2006; Royal College of Psychiatrists, 2014). In people with ASD, the rate of 
exposure to trauma in childhood is estimated between 25% and 45% (Costello & Angold, 2000; 
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McCloskey & Walker, 2000), while the risk of developing a PTSD after trauma ranged from 5% to 
45% (McCloskey & Walker, 2000). The lifetime prevalence rate of PTSD in this population is 
estimated between 6–8% (Stallard, 2006). 
 
1.5.2.2 PREVALENCE OF PSYCHIATRIC DISORDERS IN INTELLECTUAL DISABILITY 
(INTELLECTUAL DEVELOPMENTAL DISORDER) 
ID is associated with a high rate of psychiatric disorders; the point prevalence is about 40% and the 
annual incidence 8% (Cooper et al., 2007c). Cooper and her colleagues highlight how psychiatric 
comorbidity may vary considerably depending on the diagnostic criteria applied, ranging from 52.2% 
when the diagnosis is based only on clinical assessment, to 45.1% when the diagnosis is based on the 
DC-LD, up to 11.4% in surveys applying the criteria of the DSM-IV-TR, or even up to 10.9% by 
application of the Diagnostic Criteria for Research of the ICD-10 (DCR-ICD-10; WHO, 1993). 
The prevalence of unipolar depression in PwID is estimated about 3.8%, bipolar disorder 1.3%, and 
manic episode 0.6% (Cooper et al. 2007b,c; Morgan et al., 2008). The rate of anxiety disorders is 
approximately 3.2% using DC-LD criteria. Point prevalence of generalised anxiety disorder was 1.7%, 
and of agoraphobia and panic disorders about 0.4% and 0.2%, respectively (Reid et al., 2011). The 
prevalence rate of psychotic disorders in adults with ID ranges from 2.6% to 4.4% depending upon the 
diagnostic criteria used (Cooper et al., 2007a,c). Problems with eating have been estimated to prevail 
in about one third of PwID (Matson & Kuhn, 2001; Gal et al., 2011), and up to 80% in people with 
more severe impairment and PBs (Gal et al., 2011; Matson & Kuhn, 2001). Prevalence rates of PTSD 
vary substantially, from 2.5 to 60 % (Mevissen & de Jongh, 2011). Rates of co-occurring personality 
disorder ranges from 1% to 91% in a community setting and from 22% to 92% in hospital settings 
(Alexander & Cooray, 2003); Wieland and colleagues (2013) found that personality disorder-NOS 
(19.1%) was most common, followed by borderline personality disorder (8.7%). 
 
1.5.2.3 PREVALENCE OF PSYCHIATRIC DISORDERS IN SCHIZOPHRENIA AND 
SCHIZOPHRENIA SPECTRUM DISORDERS 
The prevalence rate of depression in people with schizophrenia ranges from 23% to 57% (Buckley et 
al., 2009, 2015). More than 65 % of patients with schizophrenia show symptoms of anxiety 
(Temmingh & Stein, 2015), with a prevalence of 9.8% (4.3%–15.4%) for panic disorders, 10.9% 
(2.9%–18.8%) for generalised anxiety disorder, 12.4% (4.0%–20.8%) for PTSD, and 14.9% (8.1%–
21.8%) for social phobia. The prevalence of OCD also varies widely across the studies with a rate 
ranging from 7.0% to 17.1% (Achim et al., 2011; Swets et al., 2014). The prevalence rate of substance 
abuse is particularly high among people with schizophrenia. It is estimated that more than 47% of 
patients show alcohol or substance abuse, and more than 70% are nicotine-dependent (Brady & Sinha, 
2005). 
 
 43 
1.5.3 ETIOPATHOGENESIS OF COMORBID PSYCHIATRIC DISORDERS 
 
1.5.3.1 ETIOPATHOGENESIS OF PSYCHIATRIC DISORDERS IN AUTISM AND AUTISM 
SPECTRUM DISORDER 
Little is known about the causes of comorbid psychiatric disorders in ASD (Ruedrich, 2010). Specific 
risk factors for psychiatric disorders across the lifespan include level of functioning, age, family 
history, genetic factors, and coping strategies (Helvershou et al., 2011; Chandrasekhar & Sikich, 
2015). Significant negative life events, such as family sickness and bereavement, changes in 
caregivers, structure or daily routine may significantly contribute to the occurrence of psychiatric 
disorders in ASD (Ghaziuddin et al., 1995, 2002). People with ASD with higher awareness of their 
low social impairment, more self-perceived impairment and higher rates of anxiety and rumination 
may show lower self-esteem, and discouragement that seem to increase the risk of developing or 
triggering depression (Sterling et al., 2008; Hofvander et al., 2009; Buck et al., 2014). 
 
1.5.3.2 ETIOPHATOGENESIS OF PSYCHIATRIC COMORBIDITY IN INTELLECTUAL 
DISABILITY (INTELLECTUAL DEVELOPMENTAL DISORDER)  
As well as having all the risk factors that are relevant for the whole population, PwID may have extra 
risk factors (Smiley et al., 2007). In some cases the comorbid psychiatric disorders in ID are sequelae 
of other neurological, metabolic, and infective causes of ID; in others, the risk factors for psychiatric 
disorders are not the same that underlying the condition of ID. 
The vulnerability to psychiatric disorders is created through the interaction of biological, 
psychological, social, and developmental factors including sensory impairments, multiple prescribed 
medications, multiple life events, traumatic experiences, limited communication skills, low self-
esteem, and limited coping strategies, as well as genetic and organic factors such as thyroid problems 
and epilepsy (Deb et al., 2001b; Luckasson et al., 2002; Cooper et al., 2007c).  
 
1.5.3.3 ETIOPHATOGENESIS OF PSYCHIATRIC COMORBIDITY IN SCHIZOPHRENIA 
AND SCHIZOPHRENIA SPECTRUM DISORDERS 
Schizophrenic patients may develop comorbid psychiatric disorders both by chance, consequently to 
the core symptoms, and as a consequence of some underlying shared liability with schizophrenia 
(Buckley et al., 2009). Overlap in symptoms, genetic linkage, neurobiology and neurotransmission 
suggests a common etiological mechanism that underlies the comorbid psychiatric disorders and 
schizophrenia (Samson & Wong, 2015). Dopamine and serotonin deregulation are neurotransmitter 
systems involved in schizophrenia, as well as in depression and OCD.  
Furthermore there is a growing evidence of neurochemical shared factors of vulnerability between 
substance abuse and schizophrenia (Bottas et al., 2005; Moore et al., 2007; Buckley et al., 2009). Also 
psychotic symptoms or negative life experiences may themselves be considered as stress factors 
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associated with co-occurring psychiatric disorders including PTSD (Shaw et al., 2002). In addition, 
there is some evidence that pharmacological treatments might directly aggravate psychiatric symptoms 
(Harrow et al., 1994; Green et al., 2003). 
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1.5.4  CONTINUITY, OVERLAPPING AND CO-OCCURRENCE BETWEEN 
INTELLECTUAL DISABILITY, AUTISM SPECTRUM DISORDER AND SCHIZOPHRENIA 
SPECTRUM DISORDERS 
 
Both ID and ASD are metasyndromic groups including several and different clinical conditions 
(Salvador-Carulla & Bertelli, 2008). The difficulties in defining the diagnostic boundaries between 
ASD and ID are largely documented (Palucka et al., 2008; Bryson et al., 2008; Bradley et al., 2011b). 
Some studies report that a 30 – 40% of PwID present also pervasive autistic traits (Morgan et al., 
2002; La Malfa et al., 2004; Cooper et al., 2007c), whereas a 70% of patients with autism are also 
affected by ID (Bryson & Smith, 1998; Baird et al., 2006; U.S. Developmental Disabilities Monitoring 
Network Surveillance, 2006; Edelson, 2006; Matson & Shoemaker, 2009; Hoekstra et al., 2009; 
Noterdaeme & Wriedt, 2010). The boundaries between ID, ASD and SSD are also more difficult to 
define, and they constitute an important issue considering the high co-occurrence of Schizophrenia 
and ASD (Stahlberg et al., 2004; Mouridsen et al., 2008), especially in PwID (Ghaziuddin, 2005; 
Cooper et al., 2007c). Such complexity has been associated to their broad phenotypes that overlap 
over the spectra (King & Lord, 2011), the similar cognitive dysfunctions (Kerns et al., 2008; Sasson et 
al., 2011), alterations of brain regions (Toal et al., 2009), dysregulated neurotransmission (Murphy et 
al., 2006; Tarabeux et al., 2011) and shared genetic factors (Burbach & van der Zwaag, 2009; Carroll 
& Owen, 2009; Pinto et al., 2010).  
Interestingly, both autism and schizophrenia have been described as common sense disorders 
(Minkowski, 1927; Stanghellini, 2000). Specifically, Minkowsky made a distinction between  
‘autisme riche’ and ‘autisme pauvre’, indicating with the former an intensive attempt to find meanings 
in the environment that is also peculiar of what is defined as productive schizophrenia; whereas the 
latter refers to a prevalent lack of contacts with the external world and that is closest to the current 
concept of autism. 
There is evidence of the higher rate of psychotic disorders in adult with ID in respect with the general 
population, with some studies reporting a rate of 3% for schizophrenia in PwID in comparison to the 
1% in people without ID (Turner, 1989; Hassiotis et al., 2001; Cooper et al., 2007c), and others 
suggested a comorbid SSD in 4.4% of PwID (Cooper et al., 2007c). 
However, in a context of a dual diagnosis (i.e., a developmental disorder such as ASD or ID and 
psychiatric disorder) there is evidence of a general tendency to underestimate ASD in PwID in 
presence of a diagnosis of schizophrenia (Savage et al., 2007; Palucka et al., 2009; Bradley et al., 
2011b). Research showed that about 40% of the items which examined a potential psychosis obtained 
a high score in presence of autism (Helverschou et al., 2008). Interestingly, in a twenty year follow up 
study, authors found that in twenty adults who received as children a diagnosis of ‘childhood 
schizophrenia’ (infantile autism) their symptoms did not changed over time (Howells & Guirguis, 
1984). Moreover, although none of them met Schneider’s criteria for schizophrenia (i.e., ‘first rank’ 
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symptoms), they all met Feighner’s criteria for schizophrenia (Feighner, 1972), which coincide with 
Kraepelin’s dementia praecox, Crow’s type II schizophrenia (defect state) and DSM III residual 
schizophrenia (Howells & Guirguis, 1984). 
Data collected from a survey conducted by the National Institute of Mental Health (2004) on a sample 
of subjects with childhood-onset schizophrenia found that a 21% of participants presented a lifetime 
diagnosis of ASD-NOS (Sporn et al., 2004; Towbin, 2005) and some authors found that a 26% of 
adults psychiatric patients had undiagnosed ASD and received instead a diagnosis of schizophrenia 
(Nylander & Gillberg, 2001).  It has been also described a subset of patients affected by a complex 
neurodevelopmental disorder characterized by impairments crossing the diagnostic categories, that 
received the name of ‘autism-plus’ disorder (Cochran et al., 2013) 
It is important to note that the complex diagnosis in people with ASD and ID is essential also in areas 
where there are concerns about mental ill-health and the management of psychiatric comorbidity.  
It is well known that individuals with ID are at greater risk of hospitalization for behavioural and 
mental distress, and this has been associated to the difficulties in recognizing co-occurrent ASD or 
other psychiatric disorders (Lunsky et al., 2009).  Problem behaviours (PBs) and autism have been 
found as the strongest predictors of hospital admission (Cowley et al., 2005; Bhaumik et al., 2008), 
and they resulted frequently associated with mood disorders and aggressive behaviours (Palucka & 
Lunsky, 2007).  
Therefore, there is a considerable amount of data confirming the extreme complexity in the detection 
of psychiatric illness because of the problematic distinction of psychiatric symptoms from the autism 
core symptoms and ID (Lainhart, 1999; Reaven & Hepburn, 2003; Ghaziuddin, 2005). 
It is now clear that the assessment of mental health problems in individuals with ID and ASD raises 
several theoretical questions and methodological dilemmas, and this is due to the definition and 
classification of mental health problems and to the nature of psychiatric assessment (Smiley, 2005; 
Costello & Bouras, 2006), in consideration that the mental illness presentation in PwID and ASD is 
often atypical (Bradley et al., 2011b).  
Data from literature showed that mood disorders (Bradley & Bolton, 2006), anxiety disorders (Hutton 
et al., 2008), SSD, and impulse control disorders (Bradley et al., 2004, Gadow et al., 2005; Hill and 
Furniss, 2006; McCarthy, 2007) are the most frequent psychiatric conditions in people with ASD and 
ID, and teens with autism and ID seem to present increased rates of inattention, hyperactivity and 
impulsivity compared with people affected by ID alone (Bradley & Issacs, 2006). Moreover, people 
with both autism and ID resulted more vulnerable to anxiety, mood, sleep problems, organic 
syndrome, stereotypies and tics (Bradley et al., 2004). 
In this scenario, the investigation of behavioural phenotypes may help to understand mental ill-health 
in some developmental conditions. For example, genetic studies found a statistically significant 
comorbidity between Fragile X Syndrome (FXS) and ASD, with a prevalence rate ranging from 7 to 
25% (Levitas et al., 1983; Hagerman et al., 1986; Bregman et al., 1987; Bailey et al., 1998). However, 
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neither the particular psychiatric features of FXS nor correlations with age or genetics have been 
investigated. The increased occurrence of psychiatric disorder in individuals with FXS has been 
confirmed also by the research group of the Weinberg Centre for Child Development at Tel Hashomer 
in Israel (Gabis et al., 2011). Indeed, findings showed an occurrence of specific phobias and vocal tics 
in about half of participants, whereas the criteria for autistic symptoms and schizoid personality were 
met by one third of them. 
It is evident how a more accurate assessment process of both ASD and ID could provide a better 
understanding of the ‘psychiatric’ presentation and of the associated mental distress (Bradley & 
Bolton, 2006; Palucka et al., 2008; Bradley et al., 2011a,b). 
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1.6 CATEGORICAL AND DIMENSIONAL APPROACHES 
The DSM-5 introduces an integration of a dimensional approach to diagnosis and classification with 
the DSM-IV-TR categorical approach (APA, 2013).  
Previous editions of DSM used a categorical model requiring a clinician to determine that a disorder 
was present or absent. The dimensional approach allows a clinician more liberty to assess the severity 
of a condition and does not imply a real threshold from low-functioning forms to forms with very high 
general skills. All the psychiatric disorders in DSM-5 remain in specific categories, while measures 
indicating degree of severity have been added to several combined diagnoses. Indeed, the DSM-5 
combines four different categorical disorders in the ASD diagnosis, and conceptualizes them as 
occurring along a single spectrum characterized by dysfunctional social communication and restricted, 
repetitive behaviours or interests. Using DSM-IV, people with such symptoms could be diagnosed 
with four separate disorders: autistic disorder, Asperger’s disorder, childhood disintegrative disorder, 
or PDD-NOS.  
Given the phenotypic heterogeneity of this condition, the DSM-5 introduced the concept of 
neurodevelopmental disorders that include a range of disorders associated with learning difficulties, 
skills impairment, high reduction in logical-deductive intelligence, and significant difficulty in sharing 
emotional content (APA, 2013). 
Each of the two classificatory approaches has advantages and disadvantages. Categorical approach is 
based on the kraepelinian and neo-kraepelinian perspective and refers to the process of dividing 
mental disorders into discrete entities, whereas the dimensional concept of spectrum, often used 
interchangeably to that of the continuum, includes a set of clinical forms which show a similar 
appearance or are thought to be caused by the same underlying etiological mechanism, differentiated 
according to increasing severity. The principal disadvantage of the categorical model is its tendency to 
encourage a ‘discrete entity’ view of the psychiatric disorders. Conversely, dimensional approach 
introduces quantitative variation and graded transition between different forms of the disorder, as well 
as between normality and pathology (Maj et al., 2002; Jablensky & Kendell, 2002).  
Since 2009, a dimensional approach to neural circuits and their connections with psychopathology was 
promoted. The National Institute of Mental Health (NIMH) instituted the Research Domain Criteria 
(RDoC) project to develop a research classification system for psychopathology based on 
neurobiology and observable behaviour.  
The RDoC is based on three assumptions. First, the RDoC framework conceptualizes the mental 
illnesses as disorders of brain. While neurological disorders show identifiable lesions, mental 
disorders were considered as disorders of brain circuits. Second, RDoC assumes that the dysfunction 
in neural circuits can be detected by some screening and diagnostic tools employed in neuroscience, 
such as the fMRI. Third, the RDoC framework assumes that data from genetics research and clinical 
neuroscience data from genetics and clinical neuroscience will yield biosignatures that will augment 
clinical symptoms and signs for clinical management. RDoC is intended to support research toward a 
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new classification that encourages investigators to approach to the study of the genetic, neural, and 
behavioural features of mental disorders (Insel et al., 2010; Cuthbert & Insel, 2013; Insel, 2014). 
In this context, advances in knowledge of early brain development brain highlighted the role of the 
neurodevelopmental perspective in theorizing about the aetiology of disorders. Distinctive types of 
psychopathology may have early onset, features in common, and different time courses in symptoms 
depending on the variations of the same underlying disposition. 
Genetic, anatomical, and functional imaging studies in ASD found an atypical organization of 
subcortical and cortical areas related to autistic symptoms. A damage occurring early in the brain 
development may induce a cascade of more complex deficits. Furthermore, neuronal circuits interact 
with others across the different brain regions. The cumulative consequences of these interactions 
among complex biological and also environmental systems alter the course of brain development.  
Advances in the development of dimensional models and approaches to research on psychopathology 
found that behavioural, cognitive, social, and emotional competencies share neurobiological bases, 
evolve across the brain development, and vary across individuals in different traits, abilities or mental 
disorders (Casey et al., 2014). 
Research in ASD and others neurodevelopmental disorders is in progress. How damage in one system 
may lead to deficit in another or how different brain regions develop and interact with others remains 
largely unknown.  
According to RDoC framework, in this study we have indirectly investigated the brain mechanisms 
associated with ID, ASD, and SSD.  
Disruptions in specific cerebro-cerebellar circuits in ASD might interfere with the specialization of 
cortical regions involved in motor control, memory, attention, language, and social interaction, leading 
to deficit in these domains. Extensive connections within the brain provide an anatomical substrate for 
the broad range of clinical presentations of ASD and others neurodevelopmental disorders (D’Mello & 
Stoodley, 2015). 
The international scientific community considered the extreme variability of symptoms as a 
polymorphism due to a complexity of different causal factors, both biological, and environmental. 
Among the biological factors, genetic type has a predominant role. A recent review conducted by 
Torres and colleagues (2015) found that CNVs of 1q21.1, 3q29, 15q11.2, 15q13.3, 16p11.2, 16p13.1 
and 22q11 chromosomal regions result in a wide phenotypic spectrum, ranging from normal 
development to learning problems, including ID, ASD and SSD. Waltereit and collaborators (2013) 
also analysed the functions of genes mutated in these three disorders, and selected some shared 
mechanisms in neurodevelopmental pathways, finding some similarities.  
Emerging evidence suggest that ID, ASD, and also SSD, are part of a single group of 
neurodevelopmental disorders. Aetiologically all the three syndromes are considered to result from the 
overlap between different combination of specific causative factors both genetic and environmental 
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that influence brain growth and maturation with subsequent effects on general and specific 
impairments of cognitive functioning (Owen et al., 2011). 
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1.7 DIFFERENTIAL DIAGNOSIS BETWEEN INTELLECTUAL DISABILITY, AUTISM 
SPECTRUM DISORDER AND SCHIZOPHRENIA SPECTRUM DISORDERS 
 
1.7.1 CLINICAL PRESENTATION 
A reliable diagnosis requires a great knowledge of target symptoms and a considerable attention to the 
details of differential diagnosis. Basically, ID is characterized by significant impairments in cognition, 
social and adaptive behaviour (Matson et al., 2005; Downs et al., 2008; Lifshitz et al., 2008; Myrbakk 
& von Tetzchner, 2008a; Thirion-Marissiaux & Nader-Gosbois, 2008; Yalon-Chamovitz & Weiss, 
2008; Zayac & Johnston, 2008), and by the frequent presence of stereotypies, challenging behaviours 
and autistic symptoms (Lee et al., 2008; Wilkins & Matson, 2009).  
The core symptomatology characterizing ASD consists of impairments in social interaction (e.g., 
inadequate eye contact, inappropriate peer relationships, lack of emotional reciprocity), impaired 
verbal and non-verbal communication (e.g., language delay, poor conversation skills, inability to play 
imaginatively), and a pattern of repetitive behaviours and restricted interests (e.g., repetitive motor 
movements, intense attraction to particular objects or parts of objects) (Matson et al., 2009a,b; Briegel 
et al., 2009; Gillberg, 2010; Horovitz & Matson, 2010; Leung et al., 2010; Smith & Matson, 
2010a,b,c). However, some of these difficulties are also found in PwID (Lee et al., 2008; Matson & 
Shoemaker, 2009). 
As mentioned before, there is an increased risk to receive a diagnosis of schizophrenia spectrum and 
other psychotic disorders in this kind of population, and there is evidence showing that a first 
diagnosis of schizophrenia or psychosis tends to be confirmed over time (Nylander & Gillberg, 2001; 
Bryson et al., 2008; Palucka et al., 2008; Bradley et al., 2011b).  
In order to provide a reliable and robust diagnosis of psychotic disorder in PwID, It is of extreme 
relevance the evaluation of the impact that the ID itself (e.g. cognitive fragmentation associated with 
stressful life events) and a possible co-existing ASD exert on the individual’s clinical presentation 
(Loos & Loss, 2004; Shah & Wing, 2006; Bradley et al., 2011b), even with the consideration of the 
context in which the psychotic-like symptoms appear (Hubert & Hollins, 2006). 
It is important to emphasize that some psychotic-like behaviour such as talking to one’s self, 
regression, as well particular postures that may be assumed in response to stressful events, can be part 
of the ID symptomatology, also without ASD (O'Dwyer, 2000; Hurley et al., 2003). Even some 
particular ways of experiencing the world in ASD that may result in a specific symptomatology, such 
as bizarre expression or fantastic thinking, may be confused with psychotic symptoms (Palucka et al., 
2009). 
In this challenging situation, the careful evaluation of the individual’s developmental history, the 
prodromes, the onset and the course of the condition, the presence of positive symptoms has a central 
role for determining whether the clinical manifestations belong to the autistic or schizophrenic spectra, 
or are the result of their comorbidity (Roy & Balaratnasingam, 2010; Paula-Pérez, 2012). 
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Data documenting neurological and social development from infancy are of great value, in 
consideration that the abnormalities in social cognition typically present in ASD can be detected in the 
first year of age; conversely, in schizophrenia they are evident at seven-eight years old, and more 
frequently in teenage years.   
In terms of differential diagnosis, it has been reported that SSD and ASD can be distinguished by the 
interest towards others (Fitzgerald, 2014), the level of understanding others’ meaning and emotions, 
the manifestation of positive symptoms, and the deficits in global cognition. As Crespi and Badcock 
(2008) reported, individuals with ASD are characterized by an unusual disinterest in shared sense and 
others’ thought, whereas those with schizophrenia try to interpret the other’s thought and intentions, 
and such effort in understanding can become even an obsession. Furthermore, evidence shows that 
people with ASD generally lack of contact with other persons from the infancy, and usually this can 
be evident in the first years of life; conversely, a progressive loss of contact appears to characterize 
individuals affected by schizophrenia (Asperger, 1944). 
According to literature, social cognition refers to a number of abilities encompassing the detection of 
biological motion, the identification of facial affect and metacognitive skills such as the theory of 
mind and the attribution of mental states (Blake et al., 2003).  The impairments in social cognition 
characterizing people with ASD adversely affect face processing, emotion recognition, eye gaze 
processing, face scanning processing, biological motion perception, dynamic social interactions, and 
interpretation of emotionally charged situations (Klin et al., 1999; Baron-Cohen et al., 1999; Edwards 
et al., 2002; Klin et al., 2002; Pelphrey et al., 2002; Blake et al., 2003; Sasson, 2006; Sasson et al., 
2007). It is noteworthy that similar deficits, e.g. impaired perception of emotions, theory of mind, 
perception of social cues, complex social judgments, face scanning processing, and biological motion 
have been also reported in people with schizophrenia (Loughland et al., 2002; Kim et al., 2005; Bora 
et al., 2009; Van't Wout et al., 2009; Haut & MacDonald, 2010; Kohler et al., 2010). 
However, there is evidence that these two conditions can be differentiated considering the strategies 
that people affected use for evaluating events characterized by social and emotional contents. In fact, 
in individuals with schizophrenia it has been described the so-called “jumping to conclusions” bias, 
when they have to evaluate emotional information (Freeman, 2007); instead, in people with ASD a 
poor perceptual integration has been considered the cause of a dysfunctional decoding strategy (Happé 
& Frith, 2006). Consequently, it has been elaborated a new theory conceptualizing ASD as an 
hyposocial disorder and schizophrenia as the opposite, because it is characterized by an hyper, even 
though dysfunctional, development of social attitude (Crespi & Badcock, 2008; Crespi et al., 2010). 
In contrast with what is usually described regarding ASD, in ID social cognition appear less 
compromised in respect to the general intellectual capacity, and this pattern tends to remain stable 
during the lifespan. On the other hand, impairments in cognitive and social abilities that characterize 
schizophrenia appear to gradually increase over time, and may present an exacerbation in early 
adulthood after the first psychotic episode  (Pinkham et al., 2007).  In addition, delusions and 
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hallucinations are typical symptoms of schizophrenia and generally are not present in ID as well in 
ASD (Bradley et al., 2011b). Nevertheless, approximately 90% of children with autism have 
abnormalities in sensory perception affecting smell, taste and also vision (Leekam et al., 2007), and 
they can be mistaken for hallucinations. Also the presence of pretend/imaginary friends, relationships 
with a ‘transitional object’ (when a toy is treated as a real friend), stereotypic preoccupations, concrete 
externalization of thoughts or conscience and pseudo-hallucinations should not be confused with 
hallucinations and delusions (Dossetor, 2007). Other features that can help to differentiate autism and 
schizophrenia are the typical lack of flexibility and the disturbance in response to routine changes 
characterizing autism  (Fitzgerald, 2014), and the bizarre behaviour including stereotypical speech, 
echolalia, posturing, grimacing, and rigidity characterizing the catatonia spectrum. However, mild 
forms of catatonia may also occur in autism, since they have been observed in approximately 17% of 
adolescents and young adults affected (Wing & Shah, 2006).  
In consideration of the current classification systems, it is very likely that the disorganized subtype of 
schizophrenia can be confused with autism, because of its core symptomatology represented by 
disorganized speech and behaviours, and flattened affect. This can be also the case for the residual 
type, because of the persisting negative symptoms after the psychotic episode (Roy & 
Balaratnasingam, 2010). 
It is possible to observe a mixed form of catatonia, autism and psychosis, when none of the single 
diagnoses could explain better the clinical presentation.  If a single diagnosis is given, such as 
'schizophrenia', the standard pharmacological interventions usually do not produce the expected 
response (Shorter & Wachtel, 2013).  
A recent study revealed the presence of a relationship between autistic symptomatology and 
schizotypal traits, and interestingly autism symptoms resulted associated with negative, disorganized 
and positive schizotypal ones (Ford & Crewther, 2014). It is noteworthy that individuals with an ASD 
diagnosis present some schizophrenia spectrum traits during the years of adolescence, and such 
overlap includes not only the negative schizotypal symptomatology, but also the disorganized and 
positive symptoms  (Barneveld et al., 2011). 
 
1.7.2 PSYCHIATRIC COMORBIDITY  
As Boucher et al. (2008) reported, people with both ID and ASD present several core symptoms and 
deficits which are not seen in ID and ASD alone, and a different frequency of comorbid disorders. 
Research showed an inverse relationship between IQ and severity of ASD, and the lower the IQ and 
the higher the rate of challenging behaviours in ASD (O’Brien & Pearson, 2004; Murphy et al., 2009). 
Conversely, the severity level of ASD symptoms - and not that of ID - resulted directly associated 
with the rates of stereotypies (Goldmon et al., 2009; Matson & Kozlowski, 2011). 
Accumulated evidence show the relevant impact that a comorbid condition can have on a person’s life. 
It has been reported the greater risk of hospitalization for individuals with ID for behavioural and 
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mental distress caused by a not recognized ASD or other comorbid conditions (Lunsky et al., 2009), 
and some studies demonstrate that PBs and autism are the strongest predictors of hospital admission 
for PwID (Bhaumik et al., 2008; Cowley et al., 2005). Moreover, they appear frequently associated 
with mood disorders and aggressive behaviours (Palucka & Lunsky, 2007).  
It is extremely complex to identify the presence of psychiatric disorders in individuals with autism and 
ID, because of problems in separating psychiatric manifestations from the autism and ID core 
symptomatology (Lainhart, 1999; Reaven & Hepburn, 2003; Ghaziuddin, 2005). 
For this and other reasons, the diagnostic assessment of mental health problems in individuals with ID 
and ASD raises still concerns. At the centre of debate there are the definition and classification of 
mental health conditions, and the nature of psychiatric assessment (Smiley, 2005; Costello & Bouras, 
2006), in consideration of the largely known atypical presentation of mental illness in PwID and ASD 
(Bradley et al., 2011b). 
Among comorbidities, mood disorders (Bradley & Bolton, 2006), anxiety disorders (Hutton et al., 
2008), SSD, and impulse control disorders (Bradley et al., 2004, Gadow et al., 2005; Hill & Furniss, 
2006; McCarthy, 2007c) have been described as the most frequent psychiatric conditions in people 
with ASD and ID, and higher rates of inattention, hyperactivity, and impulsive behaviours have been 
observed in teens with both autism and ID in comparison with those without ASD (Bradley & Issacs, 
2006). In addition, people with both conditions appear more vulnerable to anxiety, mood, sleep 
problems, organic syndrome, stereotypies and tics (Bradley et al., 2004). 
The study of behavioural phenotypes may be extremely useful to promote further knowledge about 
some developmental conditions such as Fragile X Syndrome (FXS), in which genetic studies showed a 
prevalence of comorbid ASD ranging from 7 to 25% (Levitas et al., 1983; Hagerman et al., 1986; 
Bregman et al., 1987; Bailey et al., 1998). Data relative to the peculiar psychiatric characteristics of 
FXS and genetic constitution are still lacking, however a recent study performed by the research group 
of the Weinberg Centre for Child Development at Tel Hashomer in Israel (Gabis et al., 2011) 
confirmed the frequent occurrence of psychiatric disorders in people with FXS. In such study, specific 
phobias and vocal tics were present in about half of participants, and interestingly one third of them 
met the criteria for autism and schizoid personality. 
 
1.7.3 NEUROANATOMICAL FEATURES 
There is consistent evidence suggesting some neuroanatomical alterations in people with ASD. As 
mentioned above, specifically, increased gray matter volume have been observed bilaterally in the 
cerebellum, in the middle temporal gyrus, in the right anterior cingulate cortex, caudate head, insula, 
fusiform gyrus, precuneus and posterior cingulate cortex, and in the left lingual gyrus. On the contrary, 
there is evidence of reduced gray matter bilaterally in the cerebellar tonsil and inferior parietal lobule, 
in the right amygdala, insula, middle temporal gyrus, caudate tail and precuneus, and in the left 
precentral gyrus. As would be expected on the basis of the clinical heterogeneity of the disorder, ASD 
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is not associated with abnormalities in one specific location alone, but it seems to result from 
alterations in multiple, spatially distributed, neural systems. Findings from neuroanatomical studies 
show that anomalies are prevalent in the neuroanatomical networks, including the limbic system, 
frontostriatal system, frontotemporal and frontoparietal network, as well as the cerebellar system. It is 
likely that the distinct clinical phenotypes partially reflect the different patterns of increased/decreased 
brain volume (Cauda et al., 2011). Neuroimaging studies found a reduction in number and size of 
neurons in the fusiform gyrus (FG), a widening and an activation deficit of the superior temporal 
sulcus (STS), and a decrease in the pruning within the amygdala (AMY) in ASD (Howard et al., 2000; 
van Kooten et al., 2008; Jou et al., 2010).  
Although the recognition of impairments in social cognition also in schizophrenic patients, there are 
only a few studies investigating FG, AMY, and ventrolateral prefrontal cortex functionality, and that 
highlighted levels of hypoactivation comparable to those found in ASD (Pinkham et al., 2008). It is 
reasonable to assume that the limbic system, and in particular the AMY altered functioning, has not 
the same central role in the pathophysiology of social cognition in schizophrenia which instead has in 
ASD. Interestingly, however, other abnormalities in the fronto-limbic circuitry in response to social 
emotional cues have been described in schizophrenia, such as reduced frontal cortex volumes (Convit 
et al., 2001), and a decreased activation in the medial-prefrontal cortex during theory of mind tasks 
(Brunet et al., 2003). Of note, only in schizophrenia a reduced thalamic activation has been reported 
(Sugranyes et al., 2011).  
Collectively, these findings relative to the functioning of social brain network in the two conditions 
may indicate that ASD and schizophrenia are characterized by shared as well distinctive brain 
mechanisms underpinning the social dysfunction, even during the similar execution of specific tasks. 
ASD and schizophrenia show overlapping deficits in theory of mind, eye gaze orienting on faces in 
social scenes, judgments of trustworthiness from faces, and discrimination of emotion from 
impoverished “point-light motion displays” (Craig et al., 2004; Sasson et al., 2007; Couture et al., 
2010). However, facial affect recognition and social orienting appear more impaired in ASD (Bolte & 
Poustka, 2003; Sasson et al., 2007). 
Computed tomography studies performed on individuals affected by chronic psychoses revealed, as 
previously mentioned, enlarged ventricular spaces, probably underlying negative symptoms, and 
hypofrontality. Considering the distinction between deficit and non-deficit schizophrenia, a disruption 
of white matter tracts has been found only in the deficit subtype of schizophrenia in the right inferior 
longitudinal fasciculus, the right arcuate fasciculus, and the left uncinate fasciculus, and not in patients 
with non-deficit schizophrenia and healthy controls. Except this difference, patients with 
schizophrenia of either subtype were characterized by cortical thickness reductions in similar 
neuroanatomic patterns in comparison with healthy controls, whereas all three groups did not differ 
relatively to surface areas and subcortical volumes. Taken together, these findings suggest that white 
matter tract disruption is a neurobiological feature of the deficit syndrome and reductions in cortical 
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thickness represent the distinctive feature of patients diagnosed as having schizophrenia (Iritani, 2013; 
Voineskos et al., 2013). 
 
1.7.4 NEUROPSYCHOLOGICAL FEATURES 
From a neuropsychological perspective, several theories aimed to explain ASD focusing on what they 
considered the underlying core deficit in brain functioning. Therefore, each theory emphasizes one 
aspect rather than another: central coherence deficit, extreme male brain functioning, theory of mind 
deficit, executive functions deficit and hypoactivity of the mirror system. The latter emphasizes the 
role of the mirror neurons, which are considered of fundamental importance for social interaction 
(Lombardo et al., 2012; Keller et al., 2011b).  
In regard to schizophrenia, theories on the extreme male brain functioning and central coherence 
deficit have not been described; in contrast, they focused on the presence of deficits in sustained 
attention and working memory as a trait marker of the disorder, and of deficits related to other 
neuropsychological aspects, such as verbal memory and learning, theory of mind, processing speed, 
visuospatial processing, motor speed, and language, especially related to negative symptoms (Meltzer, 
2004; Kurtz, 2011; Carriòn et al., 2011). 
Recently, an altered mirror system has been implicated also in schizophrenia (Enticott et al., 2008; 
Bertrand et al., 2008; Park et al., 2009; Varcin et al., 2010). Using transcranial magnetic stimulation, 
Enticott et al. (2008) identified alterations in the mirror neuron system in many individuals with 
schizophrenia, and this supports the hypothesis of an underlying connectivity deficit at the basis of the 
disorder, even though that impairment is not as substantial as in autism.  
In conclusion, collected findings suggested that autism is underpinned by abnormalities in brain 
circuitry related to social cognition and communication; instead, in ID cognitive impairments are 
related to logical-deductive skills. Differences in level and extend of disruption of neural circuits may 
account the type and the severity of the syndrome (Owen et al., 2011; Owen, 2012). 
 
Table 1. Differences between ID, ASD and SSD (Bertelli et al., 2015) 
 
CLINICAL DATUM ID ASD SSD 
ONSET AND AGE 
OF RECOGNITION 
• Before 18 yrs [most severe 
ID identified in early years 
while mild ID may not 
identified until later (e.g., 
school entry)] 
• Any time post natal but key 
defining features can be 
traced back to first three years 
 
• First episode of illness in 
adolescence or early adult 
life  
• “at risk” and prodromal 
mental states. 25-40% 
convert 
• Childhood-onset 
schizophrenia – rare before 
7-8 yrs of age 
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CLINICAL 
FEATURES AND IQ 
• IQ <70 
• Often physical stigmata 
• Clinical features associated 
with functioning level – mild, 
moderate, severe, profound 
 
• Triad of impairments: 
social, communication, 
repeat. behaviours (sensory 
abnormalities) 
• Across all functioning 
levels 
• Up to 70% have ID 
• Positive symptoms 
• Negative symptoms 
• Across all levels of IQ but 
may be premorbid decline in 
function 
 
INTEREST 
TOWARDS OTHERS 
variable from case to case unusually disinterested in 
shared sense and others’ 
thought 
try to guess other’s 
attribution of sense 
DELUSIONS not present not present (but fantastic 
thought) 
present 
HALLUCINATIONS not present not present (but sensory 
abnormalities) 
present 
ANATOMICAL 
ANOMALIES OF 
THE CNS 
variable from case to case diffused gray matter increase 
and anomalies in the 
neuroanatomical networks 
enlarged ventricular spaces 
and hypofrontality 
PSYCHIATRIC 
COMORBIDITY 
Psychopathology frequent: 
estimated to be X4 that of the 
general population 
 
Asperger: mood and anxiety 
disorders common 
Autism with ID compared to 
ID only: 
• Greater frequency of new 
onset (episodic) disorders 
e.g., mood, anxiety, 
adjustment disorders 
• Greater frequency of 
background (non episodic) 
disorders e.g., ADHD, tics, 
phobias  
• Episodic and non episodic 
disorders co-exist 
More recently the focus of 
research attention (e.g., 
depression, anxiety) 
 
 
 
 
1.8 AIM 
Differential diagnosis between ASD, ID, and SSD IN ID is often challenging especially for the 
psychiatrist without specific training. 
The aim of the research project is to identify some clinical characteristics that relate most with each of 
the three specific conditions and their combination, which might contribute in turn to the development 
of better criteria of differential diagnosis and psychiatric comorbidity. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1 Study design 
This was a transversal observational descriptive study. 
 
 
2.2 Participants, procedure and setting  
We assessed a sample of 61 adults - 23 women and 38 men – Demographic characteristics of the 
sample are shown in Table 2 and 3. 
The criteria for inclusion in the study were that the participants were age 18 or older at the beginning 
of the study. Study participants have been randomly or consecutively recruited among those attending 
the psychiatric services of CREA, the Department of Neurological and Psychiatric Sciences of the 
University of Florence (DNPS-UF), and two institutes of care attending psychiatric outpatient clinics 
which are located in Tuscany, with a diagnosis or pervasive features of ASD, ID or SSD according to 
the Diagnostic Statistical Manual of Mental Disorders 4th edition, Text Revision (DSM-IV-TR; APA, 
2000).  
The entire sample underwent to a complex psychopathological and anamnestic evaluation, through the 
administration of the instruments listed below by the candidate and in some case by other 
collaborators (psychiatrist and psychologist), to the probands themselves or to proxy informants (i.e. 
family members, educators, social workers, psychologists, or general practitioner), particularly for 
those with more severe impairment. The candidate attended all sessions of evaluation.  
Each patient had to sign an informed consent that allowed the use of their personal data, according to 
the current legislation on Personal Data Protection. Such consent included a detailed explanation of 
the study characteristics and purpose. 
The assessments were conducted in a quiet, private room for the interview and testing, which lasted 
approximately one hour for each participant. The interview and assessment consisted of two or three 
sections, especially in case of participants with ID with more severe impairment accompanied by a 
caregiver.  The assessment scheme was the following: (a) general interview for collecting 
demographic data; (b) administration of five psychopathology assessment tools; (c) neurocognitive 
assessment; (d) clinical assessment. 
 
 
2.3 Assessment tools 
• AQ - Autism Spectrum Quotient (Baron-Cohen, 2001) 
• EQ - Empathy Quotient (Baron-Cohen & Wheelwright, 2004) 
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• SPAID-G (Psychiatric Instrument for the Intellectually Disabled Adult-General version; 
Bertelli, 2012) 
• SPAID-DPS (Psychiatric Instrument for the Intellectually Disabled Adult-Pervasive 
Developmental Disorders; Bertelli, 2012) 
• SPAID-P (Psychiatric Instrument for the Intellectually Disabled Adult-Psychotic disorders; 
Bertelli, 2012)  
• WAIS (Wechsler Adult Intelligence Scale; Wechsler, 1955) 
• DSM-IV-TR (APA, 2000) 
• DC-LD (Diagnostic Criteria for Learning Disabilities; Royal College of Psychiatrists, 2001) 
• DM-ID (Diagnostic Manual for Intellectual Disabilities; National Association for Dual 
Diagnosis, 2007) 
 
1. Psychopathological assessment 
Autism Spectrum Quotient (AQ) 
The Autism-spectrum Quotient (AQ) is a 50-item questionnaire published in 2001 by Simon Baron-
Cohen and his colleagues at the Autism Research Centre at the University of Cambridge, UK. It aims 
to investigate whether adults of average intelligence have symptoms of autism. Its predominate 
clinical use is as a screening tool for high-functioning Autism Spectrum Disorders/Asperger 
Syndrome in adults. The AQ was designed as a self-administered, forced-choice questionnaire for 
quantifying the number of autistic traits. Reponses are given on a 4-point Likert scale (strongly agree 
slightly agree, slightly disagree, strongly disagree). Each item scored 1 point for responses suggesting 
autistic traits either mildly or strongly, and zero otherwise. Basically the range for possible answers is 
0 to 50. Scores of 32 or above are one of strong indicators of having as ASD. The questions cover five 
domains associated with the autism spectrum: social skills, communication skills, imagination, 
attention to detail, and attention switching/tolerance of change.  
 
Empathy Quotient (EQ) 
The Empathy Quotient (EQ) is a 60-item questionnaire (there is also a shorter, 40-item version) of 
which 40 are clinically relevant and 20 are for distraction only designed to measure empathy in adults. 
The test was developed by Simon Baron-Cohen and Sally Wheelwright at the Autism Research 
Centre, University of Cambridge (Baron-Cohen and Wheelwright, 2004). Clinically, the empathy 
measurements provided by the EQ are used in assessing the level of social impairment. Its 
predominate clinical use is as a screening tool for high-functioning Autism Spectrum Disorders in 
adults. The AQ was designed as a self-administered, forced-choice questionnaire. Reponses are given 
on a 4-point Likert scale (strongly agree slightly agree, slightly disagree, strongly disagree). Score can 
range from 0 to 80. A cut-off score fewer than 30 was the most useful to differentiate adult with from 
controls.  
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In this study we used the Italian version of AQ (Ruta et al., 2011) and EQ questionnaires (Preti et al., 
2011). 
SPAID project (Psychiatric Instrument for the Intellectually Disabled Adult)  
The SPAID project was developed by Marco O. Bertelli in 2007 to screen for psychopathology in 
adults with intellectual disabilities in response to the scientific need of acquiring a deeper knowledge 
of the issues related to psychiatric comorbidity in ID, especially in terms of clinical and 
epidemiological features, and to provide the various professionals working in this field with a tool for 
psychopathological evaluation able to elaborate a more refined assessment method.  
To overcome the limits of other tools in distinguishing single psychiatric disorders, SPAID was 
designed not as a single instrument but a package of tools, which includes a general version (SPAID-
G) used for the preliminary identification of the most important psychopathologic diagnostic areas and 
area-specific modules helping to carry out a differential diagnosis between disorders belonging to the 
same group, thus obtaining a defined diagnostic categorization. While the G form does not provide 
any chronological limits in surveying of symptoms, a large number of items related to the area-
specific modules precisely refer to the chronological criteria of DSM syndromes. 
All the tools included in the SPAID system – to date SPAID-G, SPAID-DPS for pervasive 
developmental disorders, SPAID-P for psychotic disorders, SPAID-A for anxiety disorders, and 
SPAID-U for mood disorders - were constructed considering the possibility of identifying psychiatric 
symptoms starting from the observation of behaviours, which is the only survey method applicable to 
all ID cases. The existence of a language disorder must not preclude the patient from expressing his 
state of suffering on a non-verbal level nor preclude the clinician from making inferences on the basis 
of the patient’s attitudes and behaviours. 
 
SPAID-G 
The 52 items that compose the SPAID-G evaluation define behavioural indicators of all the appearing 
symptoms with different aggregations into the various DSM-IV-TR diagnostic categories. For 
example, ‘to glance at areas where no object is to be perceived and/or to gaze constantly’ defines the 
observational/behavioural indicators of the visual hallucination symptom. 
In the calculation process of the current behavioural indicators, the SPAID-G refers to the following 
meta-syndromic groups of DSM-IV-TR: eating disorders, psychotic disorders, depressive disorder, 
manic disorder, anxiety disorders, medication side effects, delirium, dementia, substance-related 
disorders, cluster A (strange) personality disorders, cluster B (dramatic) personality disorders, cluster 
C (anxious) personality disorders, impulse control disorders, identity disorders, simulation and sexual 
disorders. 
The score for each item is dichotomous (zero or one) according to the presence or absence of the 
stated behaviour. The score for a symptom may contribute to the scores of different groupings in the 
same way in which some of the symptoms are transversely present in more than one psychiatric 
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condition. The score of a grouping becomes relevant and indicates the use of area-specific SPAID, if 
more than the half of its items are rated as 1. The mean time for administration was 30 minutes. 
 
SPAID-P  
The 19 items that compose the SPAID-P evaluation define behavioural indicators of all the appearing 
symptoms with different aggregations into the DSM-IV-TR diagnostic categories of psychotic 
disorders. In the calculation process of the behavioural indicators, the SPAID-P refers to the following 
diagnostic groups of DSM-IV-TR: schizophrenia, schizophreniform disorder, delusional disorder, 
brief psychotic disorder, and cluster A personality disorder. 
The score for each item is dichotomous (zero or one) according to the presence or absence of the 
stated behaviour. The mean time for administration was 15 minute. 
 
SPAID-DPS  
The 12 items that compose the SPAID-DPS evaluation define behavioural indicators of all the 
appearing symptoms with different aggregations into the DSM-IV-TR diagnostic categories of 
pervasive developmental disorders. In the calculation process of the behavioural indicators, the 
SPAID-DPS refers to the following diagnostic groups of DSM-IV-TR: Autism, Rett syndrome, 
Childhood disintegrative disorder, Asperger syndrome, and PDD-NOS,  
The score for each item is dichotomous (zero or one) according to the presence or absence of the 
stated behaviour. The mean time for administration was 15 minute. 
The SPAID-G tool is validated in Italian language (Bertelli et al., 2010; Bertelli et al., 2012). 
For a quick calculation of the SPAID scoring, an original software was used in the two available 
versions for DOS and Windows operating systems. 
 
2. Cognitive assessment 
Wechsler Adult Intelligence Scale (WAIS) 
The assessment battery is composed of tests relevant to cover intellectual abilities, memory and 
executive functions. 
The Wechsler Adult Intelligence Scale (WAIS) (Wechsler, 1955) is the most commonly administered 
general intelligence test for adults and is also viewed as a broad assessment of intellectual abilities. It 
is an individually administered measure of intelligence, intended for adults aged 16–89. It is the best 
standard and most widely used intelligence test in clinical practice and is intended to measure human 
intelligence reflected in both verbal and performance abilities. The original WAIS was published in 
1955 by David Wechsler, as a revision of the Wechsler-Bellevue Intelligence Scale that had been 
released in 1939. The last edition of the test (WAIS-IV) was released in 2008 from Pearson. We used 
in this study the Italian version of the WAIS-R (1981, it. tr. 1997). It consisted of six verbal and five 
performance subtests. The verbal tests were: information, comprehension, arithmetic, digit span, 
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similarities, and vocabulary. The Performance subtests were: picture arrangement, picture completion, 
block design, object assembly, and digit symbol. It provided scores for Verbal IQ, Performance IQ, 
and Full Scale-Total IQ. The mean time of administration was 60-90 minutes. 
 
The entire sample was subjected to psychopathological assessment through the use of a rating scale for 
psychodiagnostic orientation, SPAID-G. The entire sample was also evaluated with the SPAID-P and 
SPAID-DPS. Part of the sample was screened for ASD through the assessment of the Italian 
adaptations of Baron-Cohen’s AQ and EQ (30 participants). The tests were hetero-administered in the 
case of people with intellectual disabilities. 
The entire sample was evaluated for neurocognitive functions through the WAIS-R administration. 
Sub-areas scores of WAIS-R were available for part of the sample (33 participants). Total IQ score 
was estimate for the entire sample. 
For the entire 61 participants clinical diagnoses were carried out by clinical psychiatrists according to 
the DSM-IV-TR, DC-LD and DM-ID criteria. Diagnostic Criteria for Learning Disability (DC-LD) 
(Royal College of Psychiatrists, 2001) and Diagnostic Manual - Intellectual Disability (DM-ID) 
(Fletcher et al., 2007) are the adaptation of the ICD-10 and DSM-IV-TR tailored for people with 
produced by The Royal College of Psychiatrists (UK) and the National Association for Dual 
Diagnosis (USA), respectively. 
 
 
2.4 Statistical analyses 
The statistical analyses were carried out according to the following methods. 
The background characteristics were evaluated by the calculation of averages and standard deviations.  
For AQ and EQ, the analysis of variance (ANOVA) was used to assess a mean scores comparison 
between presence and absence of diagnosis at T1. 
The SPAID tools score differences were analysed through many different statistical methods. The 
SPAID-G area mean scores comparison between presence and absence of ID, ASD and SSD 
diagnoses at T0 and T1 were evaluated by Student’s t-test. The ANOVA statistical analysis was used 
to evaluate the mean scores comparison between presence and absence of diagnosis at T1 for SPAID-
G and SPAID-P delusion and hallucination items. 
The correlations between SPAID areas in ID, ASD, and SSD groups at Time 1 was estimated through 
Spearman’s R. The calculation of averages and standard deviations was used to evaluate the frequency 
of SPAID-G items in ID, ASD and SSD groups at Time 1. 
The multiple regression block-wise and stepwise were performed to evaluate the relationship between 
SPAID-G areas and ID, ASD or SSD diagnoses. Hierarchical regression analysis was applied to study 
the association between SPAID-G areas and both the three diagnoses and age and gender. 
The WAIS score differences were analysed using different types of statistical analysis. 
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The ANOVA was used to assess the comparison between WAIS test mean scores and the presence 
and absence of diagnosis at T1. The WAIS test mean scores in the total sample were calculated by the 
average, and standard deviation. The Kruskal-Wallis H test was employed to analyse the differences in 
WAIS test scores between ID, ASD and SSD at Time 1. 
Statistic pack SPSS 16.0 for Windows has been utilized to create and the update database and for 
further statistical processing of data.
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CHAPTER 3 
 
RESULTS 
 
3.1 ID, ASD, and SSD diagnoses at T0 and T1 
Comparing the diagnoses at T0 and T1 we found considerable differences. The diagnoses of ID were 
37 at T0 and 55 at T1, with an increase of around 149%. The diagnoses of ASD were 27 at T0 and 40 
at T1, with a percentage increase of around 148. The diagnoses of SSD were almost the same at T0 
and T1, 24 and 28 respectively. 
The diagnoses of co-occurrence of ASD in ID passed from 9 at T0 to 36 at T1, with an increase of 
400%. The diagnoses of co-occurrence of SSD in ID passed from 7 at T0 to 25 at T1, with an increase 
of around 357%. 
The co-occurrence of ASD and SSD was 1 at T0 and 8 at T1, referred for 7 cases to persons with ID.  
 
 
3.2 Background characteristics of the sample 
A total of 61 participants took part in the study. These comprised 38 males and 23 females with a 
mean age of 30.82 years. At T0 they included 37 persons with ID, 27 with ASD, and 24 with SSD. In 
most cases information on the ID degree was unavailable, for lack of inappropriate assessment. 
Comorbidity between ID, ASD, and/or SSD was found in a few cases, 9 ID + ASD, 7 ID + SSD, and 1 
ASD+SSD. Any participant presented co-occurrence of all the three diagnoses. 
At T0 background characteristics were not available for most participants, with the exception of 
gender, age, and, to a lesser extent, education. These have been summarised in Table 2. 
At T1 participants with ID were 55. The ID degree was distributed as follows: Borderline Intellectual 
Functioning (BIF) in 16 participants, mild in 11, moderate in 17, and severe in 4. Only 6 out of the 61 
study participants weren’t diagnosed with ID. The education level ranged from 5 (Primary school) to 
17 years (University) with a mean of 11.13 years. Participants with ASD were 40, with a gender ratio 
higher than in the other groups: 28 male and 12 female. The ID degree was moderate in the majority 
of cases. Participants with SSD were 28, with a very high prevalence of borderline ID. 
The number of cases presenting ID in comorbidity with ASD or SSD was 36 and 25, respectively. 
Participants with ID and co-occurring ASD and SSD were 7, 5 male and 2 female. Their average age 
was 33.71 years, with a preponderance of borderline intellectual functioning. 
Details on background characteristics and co-occurrence of ASD and/or SSD at T1 are shown in Table 
3 and 4. 
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Table 2. Background characteristics in the total sample at T0 
 
 
N 
 
tot= 
61 
ID level 
n (%) 
 
Age 
range 
(mean±s.d.) 
Gender 
n (%) 
 
Educational 
stage (yrs) 
 
5=Primary 
school 
17=University 
range 
(mean±s.d.) 
 
Absent BIF^ 
 
Mild Moderate Severe  Males Females  
ID 37 12 
(32,4%) 
3  
(8,1%) 
7 
(18,9%) 
 8 
(21,6%) 
7  
(18,9%) 
19-58 
(31,46±2,12) 
19  
(70,3%) 
6  
(29,7%) 
5-17 
(10,67±0,58) 
ASD 27 3 
 (25%) 
0 3 
(25%) 
3 
(25%) 
3 
(25%) 
18-46 
(25,19±1,44) 
18  
(66,7%) 
9  
(33,3%) 
5-17 
(11,96±0,43) 
SSD 24 9 
(56,2%) 
1 
(6,25%) 
1 
(6,25%) 
3 
(18,8%) 
2  
(12,5%) 
19-58 
(36,5±2,44) 
12  
(50%) 
12 
(50%) 
8-17 
(11,36±0,60) 
ID+ASD 9  0 3 
(33.3%) 
3 
(33.3%) 
3 
(33.3%) 
19-46 
(28.33±10.14) 
7 
(77.8%) 
2 
(22.2%) 
8-13 
(11.22±2.43) 
ID+SSD 7  1 
(14.3%) 
1 
(14.3%) 
3 
(42.9%) 
2 
(28.6%) 
22-58 
(43.43±12.56) 
4 
(57.1%) 
3 
(42.9%) 
5-17 
(10.33±3.98) 
ASD+SSD 1  1 
(100%) 
   19 
 
1 
(100%) 
- 13 
ID+ASD+SSD 0 - - - - - - - - - 
^ BIF: Borderline Intellectual Functioning  
 
 
 
Table 3. Background characteristics in the total sample at T1 
 
 
N 
 
tot= 
61 
ID level 
n (%) 
 
Age 
range 
(mean±s.d.) 
Gender 
n (%) 
 
Educational 
stage (yrs) 
 
5=Primary 
school 
17=University 
range 
(mean±s.d.) 
 
Absent BIF^ 
 
Mild Moderate Severe  Males Females  
ID 55  16 
(29.1%) 
11  
(20%) 
17  
(30.9%) 
4  
(20%) 
18-58 
(31.00±10.86) 
35 
(63.6%) 
20 
(36.4%) 
5-17 
(11.13±2.48) 
ASD 40 4 
(10%) 
9 
(22.5%) 
7 
(17.5%) 
12 
(30%) 
8 
(20%) 
18-58 
(28.30±10.38) 
28 
(70%) 
12 
(30%) 
5-17 
(11.44±2.57) 
SSD 28 3 
(10.7%) 
11 
(39.3%) 
5 
(17.9%) 
6 
(21.4%) 
3 
(10.7%) 
18-58 
(34.96±10.65) 
15 
(53.6%) 
13 
(46.4%) 
8-17 
(11.26±2.52) 
ID+ASD 36  9 
(25%) 
7 
(19.4%) 
12 
(33.3%) 
8 
(22.2%) 
18-58 
(28.83±10.67) 
25 
(69.4%) 
11 
(30.6%) 
5-14 
(11.26±2.47) 
ID+SSD 25  11 
(44%) 
5 
(20%) 
6 
(24%) 
3 
(12%) 
21-58 
(35.16±10.17) 
15 
(60.%) 
10 
(40.%) 
8-17 
(10.92±2.41) 
ASD+SSD 8 1 
(12.5%) 
4 
(50%) 
1 
(12.5%) 
1 
(12.5%) 
1 
(12.5%) 
19-46 
(31.88±11.25) 
5 
(62.5%) 
3 
(37.5%) 
8-13 
(11.50±2.00) 
ID+ASD+SSD 7  4 
(57.1%) 
1 
(14.3%) 
1 
(14.3%) 
1 
(14.3%) 
22-46 
(33.71±10.78) 
5 
(71.4%) 
2 
(28.6%) 
8-13 
(11.29±2.05) 
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Table 4. Total sample background characteristics stratified by intellectual disability degree 
 
 
  
ID level 
n (%) 
 
 
Age 
range 
(mean±s.d.) 
 
 
Gender 
n (%) 
 
Educational stage (yrs) 
 
5=Primary school 
17=University 
range 
(mean±s.d.) 
Males 
 
Females 
 
ID 55 
BIF 16 (29.1%) 20-58 (35.75±10.72) 12 (75%) 4 (25%) 8-17 (12.56±1.96) 
Mild 11 (20%) 19-46 (30.90±10.40) 6 (54.5%) 5 (45.5%) 8-14 (11.00±2.32) 
Moderate 17 (30.9%) 18-56 (27.65±10.35) 9 (52.9%) 8 (47.1%) 5-13 (10.31±2.62) 
Severe 4 (20%) 19-58 (29.36±11.26) 8 (72.7%) 3 (27.3%) 8-13 (10.30±2.49) 
ASD 40 
Absent 4 (10%) 19-32 (23.50±6.13) 3 (75%) 1 (25%) 9-17 (13±3.26) 
BIF 9 (22.5%) 20-45 (30.56±9.00) 7 (77.8%) 2 (22.2%) 9-13 (12.56±1.30) 
Mild 7 (17.5%) 19-46 (25.86±9.29) 4 (57.1%) 3 (42.9%) 8-14 (12.14±2.00) 
Moderate 12 (30%) 18-56 (27.33±11.81) 8 (66.7%) 4 (33.3%) 5-13 (10.58±2.93) 
Severe 8 (20%) 19-58 (31.75±12.53) 6 (75%) 2 (25%) 8-13 (9.86±2.41) 
SSD 28 
Absent 3 (10.7%) 19-52 (33.33±16.92) 0 3 (100%) 13-16 (14.00±1.73) 
BIF 11 (39.3%) 22-58 (39.18±10.64) 8 (72.7%) 3 (27.3%) 8-17 (12.36±2.37) 
Mild 5 (17.9%) 35-46 (41.00±5.09) 2 (40%) 3 (60%) 8-10 (8.80±1.09) 
Moderate 6 (21.4%) 21-36 (27.33±6.43) 2 (33.3%) 4 (66.7%) 8-12 (10.00±1.58) 
Severe 3 (10.7%) 22-34 (26.33±6.65) 3 (100%) 0 8-13 (10.67±2.51) 
ID+ASD 36 
BIF 9 (25%) 20-45 (30.56±9.00) 7 (77.8%) 2 (22.2%) 9-13 (12.56±1.33) 
Mild 7 (19.4%) 19-46 (25.86±9.29) 4 (57.1%) 3 (42.9%) 8-14 (12.14±2.03) 
Moderate 12 (33.3%) 18-56 (27.33±11.81) 8 (66.7%) 4 (33.3%) 5-13 (10.58±2.93) 
Severe 8 (22.2%) 19-58 (31.75±12.53) 6 (75%) 2 (25%) 8-13 (9.86±2.41) 
ID+SSD 25 
BIF 11 (44%) 22-58 (39.18±10.64) 8 (72.7%) 3 (27.3%) 8-17 (12.36±2.37) 
Mild 5 (20%) 35-46 (41.00±5.09) 2 (40%) 3 (60%) 8-10 (8.80±1.09) 
Moderate 6 (24%) 21-36 (27.33±6.43) 2 (33.3%) 4 (66.7%) 8-12 (10.00±1.58) 
Severe 3 (12%) 22-34 (26.33±6.65) 3 (100%) 0 8-13 (10.67±2.51) 
ASD+SSD 8 
Absent 1 (12.5%) 19 0 1 (100%) 13 
BIF 4 (50%) 22-45 (33.50±11.67) 3 (75%) 1 (25%) 9-13 (12.00±2.00) 
Mild 1 (12.5%) 46 0 1 (100%) 8 
Moderate 1 (12.5%) 22 1 (100%) 0  12 
Severe 1 (12.5%) 34 1 (100%) 0 11 
ID+ASD+ 
SSD 7 
BIF 4 (57.1%) 22-45 (33.50±11.67) 3 (75%) 1 (25%) 9-13 (12.00±2.00) 
Mild 1 (14.3%) 46 0 1 (100%) 8 
Moderate 1 (14.3%) 22 1 (100%) 0  12 
Severe 1 (14.3%) 34 1 (100%) 0 11 
 67 
3.3 AQ and EQ 
 
For AQ and EQ only a mean scores comparison between presence and absence of diagnosis at T1 was 
performed. 
For ID, no statistically significant differences were observed between those who received  a diagnosis 
at T1 and those who did not. 
Within the ASD group a statistically significant difference was found only for EQ mean scores, while 
those with SSD presented statistically significant differences for both measures, although to a lesser 
extent for AQ (see Table 5). 
 
Table 5. AQ and EQ mean scores comparison between presence and absence of diagnosis at T1  
 
 
ID ASD SSD 
F Sig. F Sig. F Sig. 
AQ tot .276 .891 1.912 .178 7.593 .010 
EQ tot .787 .545 11.267 .002 29.739 .000 
*Sig. p≤ 0.05 
 
 
 
3.4 SPAID 
 
Being the behavioural equivalents of psychopathological symptoms the main focus of our research, 
the SPAID tools score differences were analysed through many different statistical methods.  
 
3.4.1 SPAID-G area mean scores comparison between presence and absence of diagnosis at T0  
 
Within the ID group, no statistically significant SPAID-G area mean scores differences were observed 
between those who received a diagnosis at T0 and those who did not. 
For ASD, a statistically significant difference was found for Sexual disorders, Simulation, DOC, and 
especially Medication side effects mean scores. Those with SSD presented statistically significant 
differences for Sexual disorders, Medication side effects and Anxiety disorders mean scores, although 
significance for Sexual disorders and Medication side effects was lower than in those with ASD. 
Furthermore in SSD a statistically significant difference was found especially for Autism and DOC 
area mean scores (see Table 6). 
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Table 6. SPAID-G area mean scores comparison between presence and absence of diagnosis at T0 
 
SPAID-G AREA ID ASD SSD F Sig. F Sig. F Sig. 
Eating disorders .907 .472 .932 .339 .073 .789 
Psychotic disorders .681 .610 .000 .998 1.281 .262 
Depression .479 .751 1.473 .230 .012 .914 
Mania 1.870 .140 2.324 .133 3.443 .069 
Anxiety disorders 1.585 .202 5.042 .029 5.776 .020 
Medication side effects .173 .951 9.327 .003 4.231 .044 
Delirium  .748 .567 .012 .913 .312 .579 
Dementia  .576 .682 .906 .345 .156 .694 
Substance-related disorders .918 .465 .171 .681 1.662 .203 
personality disorders Cluster A (strange) .903 .474 .574 .452 .884 .351 
personality disorders Cluster B (dramatic) 1.026 .409 .714 .402 .782 .380 
personality disorders Cluster C (anxious) .098 .982 .033 .857 3.103 .084 
Impulse control disorders 1.388 .260 2.642 .110 .831 .366 
Autism  .249 .908 1.948 .168 9.301 .003 
Identity disorders  .889 .482 3.278 .075 3.419 .070 
Simulation  1.287 .296 7.481 .008 2.910 .093 
Sexual disorders  .604 .663 4.640 .035 4.250 .044 
DOC 1.699 .190 7.669 .008 10.129 .003 
*Sig. p≤ 0.05 
 
 
3.4.2 SPAID-G area mean scores comparison between presence and absence of diagnosis at T1 
 
For ID, statistically significant SPAID-G area mean score differences were found only for Simulation 
between those who received a diagnosis at T1 and those who did not. 
Participants with ASD presented statistically significant differences for DOC, Sexual, and particularly 
for Autism mean scores. Within the SSD group, a statistically significant difference was observed 
especially for DOC mean scores. Furthermore in this latter group statistically significant differences 
were also found for Identity disorders, Simulation, Depression, Sexual disorders, and Medication side 
effects (see Table 7). 
 
Table 7. SPAID-G area mean scores comparison between presence and absence of diagnosis at T1 
 
SPAID-G AREA ID ASD SSD F Sig. F Sig. F Sig. 
Eating disorders 2.356 .065 .266 .608 .602 .441 
Psychotic disorders 2.073 .097 1.877 .176 3.497 .066 
Depression 1.747 .153 2.875 .095 4.915 .030 
Mania 1.042 .394 .066 .799 .015 .904 
Anxiety disorders 1.200 .321 1.105 .297 .671 .416 
Medication side effects 1.405 .244 3.251 .076 6.425 .014 
Delirium  1.184 .328 1.881 .184 2.855 .096 
Dementia  2.307 .069 1.229 .272 3.325 .073 
Substance-related disorders 1.477 .222 .039 .844 .419 .520 
personality disorders Cluster A (strange) 1.390 .249 .201 .656 1.588 .213 
personality disorders Cluster B (dramatic) 1.109 .361 .077 .782 .261 .611 
personality disorders Cluster C (anxious) 1.116 .358 .074 .786 .785 .379 
Impulse control disorders .999 .416 1.435 .236 2.213 .142 
Autism  .660 .622 12.660 .001 3.322 .073 
Identity disorders  1.445 .231 1.445 .234 4.130 .047 
Simulation  3.083 .023 1.615 .209 4.485 .038 
Sexual disorders  1.033 .398 6.270 .015 5.086 .028 
DOC 1.825 .144 6.011 .018 23.416 .000 
*Sig. p≤ 0.05 
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3.4.3 Significant Correlations between SPAID areas in ID, ASD, and SSD groups at Time 1 
 
For the ID group, the correlations between SPAID areas resulted in the following frequency: Anxiety 
Disorders (13 correlations), Substance-related disorders (13), Psychotic disorders (12), Depression 
(11), Delirium (10), Dementia (10), Mania (9), personality disorders Cluster A (strange) (9), 
personality disorders Cluster B (dramatic) (8), Impulse control disorders (7), Identity disorders (7), 
personality disorders Cluster C (anxious) (6), Medication side effects (5), Simulation (5), Eating 
disorders (3), Autism (2), Sexual disorders (1), and DOC (1) (see Table 8). 
For the ASD group: Psychotic disorders (13), Substance-related disorders (13), Depression (11), 
Anxiety disorders (11), Delirium (10), personality disorders Cluster A (strange) (10), Mania (9), 
Dementia (9), personality disorders Cluster B (dramatic) (9), Identity disorders (8), Medication side 
effects (7), Impulse control disorders (7), Simulation (7), personality disorders Cluster C (anxious) (5), 
Eating disorders (4), DOC (3), and Autism (2). For Sexual disorders we did not find any statistically 
significant correlation (see Table 9).  
Finally, for the SSD: Anxiety disorders (9), Depression (8), Mania (8), Dementia (8), Substance-
related disorders (8), Psychotic disorders (7), Delirium (7), personality disorders Cluster A (strange) 
(6), Impulse control disorders (5), personality disorders Cluster B (dramatic) (4), Medication side 
effects (3), personality disorders Cluster C (anxious) (3), Simulation (2), Eating disorders (1), and 
Identity disorders (1). Autism, Sexual disorders, and DOC did not show any significant correlation 
(see Table 10). 
 
 70 
 
Table 8. Significant Correlations between SPAID areas in ID at Time 1 
 
Spearman R; **. Sig. 0.01 (2-way). N=always ranging from 54 to 55 (38 only for DOC) 
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Eating disorders 
Correl R   .554**   .655**   .362**          
Sig.   .000   .000   .007          
Psychotic disorders 
Correl R   .843** .698** .680** .346** .846** .800** .848** .622** .452** .485** .419**  .458**    
Sig.   .000 .000 .000 .010 .000 .000 .000 .000 .001 .000 .001  .000    
Depression 
Correl R .554** .843**  .496** .555** .660** .697** .764** .744** .616**  .475**   .409**    
Sig .000 .000  .000 .000 .000 .000 .000 .000 .000  .000   .002    
Mania 
Correl R  .698** .496**  .706**  .774** .621** .846**  .675**  .564**   .371**   
Sig.  .000 .000  .000  .000 .000 .000  .000  .000   .005   
Anxiety disorders 
Correl R  .680** .555** .706**   .642** .541** .749** .474** .563** .445** .578**   .436** .345** .535** 
Sig.  .000 .000 .000   .000 .000 .000 .000 .000 .001 .000   .001 .010 .001 
Medication side effects 
Correl R .655** .346** .660**     .407** .346**          
Sig. .000 .010 .000     .002 .010          
Delirium 
Correl R  .846** .697** .774** .642**   .765** .820** .421** .471**  .389**  .372**    
Sig.  .000 .000 .000 .000   .000 .000 .001 .000  .003  .005    
Dementia 
Correl R  .800** .764** .621** .541** .407** .765**  .666** .544**  .416**   .380**    
Sig.  .000 .000 .000 .000 .002 .000  .000 .000  .002   .004    
Substance-related disorders 
Correl R .362** .848** .744** .846** .749** .346** .820** .666**  .407** .633**  .593**  .407** .415**   
Sig. .007 .000 .000 .000 .000 .010 .000 .000  .002 .000  .000  .002 .002   
personality disorders 
Cluster A (strange) 
Correl R  .622** .616**  .474**  .421** .544** .407**   .779**  .411** .348**    
Sig  .000 .000  .000  .001 .000 .002   .000  .002 .009    
personality disorders 
Cluster B (dramatic) 
Correl R  .452**  .675** .563**  .471**  .633**    .813**  .445** .686**   
Sig.  .001  .000 .000  .000  .000    .000  .001 .000   
personality disorders 
Cluster C (anxious) 
Correl R .485**  .475**  .445**   .416**  .779**    .484**     
Sig. .000  .000  .001   .002  .000    .000     
Impulse control disorders 
Correl R  .419**  .564** .578**  .389**  .593**  .813**     .757**   
Sig.  .001  .000 .000  .003  .000  .000     .000   
Autism 
Correl R          .411**  .484**       
Sig.          .002  .000       
Identity disorders 
Correl R  .458** .409**    .372** .380** .407** .348** .445**        
Sig.  .000 .002    .005 .004 .002 .009 .001        
Simulation 
Correl R    .371** .436**    .415**  .686**  .757**      
Sig.    .005 .001    .002  .000  .000      
Sexual disorders 
Correl R     .345**              
Sig.     .010              
DOC 
Correl R     .535**              
Sig.     .001              
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Table 9. Significant Correlations between SPAID subarea in ASD at Time 1 
 
Spearman R; **. Sig. 0.01 (2-way). N=always is 40 (39 only for DCA and 32 only for DOC) 
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Eating disorders 
Correl R   .604**   .646**   .416**   .434**       
Sig.   .000   .000   .008   .006       
Psychotic disorders 
Correl R   .853** .722** .736** .427** .817** .785** .890** .666** .576** .482** .505**  .552** .424**   
Sig.   .000 .000 .000 .006 .000 .000 .000 .000 .000 .002 .001  .000 .006   
Depression 
Correl R .604** .853**  .545** .626** .739** .713** .787** .784** .669**  .460**   .479**    
Sig. .000 .000  .000 .000 .000 .000 .000 .000 .000  .003   .002    
Mania 
Correl R  .722** .545**  .756**  .828** .621** .859**  .751**  .607**   .496**   
Sig.  .000 .000  .000  .000 .000 .000  .000  .000   .001   
Anxiety disorders 
Correl R  .736** .626** .756**   .761** .637** .791** .481** .623**  .525**   .472**  .537** 
Sig.  .000 .000 .000   .000 .000 .000 .002 .000  .001   .002  .002 
Medication side effects 
Correl R .646** .427** .739**     .506** .413** .426**     .481**    
Sig. .000 .006 .000     .001 .008 .006     .002    
Delirium 
Correl R  .817** .713** .828** .761**   .705** .875** .412** .686**  .558**  .481**    
Sig.  .000 .000 .000 .000   .000 .000 .008 .000  .000  .002    
Dementia 
Correl R  .785** .787** .621** .637** .506** .705**  .691** .563**     .513**    
Sig.  .000 .000 .000 .000 .001 .000  .000 .000     .001    
Substance-related disorders 
Correl R .416** .890** .784** .859** .791** .413** .875** .691**  .483** .714**  .627**  .496** .527**   
Sig. .008 .000 .000 .000 .000 .008 .000 .000  .002 .000  .000  .001 .000   
personality disorders 
Cluster A (strange) 
Correl R  .666** .669**  .481** .426** .412** .563** .483**   .821**  .625** .468**    
Sig.  .000 .000  .002 .006 .008 .000 .002   .000  .000 .002    
personality disorders 
Cluster B (dramatic) 
Correl R  .576**  .751** .623**  .686**  .714**    .833**  .430** .724**  .614** 
Sig.  .000  .000 .000  .000  .000    .000  .006 .000  .000 
personality disorders 
Cluster C (anxious) 
Correl R .434** .482** .460**       .821**    .624**     
Sig. .006 .002 .003       .000    .000     
Impulse control disorders 
Correl R  .505**  .607** .525**  .558**  .627**  .833**     .854**   
Sig.  .001  .000 .001  .000  .000  .000     .000   
Autism 
Correl R          .625**  .624**       
Sig.          .000  .000       
Identity disorders 
Correl R  .552** .479**   .481** .481** .513** .496** .468** .430**        
Sig.  .000 .002   .002 .002 .001 .001 .002 .006        
Simulation 
Correl R  .424**  .496** .472**    .527**  .724**  .854**     .501** 
Sig.  .006  .001 .002    .000  .000  .000     .003 
Sexual disorders 
Correl R                   
Sig.                   
DOC 
Correl R     .537**      .614**     .501**   
Sig.     .002      .000     .003   
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Table 10. Significant Correlations between SPAID subarea in SSD at Time 1 
 
Spearman R; **. Sig. 0.01 (2-way). N=always 28 
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Eating disorders 
Correl R      .497**             
Sig.      .007             
Psychotic disorders 
Correl R   .833** .749** .738**  .867** .736** .882** .608**         
Sig.   .000 .000 .000  .000 .000 .000 .001         
Depression 
Correl R  .833**  .518** .625** .675** .770** .741** .743** .609**         
Sig.  .000  .005 .000 .000 .000 .000 .000 .001         
Mania 
Correl R  .749** .518**  .566**  .711** .516** .839**  .563**  .598**      
Sig.  .000 .005  .002  .000 .005 .000  .002  .001      
Anxiety disorders 
Correl R  .738** .625** .566**   .569** .487** .688** .497**  .504** .492**      
Sig.  .000 .000 .002   .002 .009 .000 .007  .006 .008      
Medication side effects 
Correl R .497**  .675**     .514**           
Sig. .007  .000     .005           
Delirium 
Correl R  .867** .770** .711** .569**   .795** .747** .550**         
Sig.  .000 .000 .000 .002   .000 .000 .002         
Dementia 
Correl R  .736** .741** .516** .487** .514** .795**  .598** .623**         
Sig.  .000 .000 .005 .009 .005 .000  .001 .000         
Substance-related disorders 
Correl R  .882** .743** .839** .688**  .747** .598**   .519**  .551**      
Sig.  .000 .000 .000 .000  .000 .001   .005  .002      
personality disorders 
Cluster A (strange) 
Correl R  .608** .609**  .497**  .550** .623**    .748**       
Sig.  .001 .001  .007  .002 .000    .000       
personality disorders 
Cluster B (dramatic) 
Correl R    .563**     .519**    .795**   .721**   
Sig.    .002     .005    .000   .000   
personality disorders 
Cluster C (anxious) 
Correl R     .504**     .748**     .513**    
Sig.     .006     .000     .005    
Impulse control disorders 
Correl R    .598** .492**    .551**  .795**     .705**   
Sig.    .001 .008    .002  .000     .000   
Autism 
Correl R                   
Sig.                   
Identity disorders 
Correl R            .513**       
Sig.            .005       
Simulation 
Correl R           .721**  .705**      
Sig.           .000  .000      
Sexual disorders 
Correl R                   
Sig.                   
DOC 
Correl R                   
Sig.                   
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3.4.4 Frequency of SPAID-G items in ID, ASD and SSD groups at Time 1 
 
Some SPAID-G items were scored positive much more than others in one, two or all the three 
diagnostic groups. The item 2 (psychomotor agitation and/or restlessness) and the item 8 (unjustified 
irritation/opposition) showed the higher scores in all the three diagnostic groups. The items 7 (loss of 
satisfaction or pleasure for activities or objects) and 16 (avoidance or escape from certain objects, 
people or situations) were frequent in ID and SSD groups, but not in ASD; while the item 9 
(indifference or lack of emotions) was less frequent in SSD. 
The item 13 (aggressiveness, both physical and verbal, toward other people or objects) was quite 
frequent across ID levels, but not in ASD and SSD groups. 
For ID, the item 26 (difficulty in making sequences of actions, and disorganized behaviour) and 29 
(attitudes of mistrust of others and/or behaviours supported by unjustified hostility) showed the 
highest scores in Mild ID level, and the item 27 (passing from one action to another without 
completing any or independently from the environmental context), 32 (indecision between more 
choices or excessive rigidity towards objects position or the way of doing things) and 33 
(inappropriate reactions to the suffering of the people or to the environmental emotional mood) 
showed the highest scores in Moderate ID degree. An additional interesting finding is that ID, 
especially the Mild level, was the group with the highest number of positive-scored items. Details are 
reported in Table 11. 
 
Table 11. Frequency of SPAID-G items in ID, ASD and SSD groups at Time 1 
 
SPAID-G 
ITEM 
ID 
ASD SSD Borderline ID mild ID moderate ID severe ID 
item 1 12 4 11 7 21 18 
item 2 15 9 15 11 37 25 
item 3 9 4 12 5 17 19 
item 4 6 4 9 7 18 11 
item 5 11 5 8 5 18 17 
item 6 4 1 2 1 5 6 
item 7 13 5 13 6 23 24 
item 8 13 9 14 10 31 23 
item 9 12 9 11 8 34 16 
item 10 5 5 8 3 18 10 
item 11 7 5 7 5 13 13 
item 12 3 1 0 1 3 3 
item 13 8 8 15 8 27 17 
item 14 4 5 7 4 17 9 
item 15 10 4 12 8 25 16 
item 16 11 7 12 8 29 20 
item 17 6 2 4 0 8 11 
item 18 5 2 2 0 6 9 
item 19 5 2 0 0 6 7 
item 20 10 3 5 1 12 13 
item 21 5 1 8 2 5 15 
item 22 5 1 7 5 14 9 
item 23 11 3 11 6 23 15 
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item 24 5 6 10 4 20 8 
item 25 8 5 8 6 25 7 
item 26 8 8 12 1 24 15 
item 27 6 5 13 3 21 13 
item 28 6 5 7 1 12 11 
item 29 9 8 6 2 15 15 
item 30 6 4 4 6 14 11 
item 31 9 6 10 5 19 17 
item 32 10 6 14 5 31 13 
item 33 8 7 14 8 29 16 
item 34 13 7 8 7 27 18 
item 35 6 4 8 6 15 16 
item 36 10 7 9 8 23 17 
item 37 11 6 10 7 24 19 
item 38 12 6 12 5 25 18 
item 39 4 4 13 4 18 8 
item 40 8 5 10 4 17 18 
item 41 7 0 4 5 12 5 
item 42 7 7 8 4 18 10 
item 43 10 5 8 6 18 18 
item 44 9 2 10 1 13 15 
item 45 4 6 8 3 16 8 
item 46 7 2 5 3 13 7 
item 47 3 1 5 2 9 7 
item 48 2 2 2 1 4 3 
item 49 10 8 6 5 23 15 
item 50 4 4 10 3 14 11 
item 51 0 3 3 1 4 3 
item 52 9 6 7 6 25 10 
item 53 2 0 1 0 3 1 
item 54 2 1 1 0 5 4 
item 55 0 0 1 1 2 0 
 
 
3.4.5 Mean scores comparison between presence and absence of diagnosis at T1 for SPAID-G and 
SPAID-P delusion and hallucination items  
 
In the ID group, no statistically significant mean score differences were found for SPAID-G and 
SPAID-P delusion and hallucination items between those who received a diagnosis at T1 and those 
who did not. 
Within both the ASD and SSD groups, a statistically significant difference was found for SPAID-P 
items 1 (arbitrarily attribution of cause-effect links) and 2 (maintaining a listening position and/or 
responding to sounds or voices not audible by others) mean scores (see Table 12), with higher scores 
in those who received a diagnosis at T1 compared with those who did not. 
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Table 12. SPAID-G and SPAID-P delusion and hallucination items comparison between presence and 
absence of diagnosis at T1 
 
SPAID-G and 
SPAID P ITEM° 
ID ASD SSD 
F Sig. F Sig. F Sig. 
SPAID-G  item 20 3.139 .021 2.984 .089 1.668 .202 
SPAID-G item 29 2.141 .088 3.377 .071 1.210 .276 
SPAID-P item 1 .508 .730 21.005 .000 19.968 .000 
SPAID-P item 7 2.099 .094 .003 .956 .993 .323 
SPAID-G item 3 1.134 .350 4.836 .032 5.177 .027 
SPAID-G item 4 1.972 .111 .261 .611 .229 .634 
SPAID-P item 2 .485 .747 14.875 .000 12.912 .001 
SPAID-P item 3 2.221 .079 .519 .474 1.974 .166 
SPAID-P item 4 .348 .844 .280 .599 4.891 .031 
*Sig. p≤ 0.005 
° G 20 and P 1: arbitrarily attribution of cause-effect links 
G 29 and P 7: attitudes of mistrust of others and/or behaviours supported by unjustified hostility 
G 3 and P 2: maintaining a listening position and/or responding to sounds or voices not audible by others 
G 4 and P 3: to cast the glance towards spaces where there are no objects to see or to gaze 
P 4: behaviours attributable to strange tactile or kinesthetic perceptions (such as to look the body with worry, scratching, hitting, or to 
communicate strange pain 
 
 
3.4.6 Multiple Regression block-wise 
 
In this statistical elaboration the three groups were treated as Independent Variables (IV) and the 
SPAID-G area as Dependent Variables (DV). The IV presented a multiple correlation (R) with the 
DV. The variance is indicated by R-square, while the corrected (for the degrees of freedom) R-square 
provides an estimate of the efficiency. The presence of autocorrelation between residuals was 
examined through the Durbin-Watson index, which ranged between 0 and 4, with negative 
correlations under 2. 
The statistical significance (Sig.) for the three groups corresponds to R that allows to see which IV is 
more important.  
The model was found not statistically significant (p >.005) in many cases, but for the relation between 
DOC subarea and SSD group. For most cases, although the model was not significant, ID was the 
group with the higher weight. 
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Table 13. SPAID-G area Multiple Regression block-wise 
 
SPAID-G AREA R  
R square 
 
Sig. F 
change 
 
Durbin-
Watson 
 
Sig. 
ID_T1 ASD_T1 SSD_T1 
Eating disorders 
 .325 .105 .098 1.881 .017 .869 .524 
Psychotic disorders 
 .265 .070 .242 1.961 .355 .976 .204 
Depression 
 .301 .090 .141 1.864 .370 .878 .157 
Mania 
 .201 .040 .499 1.752 .149 .584 .614 
Anxiety disorders 
 .208 .043 .466 1.735 .229 .483 .968 
Medication side effects 
 .229 .229 .065 2.295 .262 .999 .081 
Delirium 
 .222 .049 .404 2.048 .693 .850 .308 
Dementia 
 .235 .055 .352 1.825 .827 .794 .155 
Substance-related disorders 
 .224 .050 .399 1.933 .124 .659 .427 
personality disorders Cluster A 
(strange) .183 .034 .581 1.860 .879 .522 .189 
personality disorders Cluster B 
(dramatic) .244 .059 .317 2.189 .074 .954 .716 
personality disorders Cluster C 
(anxious) .134 .018 .790 1.910 .875 .607 .330 
Impulse control disorders 
 .250 .063 .293 2.379 .214 .806 .409 
Autism 
 .440 .193 .006 1.875 .508 .003 .381 
Identity disorders 
 .269 .072 .231 2.390 .583 .763 .115 
Simulation 
 393 .155 .022 2.147 .022 .818 .106 
Sexual disorders 
 331 .110 .083 .110 .528 .212 .517 
DOC 
 .599 .359 .000 2.334 .890 .804 .000 
*Sig. p≤ 0.005 
 
 
3.4.7 Multiple Regression stepwise.  
 
In this elaboration the three groups are treated as Independent Variables (IV) and the SPAID-G area as 
Dependent Variables (DV). The procedure followed for this elaboration is the same used for the 
regression block-wise, but for the inclusion or removal of one independent variable at each step 
instead of blocks of variables. 
The diagnosis of ID resulted to impact on the score variation of the Eating disorders and Simulation 
areas, while that of ASD on the score variation of the Autism, and Sexual disorder areas. Furthermore, 
the diagnosis of SSD was found to influence the score variation of the Depression, Medication side 
effects, Identity disorders, and DOC areas. 
Both ID and SSD groups resulted to impact on the score variation of the Simulation area. 
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Table 14. SPAID-G area Multiple Regression stepwise 
 
SPAID-G AREA R  
R square 
 
Sig. F 
change 
 
Durbin-
Watson 
 
Sig. 
 
ID_T1 
 
 
ASD_T1 
 
 
SSD_T1 
 
Eating disorders 
 .310 .096 .016 1.880 .016   
Psychotic disorders 
 - - - - - - - 
Depression 
 .277 .077 .030 1.909   .030 
Mania 
 - - - - - - - 
Anxiety disorders 
 - - - - - - - 
Medication side effects 
 .313 .098 .014 2.320   .014 
Delirium 
 - - - - - - - 
Dementia 
 - - - - - - - 
Substance-related disorders 
 - - - - - - - 
personality disorders Cluster A 
(strange) - - - - - - - 
personality disorders Cluster B 
(dramatic) - - - - - - - 
personality disorders Cluster C 
(anxious) - - - - - - - 
Impulse control disorders 
 - - - - - - - 
Autism 
 .420 .177 .001 1.919  .001  
Identity disorders 
 .256 .065 .047 2.349   . 047 
 
Simulation 
 
 
.295 .087 .021 2.147 .021  .037 
.392 .154 037     
Sexual disorders 
 .310 .096 .015 .121  .015  
DOC 
 .598 .358 .000 2.358   .000 
 *Sig. p≤ 0.05 
 
 
3.4.8 Multiple Regression hierarchical  
 
In this elaboration the first step was to input the age and gender variables, and the second step was to 
input the three groups (IV) one at a time, to see the impact on the SPAID-G areas. 
The only area for which a model significance was found is that of DOC, in which the diagnosis of 
SSD at T1 resulted to significantly impact on the score. 
For age and gender we did not find any significant impact, but for the area of Medication side effects, 
where age has a slight correlation, even if within a non-significant model. 
For other areas, although the models were not significant, ID related higher with Eating disorders and 
Simulation. 
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Table 15. SPAID-G area Multiple Regression hierarchical 
 
SPAID-G AREA R  
R square 
 
Sig. F 
change 
 
Durbin-
Watson 
 
Sig. 
 
ID_T1 ASD_T1 SSD_T1 Age Gender 
Eating disorders 
 .344 .118 .571 1.892 .023 .953 .571 .765 .383 
Psychotic disorders 
 .281 .079 .178 1.952 .355 .898 .178 .536 .821 
Depression 
 .319 .102 .215 1.831 .428 .884 .215 .458 .629 
Mania 
 .271 .073 .449 1.835 .124 .659 .449 .168 .769 
Anxiety disorders 
 .254 .064 .932 1.757 .248 .615 .932 .540 .427 
Medication side effects 
 .451 .204 .184 2.239 .343 .882 .184 .019 .507 
Delirium 
 .243 .059 .279 2.044 .710 .759 .279 .639 .622 
Dementia 
 .249 .062 .135 1.840 .796 .843 .135 .529 .949 
Substance-related disorders 
 .238 .057 .377 1.965 .124 .715 .377 .545 .989 
personality disorders Cluster A 
(strange) 
 
.267 .072 .222 1.709 .995 .651 .222 .660 .142 
personality disorders Cluster B 
(dramatic) .281 .079 .782 2.189 .060 .956 .782 .650 .299 
personality disorders Cluster C 
(anxious) 
 
.190 .036 .272 1.847 .873 .728 .272 .436 .624 
Impulse control disorders 
 .253 .064 .411 2.362 .222 .778 .411 .897 .839 
Autism 
 .491 .241 .280 1.834 .540 .007 .280 .296 .190 
Identity disorders 
 .368 .135 .178 2.472 .614 .527 .178 .248 .170 
Simulation 
 .457 .209 .167 2.313 .012 .908 .167 .197 .104 
Sexual disorders 
 .350 .122 .630 .127 .523 .274 .630 .449 .752 
DOC 
 .615 .378 .002 2.420 .923 .679 .002 .578 .414 
*Sig. p≤ 0.05 
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3.5 WAIS-R 
Being the difference in cognitive functions between the three groups one of the main focus of our 
research, the WAIS score differences were analysed using different types of statistical analysis.  
 
3.5.1 WAIS test mean scores comparison between presence and absence of diagnosis at T1  
 
For ID, statistically significant mean scores differences were found for all the WAIS subtests between 
those who received a diagnosis of ID at T1 and those who did not, but for the subtest of Block design. 
ASD and SSD groups presented statistically significant differences only for the subtest of Digit 
symbol (see Table 16).  
 
Table 16. WAIS test mean scores comparison between presence and absence of diagnosis at T1 
 
WAIS TEST ID ASD SSD F Sig. F Sig. F Sig. 
Information 12.942 .000 .070 .794 .073 .789 
Digit span 4.926 .004 .554 .462 .413 .525 
Vocabulary 7.643 .022 .882 .095 .247 .623 
Arithmetic 23.623 .000 .110 .743 .576 .454 
Comprehension 12.505 .001 .564 .459 1.435 .241 
Similarities 9.673 .000 .035 .852 .901 .350 
Picture completion 6.197 .000 1.303 .262 .763 .389 
Picture arrangement 24.544 .000 .536 .470 .015 .904 
Block design 19.290 .137 .037 .848 .435 .514 
Object assembly 12.552 .000 .995 .326 .074 .788 
Digit symbol 1.910 .000 5.424 .027 4.952 .033 
*Sig. p≤ 0.05 
 
 
3.5.2 WAIS test mean scores in the total sample  
 
The ID group scored lower than the other groups in all subtests. A less marked difference was found 
for the Digit symbol. 
Comparing the other two groups, the main score differences were identified in the Digit span, Picture 
completion, Object assembly, and Digit symbol subtests. For all these, the ASD group scored higher 
than the SSD, but for the Digit symbol. Details are reported in Table 17. 
 
Table 17. WAIS test mean scores in the total sample 
 
WAIS TEST 
ID mild + moderate + 
severe 
(mean ± sd) 
ASD 
(mean ± sd) 
SSD 
(mean ± sd) 
Valid 
N 13 (33.3%) 
Missing 
N 26 
(66.7%) 
Valid 
N 17 
(42.5%) 
Missing 
N 23 
(57.5%) 
Valid 
N 19 
(67.9%) 
 
Missing 
N 9 
(32.1%) 
 
Information 2.46 ± 1.854 6.18 ± 3.610 6.16 ± 4.153 
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Digit span 2.92 ± 2.722 7.00 ± 4.569 6.37 ± 3.905 
Vocabulary 2.38 ± 1.044 4.76 ± 3.153 5.05 ± 2.877 
Arithmetic 1.54 ±.660 4.82 ± 3.358 5.00 ± 3.197 
Comprehension 1.77 ± .927 5.41 ± 3.890 5.58 ± 3.990 
Similarities 2.69 ± 1.702 6.06 ± 4.451 6.47 ± 3.850 
Picture completion 2.77 ± 1.092 6.82 ± 4.419 5.53 ± 3.238 
Picture arrangement 1.92 ± 1.320 5.88 ± 4.060 5.47 ± 3.116 
Block design 1.62 ± .961 4.94 ± 3.960 4.89 ± 3.710 
Object assembly 2.00 ± 1.581 6.06 ± 4.657 5.16 ± 4.018 
Digit symbol 2.15 ± 1.519 2.53 ± 1.419 3.68 ± 2.136 
Verbal IQ 56.54 ± 5.010 77.41 ± 17.557 75.53 ± 17.855 
Performance IQ 55.85 ± 7.116 74.53 ± 16.934 72.16 ± 17.180 
Total IQ 52.23 ± 2.46 73.76 ± 17.177 71.74 ± 17.704 
 
 
3.5.3 Significant Differences in WAIS test scores between ID, ASD and SSD at Time 1  
 
A Kruskal-Wallis H test was run to identify differences in WAIS subtest score between groups. 
Distributions of Block Design scores were not similar for all groups, as assessed by visual inspection 
of a boxplot. The distributions of Block design score were statistically different between groups, χ2(6) 
= 13.050, p = .042. Those with ID, alone or in association with ASD or SSD, scored significantly 
lower than those with ASD or SSD alone. The performance was poorer in ASD than in SSD, both for 
the conditions themselves and for their association with ID (see Picture 1). 
The distributions of Verbal and Performance IQ scores were statistically different between groups, 
χ2(6) = 12.876, p = .045 and χ2(6) = 13.760, p = .032 respectively. Again the group with ID, alone or 
in association with ASD or SSD, scored significantly lower than the other two groups. The score was 
lower in SSD than in ASD, both for the conditions themselves and for their association with ID (see 
Picture 2 and 3). 
The distributions of Total IQ score were statistically significantly different between groups, χ2(6) = 
19.044, p = .004. Those with ID, alone or in association with ASD or SSD, scored significantly lower 
than those with ASD or SSD alone. The score was higher in ASD than in SSD, but the trend reversed 
when these conditions were associated with ID (see Picture 4). 
Difference statistical significances are detailed in Table 18.  
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Table 18. Significant Differences in WAIS test scores between ID, ASD and SSD at Time 1  
 
WAIS TEST 
 
Sig. 
 
Information .116 
Digit span .291 
Vocabulary .340 
Arithmetic .059 
Comprehension .059 
Similarities .089 
Picture completion .372 
Picture arrangement .071 
Block design .042 
Object assembly .054 
Digit symbol .258 
Verbal IQ .045 
Performance IQ .032 
Total IQ .004 
*Sig. p≤ 0.05 
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Picture 1. Distributions of Block design scores by groups
 
 
 
Picture 2. Distributions of Verbal IQ scores by groups 
 
 83 
Picture 3. Distributions of Performance IQ scores by groups 
 
 
 
Picture 4. Distributions of Total IQ scores by groups 
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CHAPTER 4 
 
DISCUSSION 
 
As far as our knowledge, which includes the above mentioned literature mapping, this is the first study 
aimed at identifying the clinical characteristics that relate most with ASD, SSD and their co-
occurrence in ID by using a combination of ID-specific neuropsychological and psychopathological 
assessment tools. Although the small sample size, our study provides new useful indications on how 
psychiatric specific instrumental assessment can improve the diagnostic sensitivity for the co-
occurrence of ASD and/or SSD in ID, but also for BIF, and ID itself. Furthermore it identifies new 
specific single and clustered behavioural equivalents of psychiatric symptoms, with pathognomonic 
value. 
 
ID-specific diagnostic process 
Previous literature findings already indicated assessment tools and diagnostic approaches tailored for 
people with ID to be quite useful in differentiating between ASD, ID and SSD (Unenge Hallerbäck et 
al., 2012), allowing a better understanding of the impact of the ID itself (e.g. cognitive fragmentation 
associated with stressful life events) on the clinical presentation (Loos & Loss, 2004; Shah & Wing, 
2006; Bradley et al., 2011b), as well as an understanding of the context in which the symptoms appear 
(Hubert & Hollins, 2006). 
 
Autism Quotient and Empathy Quotient 
Our results showed that the Autism-spectrum Questionnaire (AQ) and Empathy Questionnaire (EQ), 
which are screening tools for autism features, were more correlated with SSD than with ASD, with the 
latter scoring lower than SSD. One possible explanation for this apparently paradoxical result is that 
these tools, which were created for the high-functioning autism, might not be sensitive enough for the 
conditions with more severe symptoms, which represented the larger part of our sample. This finding 
is in line with previous studies illustrating that given the impaired introspective capacities and the 
different degrees of self-evaluation skills of individuals with ASD, AQ and EQ are not suitable to 
differentiate between ASD and other diagnoses (Naito et al., 2010; Kästner et al., 2015), particularly 
within the wide group of relational disorders. 
The mismatch between AQ and ASD raises a general issue on how the enlargement of psychiatric 
features comprised in the autism spectrum for screening purposes may have potential negative impact 
on research and clinical resources for those autistic syndromes more reliable with Kanner's 
descriptions or associated with lower personal functioning profiles and different level of ID (Bertelli, 
2016). 
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Co-occurrence of psychiatric disorders (SPAID-G areas) 
The screening for psychiatric co-occurrence through the SPAID-G revealed higher scores for 
Simulation in the presence of diagnosis of ID or SSD, for DOC and Sexual disorders in ASD and 
SSD, while Identity disorders, Depression, and Medication side effects were specifically higher in 
SSD. In general, these frequently high scored psychopathological areas can be interpreted as the areas 
with greater confounding effect on the diagnostic procedure in people with ID. Specific associations 
may indicate that some behavioural equivalents of psychopathological symptoms are interpreted by 
the majority of informants or raters as syndromic additional symptoms or alternative expressions of 
core features. This may happen for symptoms of Simulation, Sexual disorders, DOC and especially 
Medications side effects in those with ASD, for symptoms of Medications side effects, Sexual 
disorders, Anxiety disorders and especially Autism and DOC in those with SSD. 
ID is the diagnosis with the greatest number of correlations with SPAID-G areas. This might indicate a 
low specificity of many SPAID-G items for this diagnostic group. Most informants or raters seem to 
score positive many behavioural equivalents of different psychiatric syndromes every time they think 
that a psychiatric disorder is co-occurring or has co-occurred with ID. An alternative explanation is 
that the cognitive impairment (ID dimension) is associated with a broad psychopathological 
vulnerability more than relational difficulties (ASD and SSD). 
The level of specificity for the different psychopathological domains is one major question that arises 
from the use of all screening tools, even in the general population and in the cases in which tools are 
aimed at detecting a unique pathological dimension (Cruz et al., 2013). This is particularly evident in 
the field of ID, since the way people with ID present the specific psychiatric symptoms codified in the 
general is still far to be defined. All the psychopathological screening tools designed for this 
population have reported similar problems (Hatton & Taylor, 2008; Myrbakk & von Tetzchner, 
2008b). 
An attempt to increase the SPAID-G sensitivity is already in progress, by the provision of very 
detailed descriptions of the item meanings and examples of appropriate informant reports. 
The multiple regression block-wise analysis shows a relationship between SSD and DOC symptoms. 
These results are consistent with the previous researches in the general population, which show that 
DOC symptoms can occur or more frequently alternate with schizophrenic phases and may have a 
protective effect against psychotic disintegration (Stengel, 1945; Guillem et al., 2009). Therefore, 
being the SPAID-G a screening tool referring to the person’s life-span, without chronological limits, 
the association between SSD and DOC found by our statistical elaboration could express this clinical 
alternation across time. 
The multiple regression stepwise points out a strong relation between ID, Eating disorders and 
Simulation, while the ASD group results more linked to Sexual disorders. For SSD, although the 
relative high number of correlations, no substantial psychopathological link can be confirmed after the 
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exclusion of DOC for the above mentioned reasons, and the symptoms clusters which can represent 
some expressive phases or symptomatologic portions of SSD themselves. 
This regression analysis also confirms the finding of previous statistical elaborations on the strong 
relationship of ID and SSD with the SPAID-G Simulation area score. This could indicate that 
informants and raters often tend to interpret the behavioural changes they observe in people with ID 
and ID+SSD as a way to catch someone’s attention or to reach other secondary advantages. In the 
literature feigning and malingering are reported to be often overestimated in patients with 
schizophrenia or ID, among the latters this misinterpretation is most frequent in case of comorbid 
psychiatric diagnoses (Weiss et al., 2011; van Impelen et al., 2014). 
The multiple regression hierarchical reiterates the already discussed relationships with Eating 
disorders and Simulation for ID, and with DOC for SSD. This analysis also points out an interesting 
link between Medications side effects and Age, which means that for people with ID, with or without 
co-occurrence of ASD or SSD, the possibility to present side effects for any kind of pharmacological 
treatment increases as long as they grow older. One possible explanation for this relation is that in 
people with ID the getting older is associated in turn to an increase of the number of 
pharmacotherapies. 
 
Specific symptoms (SPAID items) 
For the identification of specific behaviour equivalents of symptoms to support the clinical 
differentiation between autism and schizophrenia in ID, any relevant result was reached. ‘Irritability’, 
‘agitation’, and ‘switching from one action to another’ resulted to be very unspecific epiphenomena. 
In SSD and ID, ‘indifference or lack of emotions’ (SPAID-G item n. 9) was rated as present much less 
frequently than in ASD, so in case of diagnostic doubt whether it is ASD or SSD, the score 1 in this 
item should orientate towards the former. On the contrary, ‘avoidance’ or ‘escape’ (item n. 16) 
resulted much more frequent in SSD than in ASD, the same for ‘loss of satisfaction or pleasure’ (item 
n. 7), even if to a lesser extent. 
Irritability, agitation, aggressiveness, hyperactivity, impulsivity, and other behaviours that are quite 
common in ID have been repeatedly reported to be associated with different psychiatric disorders 
(Hurley, 2008; Bertelli et al., 2012; King et al., 2014; Matson & Williams, 2014). Moreover, there are 
few standardized norms or guidelines in the classification systems for identifying “normal” or “usual” 
amounts of irritability, hyperactivity and impulsivity in persons with ID. 
The SPAID-G and SPAID-P delusion and hallucination items mean score comparison between 
presence and absence of a specific diagnosis at T1 revealed a statistically significant difference only 
for SPAID-P items 1 (arbitrarily attribution of cause-effect links) and 2 (maintaining a listening 
position and/or responding to sounds or voices not audible by others) in the ASD and SSD groups. 
Surprisingly other items related to visual and tactile/kinesthetic hallucinations, like ‘casting the glance 
to areas where there are no objects to see and/or repeatedly gazing’, and ‘positions or behaviours 
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attributable to strange tactile or kinesthetic perceptions’ (item n. 3 and 4) were not associated with 
SSD. This might be due to the informants’ higher difficulty of recognising these kinds of hallucination 
and to the scarce information on prevalence and presentation of this symptoms. Even for the general 
population, literature on disperceptive phenomena in psychotic disorders mostly refers to auditory 
hallucinations, which are also reported as the most frequent hallucinations (Chaudhury, 2010). Basing 
on these results, the SPAID-P is undergoing a process of implementation to increase its sensitivity to 
the behavioural equivalents of non-auditory hallucinations. 
Also ‘suspiciousness’ and ‘hostility’, (SPAID-G item n. 29 and SPAID–P item n. 7) did not result to 
be associated with the diagnosis of SSD, but this is in line with findings in the general population. 
They are considered rare symptoms and their presence is not necessary to make a diagnosis of 
psychotic disorder. Furthermore, in both SPAID-G and SPAID-P these two symptoms are included in 
the same item, which might induce informants and raters to score 1 only in the case in which they are 
both presents. Also this limit is being addressed in the implementation of the SPAID-P. 
 
Wechsler Adult Intelligence Scale 
The comparison of WAIS general, verbal, performance, and subtest scores between the study groups 
provided very interesting indications. The first refers to the Digit symbol subtest, which was found to 
be strongly related to the diagnosis of ASD and SSD at T1.  
This task, which has not changed since its introduction a century ago, expresses the coordination and 
speeded performance of a number of scanning, matching and motor operations. Our finding is 
consistent with the literature, which reports poor digit symbol performances in schizophrenia 
(Dickinson, 2008; Meier et al., 2014) and ASD (Lincoln et al., 1995; Spek et al., 2007; Goldstein et 
al., 2008), hypothesising a superficial working memory dysfunction in number-symbol association as 
the main cause (Nakahachi et al., 2006). The literature also concludes that simple measures of this 
kind may discriminate people with schizophrenia and autism from control samples better than more 
widely studied neuropsychological instruments (Lincoln et al., 1995; Spek et al., 2007; Goldstein et 
al., 2008). 
Our finding suggests the Digit symbol test score to be a useful indicator of the co-occurrence of ASD 
or, to a lesser extent, SSD with ID. It might also orientate for a broad neurodevelopmental disorders, 
for which a unique major diagnosis is hardly definable. 
Through the Kruskal-Wallis statistical analysis we found that the WAIS subtest that appears to 
discriminate more for the presence of ID is the Block design. This was also the subtest to have 
statistically significant differences between groups. Those with ID, alone or in association with ASD 
or SSD, scored significantly lower than those with ASD or SSD alone. ASD had a slightly worse 
performance than SSD, both for the conditions themselves and for their association with ID. 
The performance on this test is indicative of the functioning of the cerebral parietal and frontal lobes. 
It is considered one of the best measures of spatial ability and spatial visualization, although it is 
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subject to certain problems of administration, such as anxiety or over-cautious responding. The 
literature displays impairment in block design performance among schizophrenic populations, while 
superior performance of autistic individuals are reported (Shah & Frith, 1993; Frith, 2003; De Boer et 
al., 2014). Some authors indicated better performance in construction time for unsegmented version of 
the task and persons with higher general functioning (Goldstein et al., 2002; Caron et al., 2006; 
Stewart et al., 2009). 
According to our results, relatively lower scores on Block design supports the exclusion of co-
occurrence of ASD and particularly SSD with ID. 
The distributions of Verbal and Performance IQ scores resulted to be statistically different between 
our three groups. Again the group with ID, alone or in association with ASD or SSD, scored 
significantly lower than the other two groups, but this time SSD performed slightly worse than ASD, 
both alone and in co-occurrence with ID. 
IQ testing within ASD generally leads to a profile of lower verbal than performance IQ in much of the 
autistic spectrum, whether high or low functioning (Joseph et al., 2002), but this was not observed 
across all studies (Siegel et al. 1996; Mayes & Calhoun 2003; Minshew et al. 2005). Our findings are 
consistent with this minority, probably because of the very high co-occurrence of ID. 
Lower verbal IQ is commonly interpreted as a measure of communication and social impairment, 
which is one of the core symptoms of ASD (Tager-Flusberg & Joseph 2003), but the literature is not 
really unanimous in this point: beside older evidence of association between smaller IQ divergence 
(verbal > performance) and better language skills (Lincoln et al. 1998), there are recent studies 
showing that higher IQ divergences in either direction relate with social symptoms of autism (Black et 
al. 2009). 
For schizophrenia, a recent meta-analysis of 4396 cases with over 745000 controls from 12 
independent studies confirmed previous findings on significant decrements in premorbid IQ among 
future cases, with verbal and non-verbal measures being equally affected (Khandaker et al., 2011). On 
the contrary a genetic study using data from a large population sample and multiple independent large 
datasets found schizophrenia polygenic risk score to be associated only with lower performance IQ, as 
well as polygenic score for performance IQ to be associated with increased risk for schizophrenia. 
Also lower full IQ resulted to be associated with polygenic risk for schizophrenia (Hubbard et al., 
2015). 
Some efforts have been made by international research also to characterize the pattern of cognitive 
functions in ASD and SSD, and certain resemblances have become apparent such as deficits in 
abstract reasoning and the more complex aspects of memory and language. Ota and colleagues found 
higher WAIS-R scores in ASD than in schizophrenia suggesting the WAIS score measurement to be 
an easy and useful method for helping to discriminate between these two groups (Ota et al., 2011). 
Goldstein and collaborators compared well-diagnosed individuals with high-functioning autism (IQ> 
or =70) with schizophrenics divided into four subgroups by Ward’s method of cluster analysis. The 
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autism group resembled only one of the schizophrenia clusters, with both showing relatively depressed 
score on the comprehension subtest among the verbal subtests and a relatively elevated score on block 
design among the performance subtests (Goldstein et al., 2002). 
Our results confirm better WAIS scores in ASD than SSD, also in the co-occurrence with ID, they also 
suggest for ID to exclude the co-occurrence with SSD and particularly with ASD in the presence of 
lower scores on verbal and performance IQ. 
Also Total IQ mean score were found to be statistically significant different between our three groups. 
Those with ID, alone or in association with ASD or SSD, scored significantly lower than those with 
ASD or SSD alone. As for Performance and Verbal IQ scores, the total score was higher in ASD than 
in SSD, but the trend reversed when these conditions were associated with ID. 
As largely expressed in the introduction of this volume, the majority of last years’ studies on 
schizophrenia report patients’ premorbid and current total IQ scores to lay in the inferior range 
(Fioravanti et al., 2012; Bora & Murray, 2014), particularly in people with first-episode and youth-
onset (Rajji et al., 2009) and recent theories suggest this cognitive deficit to be the first expression of a 
complex neurodevelopmental disorder (Reichenberg et al., 2010; Zipursky et al., 2012). 
In ASD, the presence of a total IQ impairment is more common than in schizophrenia. Historically, it 
is estimated at 70% (Volkmar & Pauls, 2003), but recent studies encompassing all the DSM-5 
conditions, including DSM-IV-TR Asperger syndrome and pervasive developmental disorder not 
otherwise specified, suggest that it may be considerably lower (U.S. Developmental Disabilities 
Monitoring Network Surveillance, 2014). 
Khandaker and collaborators have recently reported the total IQ score reduction to partially explain 
the sequential comorbidity between ASD and SSD. In their study sample 487 (5.9%) children out of 
8220 were reported to have ASD at the age of 9 years. Compared with those without ASD showed a 
lower total IQ and a higher risk of severe psychotic symptoms across years (Khandaker et al., 2014). 
Our results confirm better WAIS total scores in ASD than SSD, unless the co-occurence of more 
severe ID, in which SSD scores are slightly higher than ASD ones. Our findings also confirm very low 
WAIS total scores to supports the exclusion of co-occurrence of high functioning ASD and, to a lesser 
extent, SSD. In the case of co-occurrence of ID and ASD the presence of a higher WAIS total score 
suggests a further co-occurrence of SSD more than ASD.  
 
Study limitations 
The present study has some general limitations that must be considered in the interpretation of results. 
The main one is the small sample size. A study with low statistical power has a reduced chance of 
detecting true associations and true differences between groups and variables. The consequences of 
this include overestimates of effect size and low reproducibility of results. The time available to 
investigate the research problem was pretty much constrained by the due date of our assignment. 
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Also the number of recruitment centers was constrained and referred to the restricted geographic area 
of Northwest Tuscany. It is possible that a considerable part of the informants and raters involved in 
the study have shared some biases in descriptions and score attributions, although the majority of the 
raters underwent a process of inter-rater reliability for the SPAID tools just before the start of the 
study.   
The study sample is not representative of the population with ID, the percentage of persons with 
moderate ID is higher than the one reported in the literature, as well as that of persons with severe ID 
is lower. No persons with profound ID have been included in the sample. 
Also the composition of the three groups was quite different. Only 6 out of the 61 study participants 
were not diagnosed with ID. Participants with ASD were 40, with a gender ratio higher than in the 
other groups: 28 male and 12 female. Participants with SSD were 28, with a very high prevalence of 
borderline ID. The number of cases presenting ID in comorbidity with ASD or SSD was 36 and 25, 
respectively. 
However, to our knowledge, this is the largest homogenous collection of data from ID-specific 
neuropsychological and psychopathological assessment tools referred to adults with ID and co-
occurrent ASD or/and SSD. 
Furthermore, the SPAID-P and SPAID-DPS, which were included in the assessment battery to assess 
SSD and ASD in people with ID, had not completed the validation process and could present some 
validity or reliability issues, although these properties had been preliminary evaluated with good 
results. 
Another limitation is represented by the recruitment method, participants weren’t included by 
randomisation, but by their consecutive referring to the clinical services of our network. 
We also regret not have included in the study tools for the assessment of specific cognitive functions 
tailored for people with ID. They could have helped in explaining the score differences between the 
co-occurrence of ASD and SSD that emerged for Digit symbol and Block design, as well as for Verbal 
and Performance IQ. 
We hope that these limitations will be revised in future researches. 
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CHAPTER 5 
 
CONCLUSIONS 
 
The present study allowed to identify some clinical and neuropsychological characteristics that relate 
most with each of the three specific conditions and their combinations. 
Surprisingly, the presence of autistic dimensional characteristics, assessed through the AQ, is not 
associated with the diagnosis of ASD, particularly with low functioning ASD and ASD co-occurrent 
with ID, which represent the waste majority of our sample. Instead AQ over threshold scores are 
associated with the diagnosis of SSD, even if to a low extent. 
The lack of empathy, assessed through the EQ, is associated with the diagnoses of both ASD and SSD, 
although to a higher extent in the latter. 
The screening for psychiatric co-occurrence through the SPAID-G revealed higher scores for 
Simulation in the presence of diagnosis of ID or SSD. Higher scores for DOC and Sexual disorders 
were found in both ASD and SSD, while Identity disorders, Depression, and Medication side effects 
are specifically higher in SSD. 
More complex statistical elaborations revealed SSD to significantly impact on DOC, Depression, 
Medication side effects, Simulation, and Identity disorder scores, ASD on Sexual disorder scores, and 
ID on Eating disorder and Simulation scores. The strong relationship between DOC and SSD, but not 
ASD, was repeatedly found through different statistical methods. 
The comparison of specific behavioural equivalents of psychiatric symptoms, assessed through 
SPAID-G items, identified higher scores for psychomotor agitation and/or restlessness and unjustified 
irritation/opposition in all the three diagnostic groups. Aggressiveness, both physical and verbal, 
toward other people or objects is quite frequent in ID, but not in ASD and SSD. Loss of satisfaction or 
pleasure for activities or objects, and avoidance or escape from certain objects, people or situations are 
frequent in ID and SSD groups, but not in ASD group, while indifference or lack of emotions is less 
frequent in SSD. Arbitrarily attribution of cause-effect links and auditory hallucinations show higher 
scores in the presence of ASD and SSD diagnoses, but not ID.  
For cognitive assessment, through the WAIS, the Block design resulted the less sensitive subtest for 
diagnosing ID, but it was found to be quite useful in differentiating from ASD and SSD. In fact those 
with ID alone or in association with ASD or SSD scored significantly lower than those with ASD or 
SSD alone. The performance was also poorer in ASD than in SSD, both for the conditions themselves 
and for their association with ID. 
Although in a not statistically significant way, ASD score better than SSD on Digit span, Picture 
completion, Object assembly, and Digit symbol subtests. SSD performs statistically significant better 
than ASD on the Digit symbol, which expresses visual-spatial, visual-motor integrative, and working 
memory skills. 
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Those with ID alone or in association with ASD or SSD also scored significantly lower for Total IQ, 
as well as for Verbal and Performance indexes.  
The Total IQ score was higher in ASD than in SSD, but the trend reverses when these conditions are 
associated with ID. The Verbal and Performance scores were lower in SSD than in ASD, both for the 
conditions themselves and for their association with ID.  
 
Table 19. Differences of psychiatric instrumental assessment between ID, ASD, SSD, ASD+ID, and 
SSD+ID 
 
TOOL ID LF*-ASD SSD ASD+ID SSD+ID 
AQ No association 
(any level of ID) 
No association Association No association Association 
EQ No association (any 
level of ID) 
Association Association 
++ 
Association 
+ 
Association 
++ 
SPAID-G 
areas 
Simulation DOC +, Sexual 
disorders ++ 
DOC ++, Simulation +, 
Sexual, Identity, 
Depressive disorders, 
Medication side effects  
n.a. n.a. 
SPAID-G 
items 
- psychomotor 
agitation and/or 
restlessness  +++ 
- unjustified 
irritation/opposition 
+++ 
- loss of satisfaction 
or pleasure for 
activities or objects 
++ 
- avoidance or 
escape from certain 
objects, people or 
situations + 
- indifference or 
lack of emotions ++ 
- aggressiveness, 
both physical and 
verbal, toward other 
people or objects ++ 
- psychomotor 
agitation and/or 
restlessness ++ 
- unjustified 
irritation/opposition 
++ 
- indifference or 
lack of emotions 
+++ 
 
- psychomotor agitation 
and/or restlessness + 
- unjustified 
irritation/opposition + 
- loss of satisfaction or 
pleasure for activities or 
objects ++ 
- avoidance or escape 
from certain objects, 
people or situations ++ 
 
- psychomotor 
agitation and/or 
restlessness ++ 
- unjustified 
irritation/opposition 
++ 
- indifference or 
lack of emotions 
+++ 
 
- psychomotor 
agitation and/or 
restlessness + 
- unjustified 
irritation/opposition 
+ 
- loss of satisfaction 
or pleasure for 
activities or objects 
++ 
- avoidance or 
escape from certain 
objects, people or 
situations ++ 
 
 
SPAID-P No association (any 
level of ID) 
- arbitrarily 
attribution of cause-
effect links +++ 
- to remain listening 
position and/or 
respond to sounds 
or voices not 
audible +++ 
- arbitrarily attribution 
of cause-effect links 
+++ 
- to remain listening 
position and/or respond 
to sounds or voices not 
audible ++ 
No association  No association  
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WAIS block design – 
verbal IQ - 
performance IQ - 
total IQ - 
 
block design --- 
digit symbol ++ 
digit span, picture 
completion, object 
assembly – 
verbal IQ ++ 
performance IQ ++ 
total IQ ++ 
 
block design –- 
digit symbol + 
verbal IQ + 
performance IQ + 
total IQ + 
 
block design --- 
verbal IQ - 
performance IQ - 
total IQ -- 
 
block design -- 
digit span, picture 
completion, object 
assembly -- 
verbal IQ - - 
performance IQ - - 
total IQ -  
 
*LF: Low-Functioning 
 
 
Our findings usefully integrate the literature indications on clinical factors to distinguish between the 
three diagnostic groups, and the co-occurrence of ASD and SSD with ID, as summarised in the 
following table. 
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Table 20. Clinical Differences between ID, ASD, SSD, ASD+ID, and SSD+ID 
 
 ID ASD SSD ASD+ID SSD+ID 
ONSET AND AGE OF 
RECOGNITION 
• Before 18 yrs [most severe ID 
identified in early  years 
while mild ID may not 
identified until later (e.g., 
school entry)] 
• Any time post natal but key 
defining features can be traced 
back to first three years 
 
• First episode of illness in 
adolescence or early adult life  
• “at risk” and prodromal mental 
states. 25-40% convert 
• Childhood-onset schizophrenia – 
rare before 7-8 yrs of age 
n.a. n.a. 
CLINICAL FEATURES AND 
IQ 
• IQ <70 
• Often physical stigmata 
• Clinical features associated with 
functioning level – mild, 
moderate, severe, profound 
• Triad of impairments: social, 
communication, repeat. 
behaviours (sensory 
abnormalities) 
• Across all functioning levels 
• Up to 70% have ID 
• Positive symptoms 
• Negative symptoms 
• Across all levels of IQ but may be 
premorbid decline in function 
 
see note on WAIS scores see note on WAIS scores 
INTEREST TOWARDS 
OTHERS 
variable from case to case unusually disinterested in shared 
sense and others’ thought 
try to guess other’s attribution of 
sense 
n.a. n.a. 
DELUSIONS not present not present (but fantastic thought) present not present (but fantastic 
thought) 
present (for severe ID as a 
behavioural equivalent)  
HALLUCINATIONS not present not present (but sensory 
abnormalities) 
present not present (but behaviours 
with confounding effect) 
present (for severe ID as a 
behavioural equivalent)  
ANATOMICAL 
ANOMALIES OF THE CNS 
variable from case to case diffused gray matter increase and 
anomalies in the neuroanatomical 
networks 
enlarged ventricular spaces and 
hypofrontality 
n.a. n.a. 
PSYCHIATRIC 
COMORBIDITY 
Psychopathology frequent: 
estimated to be X4 that of the 
general population 
 
Asperger: mood and anxiety 
disorders common 
Autism with ID compared to ID 
only: 
• Greater frequency of new onset 
(episodic) disorders e.g., mood, 
anxiety, adjustment disorders 
• Greater frequency of background 
(non episodic) disorders e.g., 
ADHD, tics, phobias  
• Episodic and non episodic 
disorders co-exist 
More recently the focus of research 
attention (e.g., depression, anxiety) 
 
No association Association 
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AQ No association (any level of ID) No association Association No association Association 
EQ No association (any level of ID) Association Association ++ Association + Association ++ 
SPAID-G 
areas 
Simulation DOC +, Sexual disorders ++ DOC ++, Simulation +, Sexual, 
Identity, Depressive disorders, 
Medication side effects  
n.a. n.a. 
SPAID-G 
items 
• psychomotor agitation and/or 
restlessness  +++ 
• unjustified irritation/opposition 
+++ 
• loss of satisfaction or pleasure 
for activities or objects ++ 
• avoidance or escape from 
certain objects, people or 
situations + 
• indifference or lack of emotions 
++ 
• aggressiveness, both physical 
and verbal, toward other people 
or objects ++ 
• psychomotor agitation and/or 
restlessness ++ 
• unjustified irritation/opposition ++ 
• indifference or lack of emotions 
+++ 
 
• psychomotor agitation and/or 
restlessness + 
• unjustified irritation/opposition + 
• loss of satisfaction or pleasure for 
activities or objects ++  
• avoidance or escape from certain 
objects, people or situations ++ 
 
• psychomotor agitation 
and/or restlessness ++ 
• unjustified 
irritation/opposition ++ 
• indifference or lack of 
emotions +++ 
 
• psychomotor agitation 
and/or restlessness + 
• unjustified 
irritation/opposition + 
• loss of satisfaction or 
pleasure for activities or 
objects ++ 
• avoidance or escape from 
certain objects, people or 
situations ++ 
 
 
SPAID-P No association (any level of ID) • arbitrarily attribution of cause-
effect links +++ 
• to remain listening position and/or 
respond to sounds or voices not 
audible +++ 
• arbitrarily attribution of cause-effect 
links +++ 
• to remain listening position and/or 
respond to sounds or voices not 
audible ++ 
No association  No association  
WAIS • block design – 
• verbal IQ - 
• performance IQ - 
• total IQ - 
 
• block design ---  
• digit symbol ++ 
• digit span, picture completion, 
object assembly – 
• verbal IQ ++ 
• performance IQ ++ 
• total IQ ++ 
• block design –- 
• digit symbol + 
• verbal IQ + 
• performance IQ + 
• total IQ + 
 
• block design --- 
• verbal IQ - 
• performance IQ - 
• total IQ -- 
 
• block design -- 
• digit span, picture 
completion, object assembly 
-- 
• verbal IQ - - 
• performance IQ - - 
• total IQ -  
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Moreover, study results indicate that the use of tools and diagnostic criteria specific for ID 
considerably increases the diagnostic sensitivity for ASD, SSD and other co-occurrent psychiatric 
disorders. 
We hope that these findings might contribute to further research aimed at defining better criteria of 
differential diagnosis and comorbidity between ID, ASD, and SSD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 97 
REFERENCES 
Abel, K., Wicks, S., Susser, E., Dalman, C., Pedersen, M., Mortensen, P., & Webb, R. (2010). Birth 
Weight, Schizophrenia, and Adult Mental Disorder. Archives of General Psychiatry, 67(9), 923.  
Abi-Dargham, A. (2007). Alterations of serotonin transmission in schizophrenia. International Review 
of  Neurobiology, 78, 133-64. 
Achim, A. M., Maziade, M., Raymond, É., Olivier, D., Mérette, C., & Roy, M.-A. (2011). How 
Prevalent Are Anxiety Disorders in Schizophrenia? A Meta-Analysis and Critical Review on a 
Significant Association. Schizophrenia Bulletin, 37(4), 811–821.  
Achkova, M. & Manolova, H. (2014). Diagnosis ‘Autism’ – from Kanner and Asperger to DSM-5. 
Journal of Intellectual Disability – Diagnosis and Treatment , 2(2), 112-118. 
Afzal, M. A., Ozoemena, L. C., O'Hare, A., Kidger, K. A., Bentley, M. L., & Minor, P. D. (2006). 
Absence of detectable measles virus genome sequence in blood of autistic children who have had their 
MMR vaccination during the routine childhood immunization schedule of UK. Journal of medical 
virology, 78(5), 623-630. 
Akbarian, S. (2014). Epigenetic mechanisms in schizophrenia. Dialogues in Clinical Neuroscience, 
16(3), 405–417. 
Aleman, A., Kahn, R., & Selten, J. (2003). Sex Differences in the Risk of Schizophrenia. Arch Gen 
Psychiatry, 60(6), 565-571.  
Alexander, R. & Cooray, S. (2003). Diagnosis of personality disorders in learning disability. The 
British Journal of Psychiatry, 182(44), 28s-31. 
Altamura, C., Fagiolini, A., Galderisi S., Rocca, P., & Rossi A. (2014). Schizophrenia today: 
epidemiology, diagnosis, course and models of care. Journal of Psychopathology, 20, 223-243.  
American Psychiatric Association (APA). (1952). DSM I Diagnostic and Statistical Manual, 1th 
Edition. Washington, D. C.: American Psychiatric Association. 
American Psychiatric Association (APA). (1968). DSM II Diagnostic and Statistical Manual, 2th 
Edition. Washington, D. C.: American Psychiatric Association. 
American Psychiatric Association (APA). (1980). DSM III Diagnostic and Statistical Manual, 3th 
Edition. Washington, D. C.: American Psychiatric Association. 
American Psychiatric Association (APA). (1987). DSM III-R Diagnostic and Statistical Manual, 3th 
Edition, Revised. Washington, D. C.: American Psychiatric Association. 
American Psychiatric Association (APA). (1994). DSM IV Diagnostic and Statistical Manual, 4th 
Edition. Washington, D. C.: American Psychiatric Association. 
American Psychiatric Association (APA). (2000). DSM IV-TR Diagnostic and Statistical Manual, 4th 
Edition, Text Revision. Washington, D. C.: American Psychiatric Association. 
American Psychiatric Association (APA). (2013). DSM 5 Diagnostic and Statistical Manual, 5th 
Edition. Washington, D. C.: American Psychiatric Association. 
Anderson, V., Catroppa, C., Morse, S., Haritou, F., & Rosenfeld, J. (2005). Functional plasticity or 
vulnerability after early brain injury? Pediatrics. 116(6), 1374-1382.  
Andrade, C. (2013). Antidepressant Use in Pregnancy and Risk of Autism Spectrum Disorders: A 
Critical Examination of the Evidence. Journal of Clinical Psychiatry, 74(09), 940-941. 
 98 
Andreasen, N. (1989). The American Concept of Schizophrenia. Schizophrenia Bulletin, 15(4), 519-
531.  
Antonova, E., Kumari, V., Morris, R., Halari, R., Anilkumar, A., Mehrotra, R., & Sharma, T. (2005). 
The Relationship of Structural Alterations to Cognitive Deficits in Schizophrenia: A Voxel-Based 
Morphometry Study. Biological Psychiatry, 58(6), 457-467. 
Antonova, E., Sharma, T., Morris, R., & Kumari, V. (2004). The relationship between brain structure 
and neurocognition in schizophrenia: a selective review. Schizophrenia Research, 70(2-3), 117-145. 
Arguello, P., & Gogos, J. (2008). A signaling pathway AKTing up in schizophrenia. Journal of 
Clinical Investigation, 118(6), 2018–2021 
Arseneault, L., Cannon, M., Witton, J., & Murray, R.M. (2004). Causal association between cannabis 
and psychosis: examination of the evidence. The British Journal of Psychiatry, 184(2), 110-117.  
Ashwood, P., & Van de Water, J. (2004). Is autism an autoimmune disease?. Autoimmunity Reviews, 
3(7-8), 557-562.  
Asperger, H. (1944). Die ‘Autistischen Psychopathen’ im Kindesalter (Autistic psychopaths in 
childhood). Archiv für Psychiatrie und Nervenkrankheiten, 117, 76-136. 
Atkinson, J., Anker, S., Braddick, O., Nokes, L., Mason, A., & Braddick, F. (2001). Visual and 
visuospatial development in young children with Williams syndrome. Developmental Medicine and 
Child Neurology, 43(05), 330.  
Auyeung, B., Baron-Cohen, S., Ashwin, E., Knickmeyer, R., Taylor, K., & Hackett, G. (2009). Fetal 
testosterone and autistic traits. British Journal of Psychology, 100(1), 1-22.  
Auyeung, B., Taylor, K., Hackett, G., & Baron-Cohen, S. (2010). Foetal testosterone and autistic traits 
in 18 to 24-month-old children. Molecular Autism, 1, 11 
Ayub, M., Saeed, K., Munshi, T., & Naeem, F. (2015). Clozapine for psychotic disorders in adults 
with intellectual disabilities. Cochrane Database of Systematic Reviews. 
Bailey, D.B. Jr., Mesibov, G.B., Hatton, D.D., Clark, R.D., Roberts, J.E., & Mayhew, L. (1998). 
Autistic behavior in young boys with fragile X syndrome. Journal of Autism and Developmental 
Disorders, 28(6), 499–508.  
Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., & Charman, T. (2006). 
Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: 
the Special Needs and Autism Project (SNAP). Lancet, 368(9531), 210-215. 
Bakhshi, K., & Chance, S. (2015). The neuropathology of schizophrenia: A selective review of past 
studies and emerging themes in brain structure and cytoarchitecture. Neuroscience, 303, 82-102.  
Barch, D. M. (2009). Neuropsychological Abnormalities in Schizophrenia and Major Mood Disorders: 
Similarities and Differences. Current Psychiatry Reports, 11(4), 313–319. 
Barlati, S., De Peri, L., Deste, G., Fusar-Poli, P., & Vita, A. (2012). Cognitive Remediation in the 
Early Course of Schizophrenia: A Critical Review. Current Pharmaceutical Design, 18(4), 534-541. 
Barneveld, P.S., Pieterse, J., de Sonneville, L., van Rijn, S., Lahuis, B., van Engeland, H., & Swaab, 
H. (2011). Overlap of autistic and schizotypal traits in adolescents with Autism Spectrum Disorders. 
Schizophrenia Research, 126(1-3), 231-236. 
Baron-Cohen, S. (1991). Precursors to a theory of mind: Understanding attention in others. In A. 
Whiten (Ed.), Natural theories of mind: Evolution, development and simulation of everyday 
mindreading (pp. 233-251). Oxford: Basil Blackwell 
 99 
Baron-Cohen, S., & Wheelwright, S. (2004). The Empathy Quotient: An Investigation of Adults with 
Asperger Syndrome or High Functioning Autism, and Normal Sex Differences. J Autism Dev Disord, 
34(2), 163-175. 
Baron-Cohen, S., Campbell, R., Karmiloff-Smith, A., Grant, J., & Walker, J. (1999). Are children with 
autism blind to the mentalistic significance of the eyes?. British Journal of Developmental 
Psychology, 13, 379–98. 
Baron-Cohen, S., Scott, F., Allison, C., Williams, J., Bolton, P., Matthews, F., & Brayne, C. (2009). 
Prevalence of autism-spectrum conditions: UK school-based population study. The British Journal of 
Psychiatry, 194(6), 500-509.  
Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The autism-spectrum 
quotient (AQ): Evidence from Asperger syndrome/high-functioning autism, males and females, 
scientists and mathematicians. Journal of Autism and Developmental Disorders, 31, 5–17. 
Bassett, A., Scherer, S., & Brzustowicz, L. (2010). Copy Number Variations in Schizophrenia: Critical 
Review and New Perspectives on Concepts of Genetics and Disease. American Journal of Psychiatry, 
167(8), 899-914.  
Baum, S., Stevenson, R., & Wallace, M. (2015). Behavioral, perceptual, and neural alterations in 
sensory and multisensory function in autism spectrum disorder. Progress in Neurobiology, 134, 140-
160.  
Bauman, M., & Kemper, T. (2005). Neuroanatomic observations of the brain in autism: a review and 
future directions. International Journal of Developmental Neuroscience, 23(2-3), 183-187.  
Baylé, F., Krebs, M., Epelbaum, C., Levy, D., & Hardy, P. (2001). Clinical features of panic attacks in 
schizophrenia. European Psychiatry, 16(6), 349-353. 
Behnke, M., & Smith, V. (2013). Prenatal Substance Abuse: Short- and Long-term Effects on the 
Exposed Fetus. Pediatrics, 131(3), e1009-e1024. 
Bejerot, S., Eriksson, J., & Mörtberg, E. (2014). Social anxiety in adult autism spectrum disorder. 
Psychiatry Research, 220(1-2), 705-707.  
Berkel, S., Marshall, C., Weiss, B., Howe, J., Roeth, R., Moog, U., & Endris, V. et al. (2010). 
Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental 
retardation. Nature Genetics, 42(6), 489-491. 
Bertelli, M. (2016). The 10th EAMHID International Congress: integrating different approaches in the 
neurodevelopmental perspective: the mental health care evolution timeline. Advances in Mental 
Health and Intellectual Disabilities. In Press. 
Bertelli, M., & Kishore, M.T. (2014). Mental health and intellectual disability: implications for global 
mental health. In Okpaku, S. (n.d.). Essentials of global mental health. P 222-230 
Bertelli, M., Salvador-Carulla, L., Scuticchio, D., Varrucciu, N., Martinez-Leal, R., Cooper, S., & 
Simeonsson, R. et al. (2014). Moving beyond intelligence in the revision of ICD-10: specific cognitive 
functions in intellectual developmental disorders. World Psychiatry, 13(1), 93-94.  
Bertelli, M., Scuticchio, D., Ferrandi, A., Ciavatta, C., La Malfa, G. P., & Mango, F., et al. (2010). 
Prevalenza degli aspetti psicopatologici nelle persone con disabilità intellettiva: Uno studio 
multicentrico sul nuovo strumento SPAID-G. Italian Journal of Psychopathology, 16(1), 53–63.  
Bertelli, M., Scuticchio, D., Ferrandi, A., Lassi, S., Mango, F., & Ciavatta, C., et al. (2012). Reliability 
and validity of the SPAID-G checklist for detecting psychiatric disorders in adults with intellectual 
disability. Research in Developmental Disabilities, 33, 382–390. 
 100 
Bertelli, M.O., Piva Merli M., Bradley E., Keller R., Varrucciu N., Del Furia C., & Panocchia N. 
(2015). The diagnostic boundary between autism spectrum disorder, intellectual developmental 
disorder and schizophrenia spectrum disorders. Advances in Mental Health and Intellectual 
Disabilities, 9(5), 243-264. 
Bertrand, M.C., Achim, A.M., Harvey, P.O., Sutton, H., Malla, A.K., & Lepage, M. (2008). Structural 
neural correlates of impairments in social cognition in first episode psychosis. Social Neuroscience, 3, 
79–88. 
Betancour, C., Sakurai, T., & Buxbaum, J. (2009). The emerging role of synaptic cell-adhesion 
pathways in the pathogenesis of autism spectrum disorders. Trends in Neurosciences, 32(7), 402-412.  
Bhaumik, S., Tyrer, F.C., McGrother, C., & Ganghadaran, S.K. (2008). Psychiatric service use and 
psychiatric disorders in adults with intellectual disability. Journal of Intellectual Disability Research, 
52(11), 986-95. 
Billstedt, E., Carina Gillberg, I. & Gillberg, C. (2007). Autism in adults: symptom patterns and early 
childhood predictors. Use of the DISCO in a community sample followed from childhood. J Child 
Psychol & Psychiat, 48(11), pp.1102-1110.  
Black, D., Wallace, G., Sokoloff, J., & Kenworthy, L. (2009). Brief Report: IQ Split Predicts Social 
Symptoms and Communication Abilities in High-Functioning Children with Autism Spectrum 
Disorders. Journal of Autism and Developmental Disorders, 39(11), 1613-1619. 
Blake, R., Turner, L.M., Smoski, M.J., Pozdol, S.L., & Stone, W.L. (2003). Visual recognition of 
biological motion is impaired in children with autism. Psychological Science, 14(2), 151–7. 
Bleuler, E. (1911), Dementia Praecox oder Gruppe der Schizophrenien. Leipzig, Germany. 
Bleuler, E. (1950), Dementia Praecox or the Group of Schizophrenias (Trans. J. Zinkin). New York, 
NY: International Universities Press. 
Boksa, P. (2008). Maternal infection during pregnancy and schizophrenia. Journal of Psychiatry & 
Neuroscience , 33(3), 183–185. 
Bolte, S., & Poustka, F. (2003). The recognition of facial affect in autistic and schizophrenic subjects 
and their first-degree relatives. Psychology Medecine, 33(5), 907–15.  
Bora, E., & Murray, R. (2014). Meta-analysis of Cognitive Deficits in Ultra-high Risk to Psychosis 
and First-Episode Psychosis: Do the Cognitive Deficits Progress Over, or After, the Onset of 
Psychosis?. Schizophrenia Bulletin, 40(4), 744-755. 
Bora, E., Yucel, M., & Pantelis, C. (2009). Theory of mind impairment in schizophrenia: meta-
analysis. Schizophrenia Research, 109(1–3), 1–9. 
Bosanac, P., & Castle, D. J. (2012). Schizophrenia and depression MJA Open, 1(4), 36-39. 
Boseley, S. (2009). Autism just as common in adults, so MMR jab is off the hook. The Guardian, 22 
September, available at: www.theguardian.com/society/2009/sep/22/autism-rate-mmr-vaccine 
Bottas, A., Cooke, R. G., & Richter, M. A. (2005). Comorbidity and pathophysiology of obsessive–
compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of 
schizophrenia? Journal of Psychiatry and Neuroscience, 30(3), 187–193. 
Boucher, J., Bigham, S., Mayes, A., & Muskett, T. (2008). Recognition and language in low 
functioning autism. Journal of Autism and Developmental Disorders, 38, 1259–1269. 
Boukhris, T., Sheehy, O., Mottron, L., & Bérard, A. (2015). Antidepressant Use During Pregnancy 
and the Risk of Autism Spectrum Disorder in Children. JAMA Pediatrics, 1. 
 101 
Bouras, N., Moss, S. & Kiernan, C. (1999). The relationship between challenging behavior and 
psychiatric disorders in people with severe intellectual disabilities. In Bouras, N. (Ed.), Psychiatric and 
behavioral disorders in mental retardation, Cambridge University, Cambridge, pp. 38–48. 
Bowie, C., Reichenberg, A., Patterson, T., Heaton, R., & Harvey, P. (2006). Determinants of Real-
World Functional Performance in Schizophrenia Subjects: Correlations With Cognition, Functional 
Capacity, and Symptoms. American Journal of Psychiatry, 163(3), 418-425. 
Boydell, J., van Os, J., McKenzie, K., & Murray, R. (2004). The association of inequality with the 
incidence of schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 39(8), 597-599.  
Bradley, E. & Bolton, P. (2006). Episodic psychiatric disorders in teenagers with learning disabilities 
with and without autism. British Journal of Psychiatry, 189(4), 361-366.  
Bradley, E. A., & Issacs, B. J. (2006). Inattention, hyperactivity, and impulsivity in teenagers with 
intellectual disabilities, with and without autism. Canadian Journal of Psychiatry, 55, 598–606.  
Bradley, E., Ames, C. & Bolton, P. (2011a). Psychiatric conditions and behavioural problems in 
adolescents with intellectual disabilities: correlates with autism. Canadian Journal of Psychiatry, 
56(2), 102-109.  
Bradley, E., Lunsky, Y., Palucka, A. & Homitidis, S. (2011b). Recognition of intellectual disabilities 
and autism in psychiatric inpatients diagnosed with schizophrenia and other psychotic disorders. 
Advances in Mental Health and Intellectual Disabilities, 5(6), 4-18. 
Bradley, E.A., Summers, J.A., Wood, H.L., & Bryson, S.E. (2004). Comparing rates of psychiatric 
and behavior disorders in adolescents and young adults with severe intellectual disability with and 
without autism. Journal of Autism and Developmental Disorders, 34, 151–161.  
Brady, K., & Sinha, R. (2005). Co-Occurring Mental and Substance Use Disorders: The 
Neurobiological Effects of Chronic Stress. FOC, 5(2), 229-239.  
Bregman, J.D., Dykens, E., Watson, M., Ort, S.I., & Leckman, J.F. (1987). Fragile-X syndrome: 
variability of phenotypic expression. Journal of the American Academy of Child and Adolescent 
Psychiatry, 26, 463-471. 
Briegel, W., Schimek, M., Kamp-Becker, I., Hofmann, C., & Schwab, K.O. (2009). Autism spectrum 
disorders in children and adolescents with Moebius sequence. European Child and Adolescent 
Psychiatry, 18(8), 515-519. 
Brugha, T., McManus, S., Bankart, J., Scott, F., Purdon, S., Smith, J., Bebbington, P., Jenkins, R. & 
Meltzer, H. (2011). Epidemiology of Autism Spectrum Disorders in Adults in the Community in 
England. Archives of General Psychiatry, 68(5), p.459-465.  
Bruijnzeel, D., & Tandon, R. (2011). The Concept of Schizophrenia: From the 1850s to the DSM-5. 
Psychiatric Annals, 41(5), 289-295. 
Brüne, M., Schaub, D., Juckel, G., & Langdon, R. (2011). Social skills and behavioral problems in 
schizophrenia: The role of mental state attribution, neurocognition and clinical symptomatology. 
Psychiatry Research, 190(1), 9-17.  
Brunet, E., Sarfati, Y., Hardy-Bayle, M.C., & Decety, J. (2003). Abnormalities of brain function 
during a nonverbal theory of mind task in schizophrenia. Neuropsychologia, 41(12), 1574–1582. 
Bryson, S.E. & Smith, I.M. (1998). Epidemiology of autism: Prevalence, associated characteristics, 
and implications for research and service delivery. Mental Retardation and Developmental 
Disabilities Research Reviews, 4, 97–103.  
 102 
Bryson, S.E., Bradley, E.A., Thompson, A., & Wainwright, A. (2008). Prevalence of autism among 
adolescents with intellectual disabilities. Canadian Journal of Psychiatry, 53(7), 449-59. 
Buchanan, A., Fahy, T., & Walsh, E. (2002). Violence and schizophrenia: examining the evidence. 
The British Journal of Psychiatry, 180(6), 490-495. 
Buck, T., Viskochil, J., Farley, M., Coon, H., McMahon, W., Morgan, J., & Bilder, D. (2014). 
Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder. Journal of 
Autism and Developmental Disorders, 44(12), 3063-3071.  
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009). Psychiatric Comorbidities and 
Schizophrenia. Schizophrenia Bulletin, 35(2), 383–402.  
Buckley, P.F., & Hwang, M.Y. (2015). Comorbid Psychiatric Disorders in Schizophrenia: More than 
Just a Chance Co-occurrence. In Obsessive-Compulsive Symptoms in Schizophrenia. De Haan, L., 
Schirmbeck, F., Zink, M. Springer International Publishing 
Burbach, J., & van der Zwaag, B. (2009). Contact in the genetics of autism and schizophrenia. Trends 
in Neurosciences, 32(2), 69-72.  
Cadman, T., Spain, D., Johnston, P., Russell, A., Mataix-Cols, D., Craig, M., & Deeley, Q. et al. 
(2015). Obsessive-Compulsive Disorder in Adults with High-Functioning Autism Spectrum Disorder: 
What Does Self-Report with the OCI-R Tell Us?. Autism Research, 8(5), 477-485.  
Cannell, J.J. (2007). Autism and vitamin D. Medical Hypotheses, 70, 750–759. 
Cannon, M., Jones, P., & Murray, R. (2002). Obstetric Complications and Schizophrenia: Historical 
and Meta-Analytic Review. American Journal of Psychiatry, 159(7), 1080-1092.  
Cardno, A., & Gottesman, I. (2000). Twin studies of schizophrenia: From bow‐and‐arrow 
concordances to Star Wars Mx and functional genomics. American Journal of Medical Genetics, 
97(1), 12-17.  
Carlsson, A. (1988). The current status of the dopamine hypothesis of schizophrenia. 
Neuropsychopharmacology, 1(3), 179-186.  
Caron, M., Mottron, L., Berthiaume, C., & Dawson, M. (2006). Cognitive mechanisms, specificity and 
neural underpinnings of visuospatial peaks in autism. Brain, 129(7), 1789-1802. 
Carriòn, R.E., Goldberg, T.E., McLaughlin, D., Auther, A.M., Correll, C.U., & Cornblatt, B.A. 
(2011). Impact of neurocognition on social and role functioning in individuals at clinical high risk for 
psychosis. American Journal of Psychiatry, 168(8), 806-813. 
Carroll, L., & Owen, M. (2009). Genetic overlap between autism, schizophrenia and bipolar disorder. 
Genome Medicine, 1(102), 1-7.  
Casey, B., Oliveri, M., & Insel, T. (2014). A Neurodevelopmental Perspective on the Research 
Domain Criteria (RDoC) Framework. Biological Psychiatry, 76(5), 350-353.  
Cauda, F., Geda, E., Sacco, K., D’Agata, F., Duca, S., Geminiani, G., & Keller R. (2011). Gray matter 
abnormality in Autism spectrum disorder: an ALE meta-analysis study. Journal of Neurology, 
Neurosurgery & Psychiatry, 82, 1304-1313. 
Chandrasekhar T, & Sikich L. (2015). Challenges in the diagnosis and treatment of depression in 
autism spectrum disorders across the lifespan. Dialogues in Clinical Neuroscience, 17(2), 219-27. 
Charlot, L., Deutsch, C., Albert, A., Hunt, A., Connor, D., & McIlvane, W. (2008). Mood and Anxiety 
Symptoms in Psychiatric Inpatients with Autism Spectrum Disorder and Depression. Journal of 
Mental Health Research in Intellectual Disabilities, 1(4), 238-253.  
 103 
Charlot, L.R. (2005). Use of behavioral equivalents for symptoms of mood disorders. In: Sturmey P, 
editor. Mood disorders in people with mental retardation. NADD Press; Kingston, NY. pp. 17–46. 
Chaudhury, S. (2010). Hallucinations: Clinical aspects and management. Industrial Psychiatry 
Journal, 19(1), 5–12.  
Chauhan, A., & Chauhan, V. (2006). Oxidative stress in autism. Pathophysiology, 13(3), 171-181.  
Chelly, J., & Mandel, J.L. (2001). Monogenic causes of X-linked mental retardation. Nature Review. 
Genetics, 2(9), 669-80. 
Chelly, J., Khelfaoui, M., Francis, F., Chérif, B., & Bienvenu, T. (2006). Genetics and 
pathophysiology of mental retardation. European Journal of Human Genetics, 14(6), 701-713.  
Chen, W., Landau, S., Sham, P., & Fombonne, E. (2004). No evidence for links between autism, 
MMR and measles virus. Psychological medicine, 34(03), 543-553. 
Ching, M.S., Shen, Y., Tan, W.H., Jeste, S.S., Morrow, E.M., Chen, X., Wu, B.L. (2010). Deletions of 
NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. American Journal of 
Medical Genetics Part B: Neuropsychiatric Genetics, 153B(4), 937-947. 
Clarke, D.M., & McKenzie, D.P. (1994). A caution on the use of cut-points applied to screening 
instruments or diagnostic criteria. Journal of Psychiatric Research, 28(2), 185-8. 
Cochran, D.M., Dvir, Y., & Frazier, J.A. (2013). "Autism-plus" Spectrum Disorders: Intersection with 
Psychosis and the Schizophrenia Spectrum. Child and Adolescent Psychiatric Clinics of North 
America, 22(4), 609-627. 
Colom, R., Jung, R., & Haier, R. (2006). Distributed brain sites for the g-factor of intelligence. 
NeuroImage, 31(3), 1359-1365.  
Convit, A., Wolf, O.T., de Leon, M.J., Patalinjug, M., Kandil, E., Caraos, C., & Cancro, R. (2001). 
Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry 
Research, 107(2), 61–73. 
Cook Jr, E., & Scherer, S. (2008). Copy-number variations associated with neuropsychiatric 
conditions. Nature, 455(7215), 919-923. 
Cooper, S. A., Smiley, E., Morrison, J., Williamson, A., & Allan, L. (2007c). Mental ill-health in 
adults with intellectual disabilities: prevalence and associated factors. British Journal of Psychiatry, 
190, 27-35. 
Cooper, S., Melville, C., & Einfeld, S. (2003). Psychiatric diagnosis, intellectual disabilities and 
Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental 
Retardation (DC-LD). Journal of Intellectual Disability Research, 47(s1), 3-15.  
Cooper, S., Smiley, E., Morrison, J., Allan, L., Williamson, A., Finlayson, J., & Jackson, A. et al. 
(2007a). Psychosis and adults with intellectual disabilities. Social Psychiatry and Psychiatric 
Epidemiology, 42(7), 530-536.  
Cooper, S., Smiley, E., Morrison, J., Williamson, A., & Allan, L. (2007b). An epidemiological 
investigation of affective disorders with a population-based cohort of 1023 adults with intellectual 
disabilities. Psychological Medicine, 37(06), 873.  
Cooper, S.A. & Bailey, N.M. (2001). Psychiatric disorders among adults with learning disabilities - 
prevalence and relationship to ability level. Irish Journal of Psychological Medicine, 18, 45-53. 
Cooray, S.E., & Bakala, A. (2005). Anxiety disorders in people with learning disabilities. Advances in 
Psychiatric Treatment, 11, 355-361. 
 104 
Cornblatt, B., Lencz, T., Smith, C., Correll, C., Auther, A., & Nakayama, E. (2003). The 
Schizophrenia Prodrome Revisited: A Neurodevelopmental Perspective. Schizophrenia Bulletin, 
29(4), 633-651.  
Costello, E., & Angold, A. (2000). Developmental psychopathology and public health: Past, present, 
and future. Development and Psychopathology, 12(4), 599-618.  
Costello, H. & Bouras, N. (2006). Assessment of mental health problems in people with intellectual 
disabilities. The Israel Journal of Psychiatry and Related Sciences, 43(4), 241-251. 
Courchesne, E., Karns, C., Davis, H., Ziccardi, R., Carper, R., Tigue, Z., & Chisum, H. et al. (2001). 
Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. 
Neurology, 57(2), 245-254.  
Courchesne, E., Pierce, K., Schumann, C., Redcay, E., Buckwalter, J., Kennedy, D., & Morgan, J. 
(2007). Mapping Early Brain Development in Autism. Neuron, 56(2), 399-413.  
Courchesne, E., Press, G., & Yeung-Courchesne, R. (1993). Parietal lobe abnormalities detected with 
MR in patients with infantile autism. American Journal of Roentgenology, 160(2), 387-393.  
Couture, S.M., Penn, D.L., Losh, M., Adolphs, R., Hurley, R., & Piven, J. (2010). Comparison of 
social cognitive functioning in schizophrenia and high functioning autism: more convergence than 
divergence. Psychological Medicine, 40(4), 569–79. 
Cowley, A., Newton, J., Sturmey, P., Bouras, N., & Holt, G. (2005). Psychiatric Inpatient Admissions 
of Adults With Intellectual Disabilities: Predictive Factors. American Journal on Mental Retardation, 
110(3), 216-225. 
Coyle, J. (2006). Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis. Cellular and 
Molecular Neurobiology, 26(4-6), 363-382.  
Craig, J.S., Hatton, C., Craig, F.B., & Bentall, R.P. (2004). Persecutory beliefs, attributions and theory 
of mind: comparison of patients with paranoid delusions, Asperger's syndrome and healthy controls. 
Schizophrenia Research, 69(1), 29–33. 
Crespi, B., & Badcock, C. (2008). Psychosis and autism as diametrical disorders of the social brain. 
Behavioral and Brain Sciences, 31, 241-320.  
Crespi, B., Stead, P., & Elliot, M. (2010). Evolution in health and medicine Sackler colloquium: 
comparative genomics of autism and schizophrenia. Proceedings of the National Academy of Sciences, 
107 (1), 1736–1741.  
Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R., & Hendrick, V. (2011). Antidepressant Use 
During Pregnancy and Childhood Autism Spectrum Disorders. Archives of General Psychiatry, 
68(11), 1104-1112. 
Cruz, B., Resende, C., Abreu, M., Rocha, F., Teixeira, A., Keefe, R., & Salgado, J. (2013). How 
specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS 
and SCoRS. Cognitive Neuropsychiatry, 18(3), 243-251. 
Cuthbert, B., & Insel, T. (2013). Toward the future of psychiatric diagnosis: the seven pillars of 
RDoC. BMC Medicine, 11(1), 126. 
D’Mello, A., & Stoodley, C. (2015). Cerebro-cerebellar circuits in autism spectrum disorder. Frontiers 
in Neuroscience, 9, 408 
Dager, S.R., Wang, L., Friedman, S.D., Shaw, D.W., Constantino, J.N., Artru, A.A., Dawson, G., & 
Csernansky, J.G. (2007). Shape mapping of the hippocampus in young children with autism spectrum 
disorder. American Journal of Neuroradiology, 28(4), 672-7. 
 105 
Daily, D. K., Ardinger, H. H., & Holmes, G. E. (2000). Identification and evaluation of mental 
retardation. American Family Physician, 61(4), 1059–1067. 
Davidson, P.W., Myers, G.J., & Weiss, B. (2004). Mercury exposure and child development 
outcomes. Pediatrics, 113, 1023–1029. 
Davis, T., Hess, J., Moree, B., Fodstad, J., Dempsey, T., Jenkins, W., & Matson, J. (2011). Anxiety 
symptoms across the lifespan in people diagnosed with Autistic Disorder. Research in Autism 
Spectrum Disorders, 5(1), 112-118.  
de Boer, M., Spek, A., & Lobbestael, J. (2014). Comparing cognitive functioning in schizophrenia and 
autism using WAIS-III. Research in Autism Spectrum Disorders, 8(7), 737-745. 
De Fossé, L., Hodge, S., Makris, N., Kennedy, D., Caviness, V., McGrath, L., & Steele, S. et al. 
(2004). Language-association cortex asymmetry in autism and specific language impairment. Annals 
of Neurology, 56(6), 757-766.  
De Hert, M., Schreurs, V., Vancampfort, D., & Van Winkel, R. (2009). Metabolic syndrome in people 
with schizophrenia: a review. World Psychiatry, 8(1), 15–22. 
de Ligt, J., Willemsen, M., van Bon, B., Kleefstra, T., Yntema, H., Kroes, T., & Vulto-van Silfhout, A. 
et al. (2012). Diagnostic Exome Sequencing in Persons with Severe Intellectual Disability. New 
England Journal of Medicine, 367(20), 1921-1929. 
de Winter, C., Jansen, A., & Evenhuis, H. (2011). Physical conditions and challenging behaviour in 
people with intellectual disability: a systematic review. Journal of Intellectual Disability Research, 
55(7), 675-698. 
Deb, S., Chaplin, R., Sohanpal, S., Unwin, G., Soni, R., & Lenotre, L. (2008). The effectiveness of 
mood stabilizers and antiepileptic medication for the management of behaviour problems in adults 
with intellectual disability: a systematic review. Journal of Intellectual Disability Research, 52(2), 
107–113, 
Deb, S., Matthews, T., Holt, G., & Bouras N. (2001a). Practice Guidelines for the Assessment and 
Diagnosis of Mental Health Problems in Adults with Intellectual Disability Pavilion Press, Brighton. 
Deb, S., Thomas, M. & Bright, C. (2001b). Mental disorder in adults with intellectual disability. 2: 
The rate of behaviour disorders among a community-based population aged between 16 and 64 years. 
Journal of Intellectual Disability Research, 45(6), 506-514. 
Depp, C., Moore, D., Sitzer, D., Palmer, B., Eyler, L., Roesch, S., & Lebowitz, B. et al. (2007). 
Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to 
schizophrenia and normal comparison subjects. Journal of Affective Disorders, 101(1-3), 201-209.  
DeStefano, F., Price, C., & Weintraub, E. (2013). Increasing Exposure to Antibody-Stimulating 
Proteins and Polysaccharides in Vaccines Is Not Associated with Risk of Autism. The Journal of 
Pediatrics, 163(2), 561-567. 
Dickinson, D. (2008). Digit symbol coding and general cognitive ability in schizophrenia: worth 
another look?. The British Journal of Psychiatry, 193(5), 354-356. 
Dossetor, D.R. (2007). All that glitters is not gold': misdiagnosis of psychosis in pervasive 
developmental disorders--a case series. Clinical Child Psychology and Psychiatry, 12(4), 537-548. 
Downs, A., Downs, R.C., & Rau K. (2008). Effects of training and feedback on Discrete Trial 
Teaching skills and student performance. Research in Developmental Disabilities, 29(3), 235-46. 
Dragich, J. (2000). Rett syndrome: a surprising result of mutation in MECP2. Human Molecular 
Genetics, 9(16), 2365-2375. 
 106 
Duke, L., Allen, D., Ross, S., Strauss, G., & Schwartz, J. (2010). Neurocognitive function in 
schizophrenia with comorbid posttraumatic stress disorder. Journal of Clinical and Experimental 
Neuropsychology, 32(7), 737-751. 
Durand, C., Perroy, J., Loll, F., Perrais, D., Fagni, L., Bourgeron, T., & Montcouquiol, M. et al. 
(2012). SHANK3 mutations identified in autism lead to modification of dendritic spine morphology 
via an actin-dependent mechanism. Molecular Psychiatry, 17(1), 71-84. 
Durkin, M. (2000). Prenatal and Postnatal Risk Factors for Mental Retardation among Children in 
Bangladesh. American Journal of Epidemiology, 152(11), 1024-1033.  
Durkin, M. (2002). The epidemiology of developmental disabilities in low-income countries. Mental 
Retardation and Developmental Disabilities Research Reviews, 8(3), 206-211. 
Edelson, M.G. (2006). Are the majority of children with autism mentally retarded? A systematic 
evaluation of the data?. Focus on Autism and Other Developmental Disabilities, 21(2), 66–83. 
Edgin, J., Pennington, B., & Mervis, C. (2010). Neuropsychological components of intellectual 
disability: the contributions of immediate, working, and associative memory. Journal of Intellectual 
Disability Research, 54(5), 406-417.  
Edwards, J., Jackson, H.J., & Pattison, P.E. (2002). Emotion recognition via facial expression and 
affective prosody in schizophrenia: a methodological review. Clinical Psychology Review, 22(6), 789–
832. 
Eigsti, I., & Shapiro, T. (2003). A systems neuroscience approach to autism: Biological, cognitive, and 
clinical perspectives. Mental Retardation and Developmental Disabilities Research Reviews, 9(3), 
206-216.  
Eisen, J.L., Beer, D.A., Pato, M.T., Venditto, T.A., & Rasmussen, S.A. (1997). Obsessive-compulsive 
disorder in patients with schizophrenia or schizoaffective disorder. American Journal of Psychiatry, 
154(2), 271-273.  
El Marroun, H., White, T., Verhulst, F., & Tiemeier, H. (2014). Maternal use of antidepressant or 
anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic 
review. European Child & Adolescent Psychiatry, 23(10), 973-992. 
Emamian, E. S. (2012). AKT/GSK3 signaling pathway and schizophrenia. Frontiers in Molecular 
Neuroscience, 5, 33. 
Emerson, E. (1995). Challenging behaviour: Analysis and intervention in people witli learning 
difficulties. Cambridge: Cambridge University Press.  
Emerson, E. (2007). Poverty and people with intellectual disabilities. Mental Retardation and 
Developmental Disabilities Research Reviews, 13(2), 107-13. 
Emerson, E., Kiernan, C., Alborz, A., Reeves, D., Mason, H., Swarbrick, R., & Mason, L. et al. 
(2001a). The prevalence of challenging behaviors: a total population study. Research in 
Developmental Disabilities, 22(1), 77-93.  
Emerson, E., Kiernan, C., Alborz, A., Reeves, D., Mason, H., Swarbrick, R., & Mason, L. et al. 
(2001b). Predicting the persistence of severe self-injurious behavior. Research in Developmental 
Disabilities, 22(1), 67-75. 
Emerson, E., Moss, S., & Kiernan, C. (1999). The relationship between challenging behaviour and 
psychiatric disorders in people with severe developmental disabilities. Psychiatric and behavioural 
disorders in developmental disabilities and mental retardation, 38-48. 
 107 
Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., & Milh, M. et al. (2010). 
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable 
neurodevelopmental phenotypes. Nature Genetics, 42(11), 1021-1026.  
Enticott, P.G., Hoy, K.E., Herring, S.E., Johnston, P.J., Daskalakis, Z.J., & Fitzgerald, P.B. (2008). 
Reduced motor facilitation during action observation in schizophrenia: a mirror neuron deficit?. 
Schizophrenia Research, 102, 116–121. 
Fazel, S., Långström, N., Hjern, A., Grann, M., & Lichtenstein, P. (2009). Schizophrenia, Substance 
Abuse, and Violent Crime. JAMA, 301(19), 2016-2023. 
Feighner, J.P., Robins, E., Guze, S.B., Woodruff, R.A., Winokur, G., & Munoz, R. (1972). Diagnostic 
criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57-63. 
Felce, D., Kerr, M., & Hastings, R. P. (2009). A general-practice based of the relationship between 
indicators of mental illness and challenging behaviour among adults with intellectual disabilities. 
Journal of Intellectual Disabilities Research, 53, 243–254 
Fernandez, B., Roberts, W., Chung, B., Weksberg, R., Meyn, S., Szatmari, P., & Joseph-George, A. et 
al. (2010). Phenotypic spectrum associated with de novo and inherited deletions and duplications at 
16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. Journal of Medical 
Genetics, 47(3), 195-203. 
Fialko, L., Freeman, D., Bebbington, P., Kuipers, E., Garety, P., Dunn, G., & Fowler, D. (2006). 
Understanding suicidal ideation in psychosis: findings from the Psychological Prevention of Relapse 
in Psychosis (PRP) trial. Acta Psychiatrica Scandinavica, 114(3), 177-186. 
Fink, M. (2013). Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatrica 
Scandinavica, Suppl. 127, 1–47. 
Fink, M., & Taylor, M. (2001). The many varieties of catatonia. European Archives of Psychiatry and 
Clinical Neurosciences, 251(S1), I8-I13.  
Fioravanti, M., Bianchi, V., & Cinti, M. (2012). Cognitive deficits in schizophrenia: an updated 
metanalysis of the scientific evidence. BMC Psychiatry, 12(1), 64. 
Fisch, G.S., Davis, R., Youngblom, J., & Gregg, J. (2011). Genotype-Phenotype Association Studies 
of Chromosome 8p Inverted Duplication Deletion Syndrome. Behavior Genetics, 41(3), 373-80. 
Fitzgerald, M. (2014). Overlap between autism and schizophrenia: history and current status. 
Advances in Mental Health and Intellectual Disabilities, 8(1), 15-23. 
Fletcher, R., Loschen, E., Stavrakaki, C. & First, M. (2007). Diagnostic Manual -- Intellectual 
Disability (DM-ID):  A Textbook of Diagnosis of Mental Disorders in Persons with Intellectual 
Disability. NADD Press, Kingston, NY. 
Focht-New, G., Clements, P. T., Barol, B., Faulkner M. J., & Pekala, K. (2008). Persons With 
Developmental Disabilities Exposed to Interpersonal Violence and Crime: Strategies and Guidance for 
Assessment. Perspectives in Psychiatric Care, 44(1), 3-13. 
Folstein, S., & Rosen-Sheidley, B. (2001). Genetics of austim: complex aetiology for a heterogeneous 
disorder. Nature Review. Genetics, 2(12), 943-955.  
Fombonne, E. (2003). Epidemiological surveys of autism and other pervasive developmental 
disorders: An update. Journal of Autism and Developmental Disorders, 33(4), 365-382. 
Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric Research, 65(6), 
591-598. 
 108 
Forbes, N.F., Carrick, L.A., McIntosh, A.M., & Lawrie, S.M. (2009). Working memory in 
schizophrenia: a meta-analysis. Psychological Medicine, 39(6), 889-905. 
Ford, T.C., & Crewther, D.P. (2014). Factor analysis demonstrates a common schizoidal phenotype 
within autistic and schizotypal tendency: implications for neuroscientific studies. Frontiers in 
Psychiatry, 5, 117. 
Frangou, S., Chitins, X., & Williams, S. (2004). Mapping IQ and gray matter density in healthy young 
people. NeuroImage, 23(3), 800-805.  
Freeman, D. (2007). Suspicious minds: the psychology of persecutory delusions. Clinical Psychology 
Review, 27(4), 425–457.  
Freitag, C. (2006). The genetics of autistic disorders and its clinical relevance: a review of the 
literature. Molecular Psychiatry, 12(1), 2-22.  
Frints, S., Froyen, G., Marynen, P., & Fryns, J. (2002). X-linked mental retardation: vanishing 
boundaries between non-specific (MRX) and syndromic (MRXS) forms. Clinical Genetics, 62(6), 
423-432. 
Frith, U. (2003). Explaining the enigma. (2nd ed.). Cambridge, MA: Blackwell Pub. 
Froese, T., Iizuka, H., & Ikegami, T. (2013b). From synthetic modeling of social interaction to 
dynamic theories of brain–body–environment–body–brain systems. Behavioral and Brain Sciences, 
36(04), 420-421. 
Froese, T., Stanghellini, G., & Bertelli, M. (2013a). Is it normal to be a principal mindreader? 
Revising theories of social cognition on the basis of schizophrenia and high functioning autism-
spectrum disorders. Research in Developmental Disabilities, 34(5), 1376-1387.  
Gabis, L.V., Baruch, Y.K., Jokel, A., & Raz, R. (2011). Psychiatric and autistic comorbidity in fragile 
X syndrome across ages. Journal of Child Neurology, 26(8), 940-948. 
Gadow, K. D., Devincent, C. J., Pomeroy, J., & Azizian, A. (2005). Comparison of DSM-IV 
symptoms in elementary school-age children with PDD versus clinic and community samples. Autism, 
9, 392–415. 
Gal, E., Hardal-Nasser, R., & Engel-Yeger, B. (2011). The relationship between the severity of eating 
problems and intellectual developmental deficit level. Research in Developmental Disabilities, 32(5), 
1464-1469. 
Gallagher, S., & Varga, S. (2015). Social cognition and psychopathology: a critical overview. World 
Psychiatry, 14(1), 5-14. 
Gallese, V. (1998). Mirror neurons and the simulation theory of mind-reading. Trends in Cognitive 
Sciences, 2(12), 493-501.  
Gardener, H., Spiegelman, D., & Buka, S. (2009). Prenatal risk factors for autism: comprehensive 
meta-analysis. The British Journal of Psychiatry, 195(1), 7-14.  
Gearon, J., Bellack, A., & Tenhula, W. (2004). Preliminary Reliability and Validity of the Clinician-
Administered PTSD Scale for Schizophrenia. Journal of Consulting and Clinical Psychology, 72(1), 
121-125.  
Georgiades, S. , Szatmari, P. , Duku, E. , Zwaigenbaum, L. , Bryson, S. , Roberts, W. & Pathways in 
ASD Study Team (2011). Phenotypic overlap between core diagnostic features and 
emotional/behavioral problems in preschool children with Autism spectrum disorder. Journal of 
Autism and Developmental Disorders, 41(10), 1321-1329. 
 109 
Geschwind, D., & Levitt, P. (2007). Autism spectrum disorders: developmental disconnection 
syndromes. Current Opinion in Neurobiology, 17(1), 103-111.  
Ghaziuddin, M. (2005). Mental Health Aspects of Autism and Asperger Syndrome. London: Jessica 
Kingsley Publishers. 
Ghaziuddin, M., Alessi, N., & Greden, J. (1995). Life events and depression in children with pervasive 
developmental disorders. J Autism Dev Disord, 25(5), 495-502.  
Ghaziuddin, M., Ghaziuddin, N., & Greden, J. (2002). Depression in persons with autism: 
Implications for research and clinical care. Journal of Autism and Developmental Disorders, 32(4), 
299–306.) 
Gibbons, R.J., McDowell, T.L., Raman, S., O'Rourke, D.M., Garrick, D., Ayyub, H., & Higgs, D.R. 
(2009). Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of 
DNA methylation. Nature Genetics, 24(4), 368-71. 
Gillberg, C. (2010). The ESSENCE in child psychiatry: Early Symptomatic Syndromes Eliciting 
Neurodevelopmental Clinical Examinations. Research in Developmental Disabilities, 31(6), 1543-
1551.  
Gillberg, C., I., Råstam, M., Wentz, E. & Gillberg, C. (2007). Cognitive and executive functions in 
anorexia nervosa ten years after onset of eating disorder. Journal of Clinical and Experimental 
Neuropsychology, 29(2), 170-178. 
Girirajan, S., Rosenfeld, J., Coe, B., Parikh, S., Friedman, N., Goldstein, A., & Filipink, R. et al. 
(2012). Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants. New 
England Journal of Medicine, 367(14), 1321-1331.  
Goldmon, S., Wang, C., Salgado, M.W., Greene, P.E., Kim, M., & Rapin, I. (2009). Motor 
stereotypies in children with autism and other developmental disorders. Developmental Medicine and 
Child Neurology, 51, 30–38. 
Goldstein, G., Allen, D., Minshew, N., Williams, D., Volkmar, F., Klin, A. and Schultz, R. (2008). 
The structure of intelligence in children and adults with high functioning autism. Neuropsychology, 
22(3), 301-312. 
Goldstein, G., Minshew, N., Allen, D., & Seaton, B. (2002). High-functioning autism and 
schizophrenia A comparison of an early and late onset neurodevelopmental disorder. Archives of 
Clinical Neuropsychology, 17(5), 461-475. 
Gong, G., Jiang, T., Zhu, C., Zang, Y., Wang, F., Xie, S., & Xiao, J. et al. (2005). Asymmetry analysis 
of cingulum based on scale-invariant parameterization by diffusion tensor imaging. Human Brain 
Mapping, 24(2), 92-98.  
Gonzáles, G., Raggio, V., Boidi, M., Tapié, A., & Roche, L. (2013). Avances en la identificación 
etiológica del retraso mental. Revista de Neurologia, 57, 75–83.  
Goodwin, R., Amador, X., Malaspina, D., Yale, S., Goetz, R., & Gorman, J. (2003). Anxiety and 
substance use comorbidity among inpatients with schizophrenia. Schizophrenia Research, 61(1), 89-
95.  
Gotham, K., Unruh, K., & Lord, C. (2015). Depression and its measurement in verbal adolescents and 
adults with autism spectrum disorder. Autism, 19(4), 491-504. 
Gottesman, I., & Erlenmeyer-Kimling, L. (2001). Family and twin strategies as a head start in defining 
prodromes and endophenotypes for hypothetical early-interventions in schizophrenia. Schizophrenia 
Research, 51(1), 93-102. 
 110 
Gravestock, S. (2000). Review: eating disorders in adults with intellectual disability. Journal of 
Intellectual Disability Research, 44, 625–37. 
Gravestock, S. (2003). Diagnosis and classification of eating disorders in adults with intellectual 
disability: the Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning 
Disabilities/Mental Retardation (DC-LD) approach. Journal of Intellectual Disability Research, 47(1), 
72-83. 
Green, A., Canuso, C., Brenner, M. and Wojcik, J. (2003). Detection and management of comorbidity 
in patients with schizophrenia. Psychiatric Clinics of North America, 26(1), 115-139.  
Griffiths, D. M., & Gardner, W. I. (2002). The integrated biopsychosocial approach to challenging 
behaviours. in Griffiths, D.M., Stavrakaki, C., and Summers J. (Ed.), Dual diagnosis: An introduction 
to the mental health needs of persons with developmental disabilities, Habilitative Mental Health 
Resource Network, Sudbury, pp. 81-114. 
Groce, N., Challenger, E., Berman-Bieler, R., Farkas, A., Yilmaz, N., Schultink, W., & Clark, D. et al. 
(2014). Malnutrition and disability: unexplored opportunities for collaboration. Paediatrics and 
International Child Health, 34(4), 308-314. 
Groen, W.B. , Swinkels, S.H. , van der Gaag, R.J. & Buitelaar, J.K. (2007). Finding effective 
screening instruments for autism using bayestheorem. Archives of Pediatrics & Adolescent Medicine , 
161(4), 415-416. 
Guillem, F., Satterthwaite, J., Pampoulova, T., & Stip, E. (2009). Relationship between psychotic and 
obsessive compulsive symptoms in schizophrenia. Schizophrenia Research, 115(2-3), 358-362. 
Hagerman, R.J., Jackson, A.W., Levitas, A., Rimland, B., & Braden, M. (1986). An analysis of autism 
in fifty males with the fragile X syndrome. American Journal of Medical Genetics, 23(1-2), 359–374. 
Hall, J., Jobson, L., & Langdon, P. (2014). Measuring symptoms of post-traumatic stress disorder in 
people with intellectual disabilities: The development and psychometric properties of the Impact of 
Event Scale-Intellectual Disabilities (IES-IDs). British Journal of Clinical Psychology, 53(3), 315-
332. 
Hamdan, F., Gauthier, J., Araki, Y., Lin, D., Yoshizawa, Y., Higashi, K., & Park, A. et al. (2011). 
Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in 
Nonsyndromic Intellectual Disability. The American Journal of Human Genetics, 88(4), 516. 
Happé, F. & Ronald, A. (2008). The ‘Fractionable Autism Triad’: A Review of Evidence from 
Behavioural, Genetic, Cognitive and Neural Research. Neuropsychol Rev, 18(4), pp.287-304.  
Happé, F., & Frith, U. (2006). The weak coherence account: detail-focused cognitive style in autism 
spectrum disorders. Journal of Autism and Developmental Disorders, 35, 5–25.  
Hardan, A., Girgis, R., Adams, J., Gilbert, A., Keshavan, M., & Minshew, N. (2006). Abnormal brain 
size effect on the thalamus in autism. Psychiatry Research: Neuroimaging, 147(2-3), 145-151.  
Hardan, A., Kilpatrick, M., Keshavan, M., & Minshew, N. (2003). Motor Performance and Anatomic 
Magnetic Resonance Imaging (MRI) of the Basal Ganglia in Autism. Journal of Child Neurology, 
18(5), 317-324. 
Hardan, A., Libove, R., Keshavan, M., Melhem, N., & Minshew, N. (2009). A Preliminary 
Longitudinal Magnetic Resonance Imaging Study of Brain Volume and Cortical Thickness in Autism. 
Biological Psychiatry, 66(4), 320-326.  
Harris, J. (2006). Intellectual disability. New York: Oxford University Press. Harris JC. New York: 
Oxford University Press; 2006. Intellectual Disability: Understanding Its Development, Causes, 
 111 
Classification, Evaluation, and Treatment. Washington, DC: American Association on Intellectual and 
Developmental Disabilities. 
Harrow, M., Yonan, C., Sands, J. and Marengo, J. (1994). Depression in Schizophrenia: Are 
Neuroleptics, Akinesia, or Anhedonia Involved?. Schizophrenia Bulletin, 20(2), 327-338. 
Hassiotis, A. (2015). Borderline intellectual functioning and neurodevelopmental disorders: 
prevalence, comorbidities and treatment approaches. Advances in Mental Health and Intellectual 
Disability, 9(5), 275-283. 
Hassiotis, A., (2001). Intellectual functioning and outcome of patients with severe psychotic illness 
randomised to intensive case management: Report from the UK700 trial. The British Journal of 
Psychiatry, 178(2), 166-171.  
Hassiotis, A., Strydom, A., Hall, I., Ali, A., Lawrence-Smith, G., Meltzer, H., Head, J., & Bebbington, 
P. (2008). Psychiatric morbidity and social functioning among adults with borderline intelligence 
living in private households. Journal of Intellectual Disability Research. 52(Pt 2), 95-106. 
Hatton, C., & Taylor, J. (2008). Factor structure of the PAS-ADD Checklist with adults with 
intellectual disabilities. Journal of Intellectual and Developmental Disability, 33(4), 330-336. 
Haut, K.M., & MacDonald, A.W. (2010). Persecutory delusions and the perception of trustworthiness 
in unfamiliar faces in schizophrenia. Psychiatry Research, 178(3), 456–60. 
Heaton, R., Gladsjo, J., Palmer, B., Kuck, J., Marcotte, T., & Jeste, D. (2001). Stability and Course of 
Neuropsychological Deficits in Schizophrenia. Archives of General Psychiatry, 58(1), 24-32. 
Heckers, S., Tandon, R., & Bustillo, J. (2009). Catatonia in the DSM--Shall We Move or Not?. 
Schizophrenia Bulletin, 36(2), 205-207. 
Heikura, U., Taanila, A., Olsen, P., Hartikainen, A., von Wendt, L., & Järvelin, M. (2003). Temporal 
Changes in Incidence and Prevalence of Intellectual Disability Between Two Birth Cohorts in 
Northern Finland. American Journal on Mental Retardation, 108(1), 19.  
Heinrichs, R., & Zakzanis, K. (1998). Neurocognitive deficit in schizophrenia: A quantitative review 
of the evidence. Neuropsychology, 12(3), 426-445.  
Helverschou, S.B. , Bakken, T.L. and Martinsen, H. (2008). Identifying symptoms of psychiatric 
disorders in people with autism and intellectual disability: an empirical conceptual analysis. Mental 
Health Aspects of Developmental Disabilities, 11(4), 105-115.  
Helverschou, S.B., Bakken, T. & Martinsen, H. (2011). Psychiatric disorders in people with Autism 
spectrum disorders: Phenomenology and recognition. (Chapter 5), (p. 53-74), In J. L. Matson & P. 
Sturmey (Eds.), International handbook of autism and pervasive developmental disorders. New York: 
Springer. 
Hemmings, C., Gravestock, S., Pickard, M., & Bouras, N. (2006). Psychiatric symptoms and problem 
behaviours in people with intellectual disabilities. Journal of Intellectual Disability Research, 50(4), 
269-276.  
Hill, J., & Furniss, F. (2006). Patterns of emotional and behavioural disturbance associated with 
autistic traits in young people with severe intellectual disabilities and challenging behaviours. 
Research in Developmental Disabilities, 27, 517–528. 
Hodgins, S. (2008). Violent behaviour among people with schizophrenia: a framework for 
investigations of causes, and effective treatment, and prevention. Philosophical Transactions of the 
Royal Society B: Biological Sciences, 363(1503), 2505-2518.  
 112 
Hoekstra, R., Happé, F., Baron-Cohen, S., & Ronald, A. (2009). Association between extreme autistic 
traits and intellectual disability: insights from a general population twin study. The British Journal of 
Psychiatry, 195(6), 531-536. 
Hofvander, B., Delorme, R., Chaste, P., Nyden, A., Wentz, E., Stahlberg, O., & Herbrecht, E. et al. 
(2009). Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum 
disorders. BMC Psychiatry, 9(1), 35.  
Holland, A.J. & Koot, H.M. (1998). Mental health and intellectual disability: an international 
perspective. Journal of Intellectual Disability Research, 42(6), 505-512. 
Hollander, E., Anagnostou, E., Chaplin, W., Esposito, K., Haznedar, M., Licalzi, E., & Wasserman, S. 
et al. (2005). Striatal Volume on Magnetic Resonance Imaging and Repetitive Behaviors in Autism. 
Biological Psychiatry, 58(3), 226-232.  
Honea, R., Crow, T., Passingham, D., & Mackay, C. (2005). Regional Deficits in Brain Volume in 
Schizophrenia: A Meta-Analysis of Voxel-Based Morphometry Studies. American Journal of 
Psychiatry, 162(12), 2233-2245.  
Horovitz, M. & Matson, J.L. (2010). Communication deficits in babies and infants with autism and 
pervasive developmental disorder – not otherwise specified (PDD-NOS). Developmental 
Neurorehabilitation, 13(6), 390-398. 
Hove, O. (2004). Prevalence of Eating Disorders in Adults With Mental Retardation Living in the 
Community. American Journal on Mental Retardation, 109(6), 501.  
Howard, M., Cowell, P., Boucher, J., Broks, P., Mayes, A., Farrant, A., & Roberts, N. (2000). 
Convergent neuroanatomical and behavioural evidence of an amygdala hypothesis of autism. 
NeuroReport, 11(13), 2931-2935. 
Howard, R., Rabins, P.V., Seeman, M.V., & Jeste, D.V. (2000). Late-Onset Schizophrenia and Very-
Late-Onset Schizophrenia-Like Psychosis: An International Consensus. American Journal of 
Psychiatry, 157(2), 172-178. 
Howells, J.G. & Guirguis, W.R. (1984). Childhood schizophrenia 20 years later. Archives of General 
Psychiatry, 41(2), 123-8. 
Howes, O. D., & Kapur, S. (2009). The Dopamine Hypothesis of Schizophrenia: Version III—The 
Final Common Pathway. Schizophrenia Bulletin, 35(3), 549–562.  
Hubbard, L., Tansey, K., Rai, D., Jones, P., Ripke, S., Chambert, K., & Moran, J. et al. (2015). 
Evidence of Common Genetic Overlap Between Schizophrenia and Cognition. Schizophrenia 
Bullettin, sbv168. 
Hubert, J., & Hollins, S. (2006). Men with severe learning disabilities and challenging behaviour in 
long-stay hospital care: qualitative study. British Journal of Psychiatry, 188, 70-74. 
Hurley, A. (2008). Depression in adults with intellectual disability: symptoms and challenging 
behaviour. Journal of Intellectual Disability Research, 52(11), 905-916.  
Hurley, A.D., Folstein, M., & Lam, N. (2003). Patients with and without intellectual disability seeking 
outpatient psychiatric services: diagnoses and prescribing pattern. Journal of Intellectual Disability 
Research, 47(1), 39-50. 
Hutton, J., Goode, S., Murphy, M., Le Couteur, A., & Rutter, M. (2008). New onset disorders in 
individuals with autism. Autism, 12, 373-90. 
Insel, T. (2010). Rethinking schizophrenia. Nature, 468(7321), 187-193.  
 113 
Insel, T. (2014). The NIMH Research Domain Criteria (RDoC) Project: Precision Medicine for 
Psychiatry. American Journal of Psychiatry, 171(4), 395-397.  
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D., Quinn, K., & Sanislow, C. et al. (2010). 
Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental 
Disorders. American Journal of Psychiatry, 167(7), 748-751.  
Iritani, S. (2013). What happens in the brain of schizophrenia patients?: an investigation from the 
viewpoint of neuropathology. Nagoya Journal of Medical Science, 75(1-2), 11-28. 
Isohanni, M., Murray, G., Jokelainen, J., Croudace, T., & Jones, P. (2004). The persistence of 
developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult 
life. A 34-year follow-up of the Northern Finland 1966 birth cohort. Schizophrenia Research, 71(2-3), 
213-225.  
Ivarsson, T., & Melin, K. (2008). Autism spectrum traits in children and adolescents with obsessive-
compulsive disorder (OCD). Journal of Anxiety Disorders, 22(6), 969-978.  
Jablensky, A. (2000). Epidemiology of schizophrenia: the global burden of disease and disability. 
European Archives of Psychiatry and Clinical Neuroscience, 250(6), 274-285.  
Jablensky, A. (2010). The diagnostic concept of schizophrenia: its history, evolution, and future 
prospects. Dialogues in Clinical Neuroscience, 12(3), 271–287. 
Jablensky, A. & Kendell, R.E. (2002). Criteria for Assessing a Classification in Psychiatry. In: Maj et 
al (eds.). Psychiatric Diagnosis and Classification. Chichester: John Wiley, 1-24.  
Jablensky, A., & Kalaydjieva, L. (2003). Genetic Epidemiology of Schizophrenia: Phenotypes, Risk 
Factors, and Reproductive Behavior. American Journal of Psychiatry, 160(3), 425-429.  
Jansen, D., Krol, B., Groothoff, J., & Post, D. (2004). People with intellectual disability and their 
health problems: a review of comparative studies. Journal of Intellectual Disability Research, 48(2), 
93-102.  
Javitt, D.C. (2010). Glutamatergic theories of schizophrenia. Israel Journal of Psychiatry and Related 
Sciences, 47(1), 4-16. 
Johnson, T. (2006). Dietary Considerations in Autism. Topics in Clinical Nutrition, 21(3), 212-225.  
Jones, I., & McDonald, L. (2014). Living with uncertainty: antidepressants and pregnancy. The British 
Journal of Psychiatry, 205(2), 103-104. 
Jopp, D., & Keys, C. (2001). Diagnostic Overshadowing Reviewed and Reconsidered. American 
Journal on Mental Retardation, 106(5), 416.  
Joseph, R., Tager-Flusberg, H., & Lord, C. (2002). Cognitive profiles and social-communicative 
functioning in children with autism spectrum disorder. Journal of Child Psychology and Psychiatry, 
43(6), 807-821. 
Jou, R.J., Minshew, N.J., Keshavan, M.S., Vitale, M.P., & Hardan, A.Y. (2010). Enlarged right 
superior temporal gyrus in children and adolescents with autism. Brain Research, 1360, 205-212. 
Kahler, S.G., & Fahey, M.C. (2003). Metabolic disorders and mental retardation. American Journal of 
Medical Genetics Part C, Seminars in Medical Genetics, 15, 117C(1) 31-41. 
Kanner, L. (1973). Autistic disturbances of affective contact. Nervous Child, 2(3), 217- 250. 
Kästner, A., Begemann, M., Michel, T., Everts, S., Stepniak, B., Bach, C., & Poustka, L. et al. (2015). 
Autism beyond diagnostic categories: characterization of autistic phenotypes in schizophrenia. BMC 
Psychiatry, 15(1). 
 114 
Kaufman, L., Ayub, M., & Vincent, J. B. (2010). The genetic basis of non-syndromic intellectual 
disability: a review. Journal of Neurodevelopmental Disorders, 2(4), 182–209.  
Ke, X., & Liu, J. (2012). Intellectual disability. In Rey JM (ed), IACAPAP e-Textbook of Child and 
Adolescent Mental Health. Geneva: International Association for Child and Adolescent Psychiatry and 
Allied Professions 2012 
Keefe, R. S. E. (2008). Should cognitive impairment be included in the diagnostic criteria for 
schizophrenia? World Psychiatry, 7(1), 22–28. 
Keefe, R., & Harvey, P. (2012). Cognitive Impairment in Schizophrenia. Novel Antischizophrenia 
Treatments, 11-37. 
Keller, R., Bugiani, S., Fantin, P., & Pirfo, E. (2011b). Mirror neurons and autism. Italian Journal of 
Psychopathology, 17(4), 404-412. 
Keller, W., Fischer, B., & Carpenter Jr., W. (2011a). Revisiting the Diagnosis of Schizophrenia: 
Where have we been and Where are We Going?. CNS Neuroscience & Therapeutics, 17(2), 83-88. 
Kelly, B., O'Callaghan, E., Waddington, J., Feeney, L., Browne, S., Scully, P., & Clarke, M. et al. 
(2010). Schizophrenia and the city: A review of literature and prospective study of psychosis and 
urbanicity in Ireland. Schizophrenia Research, 116(1), 75-89. 
Kendall, K., & Owen, M.J. (2015). Intellectual Disability and Psychiatric Comorbidity: Challenges 
and Clinical Issues. Psychiatric Times, May 26. 
Kendell, R. E. (1971). Psychiatric diagnosis in Britain and the United States. British Journal of 
Hospital Medicine, 6:147-155. 
Kendler, K. S. & Diehl, S. R. (1993) The genetics of schizophrenia: a current genetic-epidemiologic 
perspective. Schizophrenia Bulletin, 19, 261 -285. 
Kepser, L., & Homberg, J. (2014). The neurodevelopmental effects of serotonin: A behavioural 
perspective. Behavioural Brain Research, 277, 3-13. 
Kern, J., & Jones, A. (2006). Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism. 
Journal of Toxicology and Environmental Health, Part B, 9(6), 485-499.  
Kerns, J., Nuechterlein, K., Braver, T., & Barch, D. (2008). Executive Functioning Component 
Mechanisms and Schizophrenia. Biological Psychiatry, 64(1), 26-33.  
Khandaker, G. M., Barnett, J. H., White, I. R., & Jones, P. B. (2011). A quantitative meta-analysis of 
population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research, 132(2-
3), 220–227.  
Khandaker, G., Stochl, J., Zammit, S., Lewis, G., & Jones, P. (2014). A population-based longitudinal 
study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in 
adolescence. Psychological Medicine, 44(15), 3229-3238. 
Kim, J., Doop, M.L., Blake, R., & Park, S. (2005). Impaired visual recognition of biological motion in 
schizophrenia. Schizophrenia Research, 77(2–3), 299–307. 
Kim, Y., Leventhal, B., Koh, Y., Fombonne, E., Laska, E., Lim, E., Cheon, K., Kim, S., Kim, Y., Lee, 
H., Song, D. & Grinker, R. (2011). Prevalence of Autism Spectrum Disorders in a Total Population 
Sample. American Journal of Psychiatry, 168(9), 904-912.  
King, B., de Lacy, N., & Siegel, M. (2014). Psychiatric Assessment of Severe Presentations in Autism 
Spectrum Disorders and Intellectual Disability. Child and Adolescent Psychiatric Clinics of North 
America, 23(1), 1-14. 
 115 
King, B.H., & Lord C. (2011). Is schizophrenia on the autism spectrum?. Brain Research, 1380, 34–
41. 
King, B.H., Toth, K.E., Hodapp, R.M., & Dykens, E.M. (2009). Intellectual Disability. In: Sadock, 
B.J., Sadock, V.A.,  & Ruiz, P., editors. Comprehensive Textbook of Psychiatry. 9th ed. Philadelphia: 
Lippincott Williams & Wilkins. p. 3444-3474. 
Kishore, M., Nizamie, S., & Nizamie, A. (2005). The behavioural profile of psychiatric disorders in 
persons with intellectual disability. Journal of Intellectual Disability Research, 49(11), 852-857. 
Klin, A., Jones, W., Schultz, R., Volkmar, F., & Cohen, D. (2002). Visual fixation patterns during 
viewing of naturalistic social situations as predictors of social competence in individuals with autism. 
Archives of General Psychiatry, 59(9), 809–16. 
Klin, A., Sparrow, S.S., de Bildt, A., Cicchetti, D.V., Cohen, D.J., & Volkmar, F.R. (1999). A normed 
study of face recognition in autism and related disorders. Journal of Autism and Developmental 
Disorders, 29(6), 499–508. 
Kohler, C.G., Walker, J.B., Martin, E.A., Healey, K.M., & Moberg, P.J. (2010). Facial emotion 
perception in schizophrenia: a meta-analytic review. Schizophrenia Bullettin, 36(5),1009–1019. 
Kolevzon, A., Gross, R., & Reichenberg, A. (2007). Prenatal and Perinatal Risk Factors for Autism: A 
Review and Integration of Findings. Archives of Pediatric and Adolescence Medicine, 161(4), 326-
333. 
Krabbendam, L. (2005). Schizophrenia and Urbanicity: A Major Environmental Influence--
Conditional on Genetic Risk. Schizophrenia Bulletin, 31(4), 795-799.  
Kraepelin, E. (1971). Dementia praecox and paraphrenia. Translated by R. M. Barclay. Huntington, 
NY: Robert E. Krieger. 
Kraguljac, N. V., Reid, M. A., White, D. M., den Hollander, J., & Lahti, A. C. (2012). Regional 
Decoupling of N-acetyl-aspartate and Glutamate in Schizophrenia. Neuropsychopharmacology, 
37(12), 2635–2642.  
Krakowiak, P., Walker, C., Bremer, A., Baker, A., Ozonoff, S., Hansen, R., & Hertz-Picciotto, I. 
(2012). Maternal Metabolic Conditions and Risk for Autism and Other Neurodevelopmental 
Disorders. Pediatrics, 129(5), e1121-e1128. 
Krystal, J., D’Souza, D., Gallinat, J., Driesen, N., Abi-Dargham, A., Petrakis, I., & Heinz, A. et al. 
(2006). The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. 
Neurotoxicity Research, 10(3-4), 235-252. 
Kukshal, P., Bhatia, T., Bhagwat, A., Gur, R., Gur, R., Deshpande, S., & Nimgaonkar, V. et al. (2013). 
Association study of Neuregulin-1 gene polymorphisms in a north Indian schizophrenia sample. 
Schizophrenia Research, 144(1-3), 24-30.  
Kumra, S., Shaw, M., Merka, P., Nakayama, E., & Augustin, R. (2001). Childhood-onset 
schizophrenia: research update. Canadian Journal of Psychiatry, 46(10), 923–930. 
Kurtz, M.M. (2011). Neurocognition as a Predictor of Response to Evidence-Based Psychosocial 
Interventions in Schizophrenia: What is the State of the Evidence?. Clinical Psychology Review, 
31(4), 663–672. 
La Malfa, G., Lassi, G., Bertelli, M., Salvini, R., & Placidi, G.F. (2004). Autism and intellectual 
disability: A study of prevalence on a sample of the Italian population. Journal of Intellectual 
Disability Research, 48, 262–267. 
 116 
Labbate, L.A., Young, P.C., & Arana, G.W. (1999). Panic disorder in schizophrenia. Canadian 
Journal of Psychiatry, 44, 488–490. 
Lainhart, J., & Folstein, S. (1994). Affective disorders in people with autism: A review of published 
cases. J Autism Dev Disord, 24(5), 587-601.  
Lainhart, J.E. (1999). Psychiatric problems in individuals with autism, their parents and siblings. 
International Review of Psychiatry, 11, 278–298. 
LaSalle, J. (2011). A genomic point-of-view on environmental factors influencing the human brain 
methylome. Epigenetics, 6(7), 862-869.  
Lau, C., Wang, H., Hsu, J., & Liu, M. (2013). Does the dopamine hypothesis explain schizophrenia?. 
Reviews in the Neurosciences, 24(4).  
Lazoff T, Zhong L, Piperni T, Fombonne E. (2010). Prevalence of pervasive developmental disorders 
among children at the English Montreal School Board. Canadian Journal of  Psychiatry, 55(11), 715-
720. 
Lee, L.C., Harrington, R.A., Chang, J.J., & Conners, S.L. (2008). Increased risk of injury in children 
with developmental disabilities. Research in Developmental Disabilities, 29, 247–255. 
Leekam, S.R., Nieto, C., Libby, S.J., Wing, L., & Gould, J. (2007). Describing the sensory 
abnormalities of children and adults with autism. Journal of Autism and Developmental Disorders, 
37(5), 894-910. 
Lefebvre, A., Beggiato, A., Bourgeron, T., & Toro, R. (2015). Neuroanatomical Diversity of Corpus 
Callosum and Brain Volume in Autism: Meta-analysis, Analysis of the Autism Brain Imaging Data 
Exchange Project, and Simulation. Biological Psychiatry, 78(2), 126-134. 
Leonard, H., & Wen, X. (2002). The epidemiology of mental retardation: Challenges and 
opportunities in the new millennium. Mental Retardation and Developmental Disabilities Research 
Reviews, 8(3), 117-134.  
Leonard, H., Petterson, B., De Klerk, N., Zubrick, S., Glasson, E., Sanders, R., & Bower, C. (2005). 
Association of sociodemographic characteristics of children with intellectual disability in Western 
Australia. Social Science & Medicine, 60(7), 1499-1513.  
Leung, C. , Mak, R. , Lau, V. , Cheung, J. & Lam, C. (2010). Development of a preschool 
developmental assessment scale for assessment of developmental disabilities. Research in 
Developmental Disabilities , 31(6), 1358-1365. 
Levine, B., Black, S.E., Cabeza, R., Sinden, M., Mcintosh, A.R., Toth, J.P., Tulving, E., & Stuss, D.T. 
(1998). Episodic memory and the self in a case of isolated retrograde amnesia. Brain, 121, 1951–1973. 
Levitas, A., Hagerman, R.J., Braden, M., Rimland, B., Mcbogg, P., & Matus, I. (1983). Autism and 
the fragile X syndrome. Journal of Developmental and Behavioral Pediatrics, 4, 151-158. 
Levy, P. (2009). Inborn Errors of Metabolism: Part 2: Specific Disorders. Pediatrics in Review, 30(4), 
e22-e28. 
Leyfer, O., Folstein, S., Bacalman, S., Davis, N., Dinh, E., Morgan, J., & Tager-Flusberg, H. et al. 
(2006). Comorbid Psychiatric Disorders in Children with Autism: Interview Development and Rates 
of Disorders. Journal of Autism and Developmental Disorders, 36(7), 849-861.  
Li, Y., Ou, J., Liu, L., Zhang, D., Zhao, J., & Tang, S. (2015). Association Between Maternal Obesity 
and Autism Spectrum Disorder in Offspring: A Meta-analysis. Journal of Autism and Developmental 
Disorders. 
 117 
Libbey, J., Sweeten, T., McMahon, W., & Fujinami, R. (2005). Autistic disorder and viral infections. 
Journal of NeuroVirology, 11(1), 1-10.  
Lifshitz, H., Merrick, J., & Morad, M. (2008). Health status and ADL functioning of older persons 
with intellectual disability: Community residence versus residential care centers. Research in 
Developmental Disabilities, 29, 301–315. 
Lincoln, A. J., Allen, M. H., & Kilman, A. (1995). The assessment and interpretation of intellectual 
abilities in people with autism. In E. Schopler & G. B. Mesibov (Eds.), Learning and cognition in 
autism (pp. 89–118). New York: Plenum Press. 
Lincoln, A., Courchesne, E., Allen, M., Hanson, E., & Ene, M. (1998). Neurobiology of Asperger 
syndrome: seven case studies and quantitative magnetic resonance imaging findings. In: Schopler E, 
Mesibov G, Kunce LJ, editors. Asperger syndrome or high-functioning autism? New York: Kluwer 
Academic Press;. pp. 145–166. 
Loke, Y. J., Hannan, A. J., & Craig, J. M. (2015). The Role of Epigenetic Change in Autism Spectrum 
Disorders. Frontiers in Neurology, 6, 107.  
Lombardo, M.V., Ashwin, E., Auyeung, B., Chakrabarti, B., Taylor, K., Hackett, & Baron-Cohen, S. 
(2012). Fetal testosterone influences sexually dimorphic gray matter in the human brain. Journal of 
Neuroscience, 32(2), 674-80. 
Loos, H.G., & Loos Miller, I.M. (2004). Shutdown states and stress instability in autism. Retrieved 
from http://www.ingridloosmiller.com/ files/SI-SDinAutism.pdf. 
Lord, C. (2011). Epidemiology: How common is autism?. Nature, 474(7350), 166-168. 
Loughland, C.M., Williams, L.M., & Gordon, E. (2002). Visual scanpaths to positive and negative 
facial emotions in an outpatient schizophrenia sample. Schizophrenia Research, 55(1–2), 159–170. 
Lowe, K., Allen, D., Jones, E., Brophy, S., Moore, K., & James, W. (2007). Challenging behaviours: 
prevalence and topographies. Journal of Intellectual Disability Research, 51(8), 625-636. 
Luckasson, R., Borthwick-Duffy, S., Buntinx, W. H. E., Coulter, D. L., Craig, E. M., Reeve, A., 
Schalock, R. L., Snell, M. E., Spitalnick, D. M., Spreat, S., & Tasse, M. J. (2002). Mental retarda- 
tion: Definition, classification, and systems of supports (10th Ed.). Washington DC: American 
Association on Mental Retardation. 
Lunsky, Y., Gracey, C., & Bradley, E. (2009). Adults with Autism Spectrum Disorders using 
psychiatric hospitals in Ontario: Clinical profile and service needs. Research in Autism Spectrum 
Disorders, 3(4), 1006-1013.  
Magri, C., Sacchetti, E., Traversa, M., Valsecchi, P., Gardella, R., Bonvicini, C., & Minelli, A. et al. 
(2010). New Copy Number Variations in Schizophrenia. PLoS ONE, 5(10), e13422.  
Maj, M., Gaebel, W., Lopez-Ibor, J.J., & Sartorius N. (2002). Psychiatric diagnosis and classification. 
Chichester: New York: John Wiley.Wiley.  
Maki, P., Veijola, J., Jones, P.B., Murray, G.K., Koponen, H., Tienari, P., Miettunen, J., Tanskanen, 
P., Wahlberg, K.E., Koskinen, J., Lauronen, E., & Isohanni, M. (2005). Predictors of schizophrenia--a 
review. British Medical Bulletin, 73-74(1), 1-15. 
Malhotra, D., & Sebat, J. (2012). CNVs: Harbingers of a Rare Variant Revolution in Psychiatric 
Genetics. Cell, 148(6), 1223-1241.  
Mann, J., Pan, C., Rao, G., McDermott, S., & Hardin, J. (2013). Children Born to Diabetic Mothers 
May be More Likely to Have Intellectual Disability. Maternal and Child Health Journal, 17(5), 928-
932. 
 118 
Mari-Bauset, S., Zazpe, I., Mari-Sanchis, A., Llopis-Gonzalez, A., & Morales-Suarez-Varela, M. 
(2014). Evidence of the Gluten-Free and Casein-Free Diet in Autism Spectrum Disorders: A 
Systematic Review. Journal of Child Neurology, 29(12), 1718-1727.  
Marlow, N., Wolke, D., Bracewell, M. A., & Samara, M. (2005). Neurologic and developmental 
disability at six years of age after extremely preterm birth. New England Journal of Medicine, 352(1), 
9-19. 
Marshall, C.R., & Scherer, S.W. (2012). Detection and characterization of copy number variation in 
autism spectrum disorder. Methods in Molecular Biology, 838, 115-35. 
Martin, J. (2005). The Corticospinal System: From Development to Motor Control. The 
Neuroscientist, 11(2), 161-173.  
Matson, J. (2009). Aggression and Tantrums in Children with Autism: A Review of Behavioral 
Treatments and Maintaining Variables. Journal of Mental Health Research in Intellectual Disabilities, 
2(3), 169-187.  
Matson, J. L., & Sturmey, P. (2011). International Handbook of Autism and Pervasive Developmental 
Disorders. New York: Springer. pp. 53–74 
Matson, J. L., Dixon, D. R., Matson, M. L., & Logan, J. R. (2005). Classifying mental retardation and 
specific strengths and deficit areas in severe and profound mentally retarded persons with the 
MESSIER. Research in Developmental Disabilities, 26, 41–45. 
Matson, J., & Cervantes, P. (2014). Commonly studied comorbid psychopathologies among persons 
with autism spectrum disorder. Research in Developmental Disabilities, 35(5), 952-962.  
Matson, J., & Williams, L. (2014). The making of a field: The development of comorbid 
psychopathology research for persons with intellectual disabilities and autism. Research in 
Developmental Disabilities, 35(1), 234-238. 
Matson, J., González, M., Terlonge, C., Thorson, R. & Laud, R. (2007). What symptoms predict the 
diagnosis of mania in persons with severe/profound intellectual disability in clinical practice?. Journal 
of Intellectual Disability Research, 51(1), 25-31.  
Matson, J., Sipes, M., Fodstad, J., & Fitzgerald, M. (2011). Issues in the Management of Challenging 
Behaviours of Adults with Autism Spectrum Disorder. CNS Drugs, 25(7), 597-606.  
Matson, J..L.; & Kuhn, D.E. (2001). Identifying feeding problems in mentally retarded persons: 
development and reliability of the screening tool of feeding problems (STEP). Research in 
Developmental Disabilities, 21, 165-172. 
Matson, J.L. , Dempsey, T. & Fodstad, J.C. (2009a). Stereotypies and repetitive/restrictive behaviors 
in infants with autism and pervasive developmental disorder. Developmental Neurorehabilitation , 
12(3), 122-127.  
Matson, J.L. , Dempsey, T. & LoVullo, S.V. (2009b). Characteristics of social skills for adults with 
intellectual disability, autism, and PDD-NOS. Research in Autism Spectrum Disorders , 3(1), 207-213. 
Matson, J.L. & Kozlowski, A.M. (2011). The increasing prevalence of autism spectrum disorders. 
Research in Autism Spectrum Disorders, 5(1), 418-425.  
Matson, J.L., & Shoemaker, M. (2009). Intellectual disability and its relationship to autism spectrum 
disorders. Research In Developmental Disabilities, 30(6), 1107-14. 
Mattila, M.-L., Hurtig, T., Haapsamo, H., Jussila, K., Kuusikko-Guaffin, S., Kielinen, M., & Linna, 
S.L., et al. (2010). Comorbid Psychiatry Disorders Associated with Asberger Syndrome/ High 
 119 
Functioning Autism: A Community and Clinic-based study. Journal of Autism Developmental 
Disorders, 1080-1093. 
Maulik, P., Mascarenhas, M., Mathers, C., Dua, T., & Saxena, S. (2011). Prevalence of intellectual 
disability: A meta-analysis of population-based studies. Research in Developmental Disabilities, 
32(2), 419-436. 
Mavromatis, M. (2000). The diagnosis and treatment of borderline personality disorder in persons 
with developmental disability-3 case reports. Mental Health Aspects of Developmental Disabilities, 3, 
89-97. 
Maximo, J.O., Cadena, E.J., & Kana, R.K. (2014). The implications of brain connectivity in the 
neuropsychology of Autism. Neuropsychology Review, 24, 16–31. 
Mayes, S., & Calhoun, S. (2003). Ability Profiles in Children with Autism: Influence of Age and IQ. 
Autism, 7(1), 65-80. 
Mayville, S., Matson, J., Laud, R., Cooper, C., & Kuhn, D. (2005). The Relationship Between 
Depression and Feeding Disorder Symptoms Among Persons with Severe and Profound Mental 
Retardation. Journal of Developmental and Physical Disabilities, 17(3), 213-224.  
McCarthy, J. (2007). Children with autism spectrum disorders and intellectual disability. Current 
Opinion in Psychiatry, 20, 472–476. 
McCarthy, J., Hemmings, C., Kravariti, E., Dworzynski, K., Holt, G., Bouras, N., & Tsakanikos, E. 
(2010). Challenging behavior and co-morbid psychopathology in adults with intellectual disability and 
autism spectrum disorders. Research in Developmental Disabilities, 31(2), 362-366. 
McClean, B., & Grey, I. (2007). Modifying challenging behavior and planning positive supports. In: 
Carr A, O’Reilly G, Noonan Walsh P, et al., editors. The handbook of intellectual disability and 
clinical psychology practice. New York (NY): Routledge, pp. 643–84. 
McCloskey, A.L., & Walker, M. (2000). Posttraumatic Stress in Children Exposed to Family Violence 
and Single-Event Trauma. Journal of the American Academy of Child & Adolescent Psychiatry, 39(1), 
108-115.  
McDaniel, M.A., (2005). Big-brained people are smarter: A meta-analysis of the relationship between 
in vivo brain volume and intelligence. Intelligence, 33, 337–346. 
McDougle, C. J., Kresch, L. E., Goodman, W. K., Naylor, S.T., Volkmar, F.R., Cohen, D.J., & Price, 
L.H. (1995) A case-controlled study of repetitive thoughts and behaviour in adults with autistic 
disorder and obsessive-compulsive disorder. American Journal of Psychiatry, 152, 772 -777. 
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: A Concise Overview of 
Incidence, Prevalence, and Mortality. Epidemiologic Reviews, 30(1), 67-76.  
McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., & Chant, D. (2004). A systematic 
review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, 
migrant status and methodology. BMC Medicine, 2, 13. 
Mehtar, M., & Mukaddes, N. M. (2011). Posttraumatic Stress Disorder in individuals with diagnosis 
of Autistic Spectrum Disorders. Research in Autism Spectrum Disorders, 5, 539–546 
Meier, M., Caspi, A., Reichenberg, A., Keefe, R., Fisher, H., Harrington, H., & Houts, R. et al. (2014). 
Neuropsychological Decline in Schizophrenia From the Premorbid to the Postonset Period: Evidence 
From a Population-Representative Longitudinal Study. American Journal of Psychiatry, 171(1), 91-
101. 
 120 
Meltzer, H. (2006). Treatment of Suicidality in Schizophrenia. Annals of the New York Academy of 
Sciences, 932(1), 44-60. 
Meltzer, H.Y. (2004). Cognitive factors in schizophrenia: causes, impact, and treatment. CNS 
Spectrums, 10(11), 15-24. 
Meltzer, H.Y., & Fatemi, S.H. (2000). Schizophrenia and other psychotic disorders. In: Ebert MH, 
Loosen PT, Nurcombe B, editors. Current Diagnosis and Treatment in Psychiatry. Norwalk, Conn: 
Appleton and Lange; pp. 260–277. 
Mesholam-Gately, R., Giuliano, A., Goff, K., Faraone, S., & Seidman, L. (2009). Neurocognition in 
first-episode schizophrenia: A meta-analytic review. Neuropsychology, 23(3), 315-336. 
Mevissen, L., & de Jongh, A. (2011). PTSD and its treatment in people with intellectual disabilities. 
Clinical Psychology Review, 30(3), 308-316.  
Minkowski E. (1927). La schizophrénie. Psychopathologie des schizoïdes et des schizophrènes. 1° ed., 
Payot, Paris. 
Minshew, N., & Keller, T. (2010). The nature of brain dysfunction in autism: functional brain imaging 
studies. Current Opinion in Neurology, 23(2), 124-130.  
Minshew, N., Turner, C., & Goldstein, G. (2005). The Application of Short Forms of the Wechsler 
Intelligence Scales in Adults and Children with High Functioning Autism. Journal of Autism and 
Developmental Disorders, 35(1), 45-52. 
Minshew, N.J., Sweeney, J. A., Bauman, M. L., & Webb, S.J. (2005). Neurologic aspects of autism. 
Neurologic aspects of autism. In F. Volkmar et al. (Eds.), Handbook of Autism and Pervasive 
Developmental Disorders (pp.473-514). Hoboken, NJ: John Wiley & Sons. 
Mizuno, A., Villalobos, M. E., Davies, M. M., Dahl, B. C., & Muller, R. A. (2006). Partially enhanced 
thalamocortical functional connectivity in autism. Brain Research, 1104, 160-74. 
Moeschler, J. & Shevell, M. (2006). Clinical genetic evaluation of the child with mental retardation or 
developmental delays. Pediatrics. 117(6), 2304-2316. 
Money, J. (1993). Specific neurocognitional impairments associated with turner (45,X) and Klinefelter 
(47,XXY) syndromes: A review. Biodemography and Social Biology, 40(1-2), 147-151.  
Moore, T.H., Zammit, S., Lingford-Hughes, A., Barnes, T.R., Jones, P.B., Burke, M., & Lewis, G. 
(2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. 
Lancet, 28, 370(9584), 319-28. 
Morgan, C., & Fisher, H. (2006). Environment and Schizophrenia: Environmental Factors in 
Schizophrenia: Childhood Trauma--A Critical Review. Schizophrenia Bulletin, 33(1), 3-10.  
Morgan, C.N., Roy, M., Nasr, A., Chance, P., Hand, M., Mlele, T., & Roy, A. (2002). A community 
study establishing the prevalence rate of autistic disorder in adults with learning disability. Psychiatric 
Bulletin, 26, 127 -129. 
Morgan, V.A., Leonard, H., Bourke, J., & Jablensky, A. (2008). Intellectual disability co-occurring 
with schizophrenia and other psychiatric illness: population-based study. British Journal of 
Psychiatry, 193, 364–372. 
Mork, E., Mehlum, L., Barrett, E., Agartz, I., Harkavy-Friedman, J., Lorentzen, S., & Melle, I. et al. 
(2012). Self-Harm in Patients with Schizophrenia Spectrum Disorders. Archives of Suicide Research, 
16(2), 111-123.  
Morrow, E. (2010). Genomic Copy Number Variation in Disorders of Cognitive Development. 
Journal of the American Academy of Child & Adolescent Psychiatry, 49(11), 1091-1104. 
 121 
Moss, S., Emerson, E., Kiernan, C., Turner, S., Hatton, C., & Alborz, A. (2000). Psychiatric symptoms 
in adults with learning disability and challenging behaviour. The British Journal of Psychiatry, 177(5), 
452-456. 
Mouridsen, S., & Sorensen, S. (1995). Psychological aspects of von Recklinghausen 
neurofibromatosis (NF1). Journal of Medical Genetics, 32(12), 921-924. 
Mouridsen, S.E., Rich, B., & Isager, T. (2008). Psychiatric disorders in adults diagnosed as children 
with atypical autism: A case control study. Journal of Neural Transmission, 115, 135-13. 
Muir, W. J., Pickard, B. S. & Blackwood, D. H. R. (2006). Chromosomal abnormalities and psychosis. 
The British Journal of Psychiatry, 188(6), 501-503. 
Mulholland, C., & Cooper, S. (2000). The symptom of depression in schizophrenia and its 
management. Advances in Psychiatric Treatment, 6(3), 169-177. 
Müller, N., & Schwarz, M. (2006). Schizophrenia as an inflammation-mediated dysbalance of 
glutamatergic neurotransmission. Neurotoxicity Research, 10(2), 131-148.  
Müller, N., Weidinger, E., Leitner, B., & Schwarz, M. (2015). The role of inflammation in 
schizophrenia. Frontiers in Neuroscience, 9, 372.  
Muller, R., Shih, P., Keehn, B., Deyoe, J., Leyden, K., & Shukla, D. (2011). Underconnected, but 
How? A Survey of Functional Connectivity MRI Studies in Autism Spectrum Disorders. Cerebral 
Cortex, 21(10), 2233-2243.  
Murphy, D., Daly, E., Schmitz, N., Toal, F., Murphy, K., Curran, S., & Erlandsson, K. et al. (2006). 
Cortical Serotonin 5-HT 2A Receptor Binding and Social Communication in Adults With Asperger’s 
Syndrome: An in Vivo SPECT Study. American Journal of Psychiatry, 163(5), 934-936.  
Murphy, O., Healy, O., & Leader, G. (2009). Risk factors for challenging behaviors among 157 
children with autism spectrum disorders in Ireland. Research in Autism Spectrum Disorders, 3, 474–
482. 
Myrbakk, E., & von Tetzchner, S. (2008a). Psychiatric disorders and behavior problems in people 
with intellectual disability. Research in Developmental Disabilities, 29, 316–332. 
Myrbakk, E., & von Tetzchner, S. (2008b). Screening Individuals With Intellectual Disability for 
Psychiatric Disorders: Comparison of Four Measures. American Journal on Mental Retardation, 
113(1), 54-70. 
Nadeau, J., Sulkowski, M. L., Ung, D., Wood, J. J., Lewin, A. B., Murphy, T. K., May, J.E., & Storch, 
E. A. (2011). Treatment of comorbid anxiety and autism spectrum disorders. Neuropsychiatry, 1(6), 
567–578. 
Naito, K., Matsui, Y., Maeda, K., & Tanaka, K. (2010). Evaluation of the validity of the Autism 
Spectrum Quotient (AQ) in differentiating high-functioning autistic spectrum disorder from 
schizophrenia. The Kobe Journal of Medical Sciences, 30;56(3), E116-24. 
Nakahachi, T., Iwase, M., Takahashi, H., Honaga, E., Sekiyama, R., Ukai, S., & Ishii, R. et al. (2006). 
Discrepancy of performance among working memory-related tasks in autism spectrum disorders was 
caused by task characteristics, apart from working memory, which could interfere with task execution. 
Psychiatry and Clinical Neuroscience, 60(3), 312-318. 
Nan, X., Hou, J., Maclean, A., Nasir, J., Lafuente, M., Shu, X., & Kriaucionis, S. et al. (2007). 
Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause 
inherited mental retardation. Proceedings of the National Academy of Sciences, 104(8), 2709-2714. 
 122 
Newschaffer, C.J. , Croen, L.A. , Daniels, J. , Giarelli, E. , Grether, J.K. , Levy, S.E. and Windham, 
G.C. (2007). The epidemiology of autism spectrum disorders. Annual Review of Public Health, 28(1), 
235-258. 
Nicolson, R., DeVito, T., Vidal, C., Sui, Y., Hayashi, K., Drost, D., & Williamson, P. et al. (2006). 
Detection and mapping of hippocampal abnormalities in autism. Psychiatry Research: Neuroimaging, 
148(1), 11-21.  
Njiokiktjien, C., de Sonneville, L., & Vaal, J. (1994). Callosal size in children with learning 
disabilities. Behavioural Brain Research, 64(1-2), 213-218.  
Noonan, S. K., Haist, F., & Müller, R. A. (2009). Aberrant functional connectivity in autism: evidence 
from low-frequency BOLD signal fluctuations. Brain Research, 1262, 48-63. 
Noor, A., Whibley, A., Marshall, C., Gianakopoulos, P., Piton, A., Carson, A., & Orlic-Milacic, M. et 
al. (2010). Disruption at the PTCHD1 Locus on Xp22.11 in Autism Spectrum Disorder and 
Intellectual Disability. Science Translational Medicine, 2(49), 49-68.  
Nosarti, C., Rushe, T.M., Woodruff, P.W., Stewart, A.L., Rifkin, L., & Murray, R.M. (2004). Corpus 
callosum size and very preterm birth: relationship to neuropsychological outcome. Brain, 127, 2080–
2089.  
Noterdaeme, M.A., & Wriedt, E. (2010). Comorbidity in autism spectrum disorders - I. Mental 
retardation and psychiatric comorbidity. Zeitschrift fur Kinder und Jugendpsychiatrie und 
Psychotherapie, 38(4), 257-266. 
Noyola, D., Demmler, G., Nelson, C., Griesser, C., Williamson, W., Atkins, J., & Rozelle, J. et al. 
(2001). Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus 
infection. Pediatrics, 138(3), 325-331.  
Nyaradi, A., Li, J., Hickling, S., Foster, J., & Oddy, W. H. (2013). The role of nutrition in children’s 
neurocognitive development, from pregnancy through childhood. Frontiers in Human Neuroscience, 
7, 97.  
Nylander, L. & Gillberg, C. (2001). Screening for autism spectrum disorders in adult psychiatric 
outpatients: a preliminary report. Acta Psychiatrica Scandinavica , 103(6), 428-434. 
O'Brien, G., & Yule, W. (1995). Behavioural phenotypes. London: Mac Keith Press.  
O'Dowd, A. (2014). Antidepressants in pregnancy are linked to ADHD but not to autism, says study. 
British Medical Journal, 349(aug26 25), g5315-g5315. 
O’Brien, G., & Pearson, J. (2004). Autism and learning disability. Autism, 125–140. 
O’Dwyer, J.M. (2000). Autistic disorder and schizophrenia: similarities and differences and their 
coexistence in two cases. Mental Health Aspects of Developmental Disabilities, 3(4), 121-131.  
Öngür, D., & Goff, D. (2005). Obsessive–compulsive symptoms in schizophrenia: associated clinical 
features, cognitive function and medication status. Schizophrenia Research, 75(2-3), 349-362. 
Oosterling, I., Swinkels, S., van der Gaag, R., Visser, J., Dietz, C., & Buitelaar, J. (2009). 
Comparative Analysis of Three Screening Instruments for Autism Spectrum Disorder in Toddlers at 
High Risk. Journal of Autism and Developmental Disorders, 39(6), 897-909.  
Orellana, G., & Slachevsky, A. (2013). Executive Functioning in Schizophrenia. Frontiers in 
Psychiatry, 4, 35.  
Orsini, A., & Laicardi, C. (1997), WAIS-R. Contributo alla taratura italiana. Giunti O.S. 
Organizzazioni Speciali, Firenze. 
 123 
Ota, T., Iida, J., & Kishimoto, T. (2011). [Value of ancillary testing in the diagnosis of pervasive 
developmental disorder in adults]. Seishin Shinkeigaku Zasshi. 113(11), 1137-1144. 
Owen, M.J. (2012). Intellectual disability and major psychiatric disorders: a continuum of 
neurodevelopmental causality. British Journal of Psychiatry, 200(4), 268-269. 
Owen, M.J., O'Donovan, M.C., Thapar, A., & Craddock, N. (2011). Neurodevelopmental hypothesis 
of schizophrenia. British Journal of Psychiatry, 198(3), 173-175. 
Owen, M.J., O’Donovan, M.C., & Gottesman, I.I. (2004). Schizophrenia. In: McGuffin, P., Owen, 
M.J., & Gottesman, I.I. (eds) Psychiatric Genetics and Genomics. Oxford: Oxford University Press, 
247–266. 
Ozonoff, S., Heung, K., Byrd, R., Hansen, R., & Hertz-Picciotto, I. (2008). The Onset of Autism: 
Patterns of Symptom Emergence in the First Years of Life. Autism Research : Official Journal of the 
International Society for Autism Research, 1(6), 320–328. 
Pallanti, S., Quercioli, L., & Hollander, E. (2004). Social Anxiety in Outpatients With Schizophrenia: 
A Relevant Cause of Disability. American Journal of Psychiatry, 161(1), 53-58. 
Palucka, A.M. , Lunsky, Y. , Gofine, T. , White, S.E. & Reid, M. (2009). Brief report: comparison of 
referrals of individuals with and without a diagnosis of psychotic disorder to a specialized dual 
diagnosis program. Journal on Developmental Disabilities, 15(2), 103-109. 
Palucka, A.M., & Lunsky, Y. (2007). Review of inpatient admissions of individuals with Autism 
Spectrum Disorders to a specialized dual diagnosis program. Journal on Developmental Disabilities, 
13, 205-209. 
Palucka, A.M., Bradley, E., & Lunsky, Y. (2008). A case of unrecognised Intellectual Disability and 
Autism misdiagnosed as Schizophrenia: are there lessons to be learned?. Mental Health Aspects of 
Developmental Disabilities, 11, 55–60. 
Pantelis, C., Velakoulis, D., McGorry, P., Wood, S., Suckling, J., Phillips, L., & Yung, A. et al. 
(2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and 
longitudinal MRI comparison. The Lancet, 361(9354), 281-288.  
Park, K.M., Kim, J.J., Ku, J., Kim, S.Y., Lee, H.R., Kim, S.I., & Yoon, K.J. (2009). Neural basis of 
attributional style in schizophrenia. Neuroscience Letters, 459, 35–40.  
Patterson, D., & Costa, A. C. S. (2005) Down syndrome and genetics—A case of linked histories. 
Nature Reviews Genetics 6, 137–147.  
Paula-Pérez, I. (2012). Differential diagnosis between the autistic spectrum and the schizophrenic 
spectrum. Revista de Neurología, 54(1), S51-62. 
Pedersen, C.B., & Mortensen, P.B. (2001). Evidence of a Dose-Response Relationship Between 
Urbanicity During Upbringing and Schizophrenia Risk. Archives of General Psychiatry, 58(11), 1039-
1046. 
Peleikis, D., Varga, M., Sundet, K., Lorentzen, S., Agartz, I., & Andreassen, O. (2013). Schizophrenia 
patients with and without Post-traumatic Stress Disorder (PTSD) have different mood symptom levels 
but same cognitive functioning. Acta Psychiatrica Scandinavica, 127(6), 455-463.  
Pelphrey, K.A., Sasson, N.J., Reznick, J.S., Paul, G., Goldman, B.D., & Piven, J. (2002). Visual 
scanning of faces in autism. Journal of Autism and Developmental Disorders, 32(4), 249–261. 
Persico, A. & Bourgeron, T. (2006). Searching for ways out of the autism maze: genetic, epigenetic 
and environmental clues. Trends in Neurosciences, 29(7), 349-358.  
 124 
Pfundt, R., & Veltman, J. (2012). Structural Genomic Variation in Intellectual Disability. Methods in 
Molecular Biology, 77-95. 
Picken, A., & Tarrier, N. (2011). Trauma and comorbid posttraumatic stress disorder in individuals 
with schizophrenia and substance abuse. Comprehensive Psychiatry, 52(5), 490-497.  
Pinkham, A.E., Hopfinger, J.B., Pelphrey, K.A., Piven, J., & Penn, D.L. (2008). Neural bases for 
impaired social cognition in schizophrenia and autism spectrum disorders. Schizophrenia Research, 
99, 164–175. 
Pinkham, A.E., Penn, D.L., Perkins, D.O., Graham, K.A., & Siegel, M. (2007). Emotion perception 
and social skill over the course of psychosis: a comparison of individuals "at-risk" for psychosis and 
individuals with early and chronic schizophrenia spectrum illness. Cognitive Neuropsychiatry, 12(3), 
198–212.  
Pinto, D., Pagnamenta, A.T., Klei, L., Anney, R., Merico, D., Regan, R., & Betancur, C. (2010). 
Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 
466(7304), 368-372.  
Plitman, E., Nakajima, S., de la Fuente-Sandoval, C., Gerretsen, P., Chakravarty, M., Kobylianskii, J., 
& Chung, J. et al. (2014). Glutamate-mediated excitotoxicity in schizophrenia: A review. European 
Neuropsychopharmacology, 24(10), 1591-1605.  
Plomin, R., & Kosslyn, S. (2001). Genes, brain and cognition. Nature Neuroscience, 4(12), 1153-
1154. 
Pocklington, A., Rees, E., Walters, J., Han, J., Kavanagh, D., Chambert, K., & Holmans, P. et al. 
(2015). Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in 
Schizophrenia. Neuron, 86(5), 1203-1214.  
Posserud, M., Lundervold, A., Lie, S., & Gillberg, C. (2010). The prevalence of autism spectrum 
disorders: impact of diagnostic instrument and non-response bias. Social Psychiatry and Psychiatric 
Epidemiology, 45(3), 319-327.  
Poyurovsky, M., Kriss, V., Weisman, G., Faragian, S., Kurs, R., Schneidman, M., & Fuchs, C. et al. 
(2003). Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and 
Without Obsessive-Compulsive Disorder. Journal of Clinical Psychiatry, 64(11), 1300-1307. 
Prasher, V., & Janicki, M. (Eds.). (2008). Physical health of adults with intellectual disabilities. John 
Wiley & Sons. 
Preti, A., Vellante, M., Baron-Cohen, S., Zucca, G., Petretto, D., & Masala, C. (2011). The Empathy 
Quotient: A cross-cultural comparison of the Italian version. Cognitive Neuropsychiatry, 16(1), 50-70.  
Pruessner, J.C., Champagne, F., Meaney, M.J., & Dagher, A. (2004). Dopamine Release in Response 
to a Psychological Stress in Humans and Its Relationship to Early Life Maternal Care: A Positron 
Emission Tomography Study Using [11C]Raclopride. Journal of Neuroscience, 24(11), 2825-2831. 
Rajji, T., Ismail, Z., & Mulsant, B. (2009). Age at onset and cognition in schizophrenia: meta-analysis. 
The British Journal of Psychiatry, 195(4), 286-293. 
Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. R. C. (2005). The neurodevelopmental 
model of schizophrenia: update 2005. Molecular psychiatry, 10(5), 434-449. 
Rastam, M. (2008). Eating disturbances in autism spectrum disorders with focus on adolescent and 
adult years. Clinical Neuropsychiatry, 5(1), 31-42. 
 125 
Rauch, A., Hoyer, J., Guth, S., Zweier, C., Kraus, C., Becker, C., & Zenker, M. et al. (2006). 
Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or 
mental retardation. American Journal of Medical Genetics, 140A(19), 2063-2074. 
Raznahan, A., Higgins, N., Griffiths, P., Humphrey, A., Yates, J., & Bolton, P. (2007). Biological 
markers of intellectual disability in tuberous sclerosis. Psychological Medicine, 37(09), 1293. 
Read, J., Agar, K., Argyle, N., & Aderhold, V. (2003). Sexual and physical abuse during childhood 
and adulthood as predictors of hallucinations, delusions and thought disorder. Psychology and 
Psychotherapy: Theory, Research and Practice, 76(1), 1-22.  
Reaven, J., & Hepburn, S. (2003). Cognitive-behavioral treatment of obsessive-compulsive disorder in 
a child with Asperger syndrome: a case report. Autism, 7(2), 145-164. 
Redcay, E. (2008). The superior temporal sulcus performs a common function for social and speech 
perception: mplications for the emergence of autism. Neuroscience and Biobehaioral Review. 32, 
123–142. 
Reichenberg, A. (2010). The assessment of neuropsychological functioning in schizophrenia. 
Dialogues in Clinical Neuroscience, 12(3), 383-392. 
Reichenberg, A., Caspi, A., Harrington, H., Houts, R., Keefe, R., Murray, R., & Poulton, R. et al. 
(2010). Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-
Year Study. American Journal of Psychiatry, 167(2), 160-169.  
Reichenberg, A., Harvey, P., Bowie, C., Mojtabai, R., Rabinowitz, J., Heaton, R., & Bromet, E. 
(2008). Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective 
Disorders. Schizophrenia Bulletin, 35(5), 1022-1029.  
Reid, K., Smiley, E., & Cooper, S. (2011). Prevalence and associations of anxiety disorders in adults 
with intellectual disabilities. Journal of Intellectual Disability Research, 55(2), 172-181.  
Reiss, A., Abrams, M., Singer, H., Ross, J., & Denckla, M. (1996). Brain development, gender and IQ 
in children. Brain, 119(5), 1763-1774.  
Reiss, S. & Szyszko, J. (1983). Diagnostic overshadowing and professional experience with mentally 
retarded people. American Journal of Mental Deficiency, 8, 396–402. 
Reiss, S., Levtan, G.W. & Szyszko, J. (1982). Emotional disturbance and mental retardation: 
Diagnostic overshadowing. American Journal of Mental Deficiency, 86, 567–574. 
Resnick, S., Bond, G., & Mueser, K. (2003). Trauma and posttraumatic stress disorder in people with 
schizophrenia. Journal of Abnormal Psychology, 112(3), 415-423.  
Rezvani, A., & Levin, E. (2001). Cognitive effects of nicotine. Biological Psychiatry, 49(3), 258-267.  
Riley, E., McGovern, D., Mockler, D., Doku, V., ÓCeallaigh, S., Fannon, D., & Tennakoon, L. et al. 
(2000). Neuropsychological functioning in first-episode psychosis — evidence of specific deficits. 
Schizophrenia Research, 43(1), 47-55.  
Ripke, S., Neale, B., Corvin, A., Walters, J., Farh, K., Holmans, P., & Lee, P. et al. (2014). Biological 
insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427. 
Ritchie, K., Jaussent, I., Stewart, R., Dupuy, A., Courtet, P., Malafosse, A., & Ancelin, M. (2010). 
Adverse childhood environment and late-life cognitive functioning. International Journal of Geriatric 
Psychiatry, 26(5), 503-510. 
Rizzolati, G., Fadiga, L., Gallese, V., & Fogassi, L. (1996). Premotor Cortex and the Recognition of 
Motor Actions, Cognitive Brain Research, 3, 131-141. 
 126 
Roberts, A., Lyall, K., Hart, J., Laden, F., Just, A., Bobb, J., & Koenen, K. et al. (2013). Perinatal Air 
Pollutant Exposures and Autism Spectrum Disorder in the Children of Nurses’ Health Study II 
Participants. Environ Health Perspect, 121(8), 978-84.  
Roberts, W., & Harford, M. (2002). Immunization and children at risk for autism. Paediatrics & Child 
Health, 7(9), 623–632 
Rojas, D. C., Camou, S. L., Reite, M. L., Rogers, S. J. (2005). Planum temporale volume in children 
and adolescents with autism, Journal of Autism and Developmental Disorders, 35 (4), 479–86. 
Ropers, H.H., & Hamel, B.C.J. (2005). X-linked mental retardation. Nature Review. Genetics, 6(1), 
46–57. 
Roth, T. L., Lubin, F. D., Sodhi, M., & Kleinman, J. E. (2009). Epigenetic mechanisms in 
schizophrenia. Biochimica et Biophysica Acta, 1790(9), 869–877.  
Roy, M., & Balaratnasingam, S. (2010). Missed diagnosis of autism in an Australian indigenous 
psychiatric population. Australasian Psychiatry, 18(6), 534-537. 
Royal College of Psychiatrists (2001), Diagnostic Criteria for Psychiatric Disorders for use with 
Adults with Learning Disabilities/Mental Retardation (DC-LD), Gaskell, Londra. 
Royal College of Psychiatrists (2014). Good practice in the management of autism in adults. College 
Report No. 191, Gaskell, London. 
Rubenstein, J., & Merzenich, M. (2003). Model of autism: increased ratio of excitation/inhibition in 
key neural systems. Genes, Brain and Behavior, 2(5), 255-267.  
Ruedrich, S. (2010), Mental illness. In O’Hara, J., McCarthy, J.and Bouras, N. (Eds.). Intellectual 
disability and ill health: a review of the evidence. Cambridge University Press, Cambridge, pp. 165-
177. 
Ruta, L., Mazzone, D., Mazzone, L., Wheelwright, S., & Baron-Cohen, S. (2011). The Autism-
Spectrum Quotient—Italian Version: A Cross-Cultural Confirmation of the Broader Autism 
Phenotype. Journal of Autism and Developmental Disorders, 42(4), 625-633. 
Rutter, M. (2005). Incidence of autism spectrum disorders: Changes over time and their meaning. Acta 
Paediatrica, 94(1), 2-15.  
Ruzzano, L., Borsboom, D., & Geurts, H. (2015). Repetitive Behaviors in Autism and Obsessive–
Compulsive Disorder: New Perspectives from a Network Analysis. Journal of Autism and 
Developmental Disorders, 45(1), 192-202. 
Ryan, M., & Thakore, J. (2002). Physical consequences of schizophrenia and its treatment. Life 
Sciences, 71(3), 239-257.  
Salvador-Carulla L., & Bertelli M. (2008). ‘Mental retardation' or ‘intellectual disability’: time for a 
conceptual change. Psychopathology, 41(1), 10-16. 
Salvador-Carulla, L., Reed, G., Vaez-Azizi, L., Cooper, S., Leal, R., Bertelli, M., & Adnams, C. et al. 
(2011). Intellectual developmental disorders: towards a new name, definition and framework for 
“mental retardation/intellectual disability” in ICD-11. World Psychiatry, 10(3), 175-180. 
Samsom, J. N., & Wong, A. H. C. (2015). Schizophrenia and Depression Co-Morbidity: What We 
have Learned from Animal Models. Frontiers in Psychiatry, 6, 13.  
Sanchez-Mut, J., Huertas, D., & Esteller, M. (2012). Aberrant epigenetic landscape in intellectual 
disability. Progress in Brain Research, 53-71. 
 127 
Sasson, N. J., Pinkham, A. E., Carpenter, K. L., & Belger, A. (2011). The benefit of directly 
comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment. 
Journal of Neurodevelopmental Disorders, 3(2), 87-100.   
Sasson, N., Tsuchiya, N., Hurley, R., Couture, S.M., Penn, D.L., Adolphs, R., & Piven, J. (2007). 
Orienting to social stimuli differentiates social cognitive impairment in autism and schizophrenia. 
Neuropsychologia, 45(11), 2580–2588. 
Sasson, N.J. (2006). The development of face processing in autism. Journal of Autism and 
Developmental Disorders, 36(3), 381–394. 
Saunders, J., Gandal, M., Roberts, T., & Siegel, S. (2012). NMDA antagonist MK801 recreates 
auditory electrophysiology disruption present in autism and other neurodevelopmental disorders. 
Behavioural Brain Research, 234(2), 233-237. 
Savage, M., Benia, F., Balanquit, M. & Palucka, A.M. (2007). Unrecognized medical concern as cause 
of ‘psychiatric’ disorder and challenging behaviour in developmental disability: a case study. Journal 
on Developmental Disabilities, 13(3), 205-210. 
Schaaf, C. & Zoghbi, H. (2011). Solving the Autism Puzzle a Few Pieces at a Time. Neuron, 70(5), 
806-808.  
Schalock, R.L., Borthwick-Duffy, S.A., Bradley, M., Buntinx, H.E., Coulter, D.L., & Craig, E.M.P. et 
al. (2010). Intellectual disability: definition, classification, and systems of supports.11th ed. 
Washington, DC: American Association on Intellectual and Developmental Disabilities. 
Schirmbeck, F., & Zink, M. (2013). Comorbid obsessive-compulsive symptoms in schizophrenia: 
contributions of pharmacological and genetic factors. Frontiers in Pharmacology, 4, 99.  
Schneider, K. (1959). Clinical Psychopathology. New York: Grune and Stratton.  
Schultz, R. (2005). Developmental deficits in social perception in autism: the role of the amygdala and 
fusiform face area. International Journal of Developmental Neuroscience, 23(2-3), 125-141.  
Schumann, C. M., Hamstra, J., Goodlin-Jones, B. L., Lotspeich, L.J., Kwon, H., Buonocore, M.H., & 
Lammers, C.R., et al. (2004). The amygdale is enlarged in children but not adolescents with autism; 
the hippocampus is enlarged at all ages, Journal of Neuroscience, 24(28), 6392-6401.  
Selvaraj, S., Arnone, D., Cappai, A., & Howes, O. (2014). Alterations in the serotonin system in 
schizophrenia: A systematic review and meta-analysis of postmortem and molecular imaging studies. 
Neuroscience & Biobehavioral Reviews, 45, 233-245. 
Semerari, A., Cucchi, M., Dimaggio, G., Cavadini, D., Carcione, A., Battelli, V., & Nicolò, G. et al. 
(2012). The development of the Metacognition Assessment Interview: Instrument description, factor 
structure and reliability in a non-clinical sample. Psychiatry Research, 200(2-3), 890-895. 
Shah, A., & Frith, U. (1993). Why Do Autistic Individuals Show Superior Performance on the Block 
Design Task?. J Child Psychol & Psychiat, 34(8), 1351-1364. 
Shah, A., & Wing, L. (2006). Psychological approaches to chronic catatonia-like deterioration in 
autism spectrum disorders. International Review of Neurobiology, 72, 245-64. 
Shaw, K., McFarlane, A., Bookless, C. and Air, T. (2002). The aetiology of postpsychotic 
posttraumatic stress disorder following a psychotic episode. Journal of Traumatic Stress, 15(1), 39-47.  
Shen, Y., Dies, K., Holm, I., Bridgemohan, C., Sobeih, M., Caronna, E., & Miller, K., et al. (2010). 
Clinical Genetic Testing for Patients With Autism Spectrum Disorders. Pediatrics, 125(4), e727-e735.  
Shenton, M., Dickey, C., Frumin, M., & McCarley, R. (2001). A review of MRI findings in 
schizophrenia. Schizophrenia Research, 49(1-2), 1-52.  
 128 
Shorter, E., & Wachtel, L.E. (2013). Childhood catatonia, autism and psychosis past and present: is 
there an 'iron triangle'?. Acta Psychiatrica Scandinavica, 128(1), 21-33.  
Shorter, K., & Miller, B. (2015). Epigenetic mechanisms in schizophrenia. Progress in Biophysics and 
Molecular Biology, 118(1-2), 1-7.  
Shoubridge, C., Tarpey, P.S., Abidi, F., Ramsden, S.L., Rujirabanjerd, S., Murphy, J.A., & Gécz, J. 
(2010). Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic 
intellectual disability. Nature Genetics, 42(6), 486-488.  
Siegel, D.J., Minshew, N.J., & Goldstein, G. (1996). Wechsler IQ profiles in diagnosis of high-
functioning autism. Journal of Autism and Developmental Disorders, 26, 389–406. 
Sigafoos, J., (2000). Communication development and aberrant behavior in children with 
developmental disabilities. Education and Training in Developmental Disabilities, 35(2), 168–76. 
Silver, W. & Rapin, I. (2012). Neurobiological Basis of Autism. Pediatric Clinics of North America, 
59(1), 45-61.  
Sim, K., Mahendran, R., Siris, S., Heckers, S., & Chong, S. (2004). Subjective quality of life in first 
episode schizophrenia spectrum disorders with comorbid depression. Psychiatry Research, 129(2), 
141-147.  
Siris, S.G. (2001). Suicide and schizophrenia. Journal of Psychopharmacology, 15 (2), 127-135. 
Sithisarn, T., Granger, D., & Bada, H. (2012). Consequences of prenatal substance use. International 
Journal of Adolescent Medicine and Health, 24(2). 
Skuse, D., & Gallagher, L. (2011). Genetic Influences on Social Cognition. Pediatric Research, 69(5 
Part 2), 85R-91R. 
Smiley, E. (2005). Epidemiology of mental health problems in adults with learning disability: an 
update. Advances in Psychiatric Treatment, 11(3), 214-222. 
Smiley, E., Cooper, S., Finlayson, J., Jackson, A., Allan, L., Mantry, D., & Mcgrother, C. et al. (2007). 
Incidence and predictors of mental ill-health in adults with intellectual disabilities: Prospective study. 
The British Journal of Psychiatry, 191(4), 313-319.  
Smith, D., Langan, J., McLean, G., Guthrie, B., & Mercer, S. (2013). Schizophrenia is associated with 
excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in 
primary care: cross-sectional study. BMJ Open, 3(4), e002808-e002808. 
Smith, K.R. & Matson, J.L. (2010a). Psychopathology: differences among adults with intellectually 
disabled, comorbid autism spectrum disorders and epilepsy. Research in Developmental Disabilities, 
31(3), 743-749.  
Smith, K.R. & Matson, J.L. (2010b). Behavior problems: differences among intellectually disabled 
adults with co-morbid autism spectrum disorders and epilepsy. Research in Developmental 
Disabilities, 31(5), 1062-1069.  
Smith, K.R. & Matson, J.L. (2010c). Social skills: differences among adults with intellectual 
disabilities, co-morbid autism spectrum disorders and epilepsy. Research in Developmental 
Disabilities , 31(6), 1366-1372. 
Sovner, R. (1986). Limiting factors in the use of DSM-III criteria with mentally ill/ mentally retarded 
persons. Psychopharmacology Bulletin, 24, 1055–1059. 
Sovner, R. & DesNoyers Hurley, A. (1986). Four factors affecting the diagnosis of psychiatric 
disorders in mentally retarded persons. Psychiatric Aspects of Mental Retardation Reviews, 5, 45–48. 
 129 
Sowell, E.R., Thompson, P.M., Tessner, K.D., Toga, A.W. (2001). Mapping continued brain growth 
and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent 
brain maturation. Journal of Neuroscience, 21, 8819–8829. 
Spek, A., Scholte, E., & van Berckelaer-Onnes, I. (2007). Brief Report: The Use of WAIS-III in 
Adults with HFA and Asperger Syndrome. Journal of Autism and Developmental Disorders, 38(4), 
782-787. 
Spencer, M.D., Gibson, R.J., Moorhead, T.W., Keston, P.M., Hoare, P., Best, J.J., Lawrie, S.M., & 
Johnstone, E.C. (2005). Qualitative assessment of brain anomalies in adolescents with mental 
retardation. American Journal of Neuroradiology, 26(10), 2691-7. 
Sporn, A., Addington, A., Gogtay, N., Ordoñez, A., Gornick, M., Clasen, L., & Greenstein, D. et al. 
(2004). Pervasive developmental disorder and childhood-onset schizophrenia: comorbid disorder or a 
phenotypic variant of a very early onset illness?. Biological Psychiatry, 55(10), 989-994. 
St Clair, D. (2009). Copy Number Variation and Schizophrenia. Schizophrenia Bulletin, 35(1), 9–12.  
Stahlberg, O., Soderstrom, H., Rastam, M., & Gillberg, C. (2004). Bipolar disorder, schizophrenia, 
and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum 
disorders. Journal of Neural Transmission, 111, 891–902. 
Stallard, P. (2006). Post-traumatic Stres Disorder in C. Gillberg, R. Harrington, H.C. Steinhausen 
(Eds.), A clinician’s handbook of child and adolescent psychiatry, Cambridge University Press, UK, 
pp. 221–245. 
Stanfield, A., McIntosh, A., Spencer, M., Philip, R., Gaur, S., & Lawrie, S. (2008). Towards a 
neuroanatomy of autism: A systematic review and meta-analysis of structural magnetic resonance 
imaging studies. European Psychiatry, 23(4), 289-299. 
Stanghellini G. (2000). Il valzer delle identità’. Informacritica, UISS editore Firenze. 
Stavrakaki, C. (2002) The DSM–IV and how it applies to persons with developmental disabilities. In 
Dual Diagnosis: An Introduction to the Mental Health Needs of Persons with Developmental 
Disabilities (eds D. Griffiths, C. Stavrakaki & J. Summers), pp. 115–149. Ontario: Habilitative Mental 
Health Resource Network. 
Stengel, E. (1945). A Study on some Clinical Aspects of the Relationship Between Obsessional 
Neurosis and Psychotic Reaction Types. The British Journal of Psychiatry, 91(383), 166-187. 
Sterling, L., Dawson, G., Estes, A., & Greenson, J. (2008). Characteristics Associated with Presence 
of Depressive Symptoms in Adults with Autism Spectrum Disorder. Journal of Autism and 
Developmental Disorders, 38(6), 1011-1018.  
Stewart, M., Barnard, L., Pearson, J., Hasan, R., & O’Brien, G. (2006). Presentation of depression in 
autism and Asperger syndrome: A review. Autism, 10(1), 103-116.  
Stewart, M., Watson, J., Allcock, A., & Yaqoob, T. (2009). Autistic traits predict performance on the 
block design. Autism, 13(2), 133-142. 
Stone, J., O’Donovan, M., Gurling, H., Kirov, G., Blackwood, D., Corvin, A., & Craddock, N. et al. 
(2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature, 
455(7210), 237-241. 
Stratton, K. (2012). Adverse effects of vaccines. Washington, D.C.: National Academies Press. 
Strauss, G., Duke, L., Ross, S., & Allen, D. (2009). Posttraumatic Stress Disorder and Negative 
Symptoms of Schizophrenia. Schizophrenia Bulletin, 37(3), 603-610. 
 130 
Strømme, P., & Hagberg, G. (2007). Aetiology in severe and mild mental retardation: a population-
based study of Norwegian children. Developmental Medicine & Child Neurology, 42(2), 76-86. 
Sturmey, P. & Ley, T. (1990). The psychopathology instrument for mentally retarded adults: Internal 
consistencies and relationship to behaviour problems. British Journal of Psychiatry, 156, 428–430. 
Südhof, T. (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature, 
455(7215), 903-911. 
Sugranyes, G., Kyriakopoulos, M., Corrigall, R., Taylor, E., & Frangou, S. (2011). Autism Spectrum 
Disorders and Schizophrenia: Meta-Analysis of the Neural Correlates of Social Cognition. PLoS ONE, 
6(10), e25322.  
Sullivan, P., Kendler, K., & Neale, M. (2003). Schizophrenia as a Complex Trait. Archives of General 
Psychiatry, 60(12), 1187.  
Sun, X., Allison, C., Matthews, F., Sharp, S., Auyeung, B., Baron-Cohen, S. and Brayne, C. (2013). 
Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-
analysis. Molecular Autism, 4(1),7.  
Suri, R., Lin, A., Cohen, L., & Altshuler, L. (2014). Acute and Long-Term Behavioral Outcome of 
Infants and Children Exposed in Utero to Either Maternal Depression or Antidepressants. Journal of 
Clinical Psychiatry, e1142-e1152. 
Swets, M., Dekker, J., van Emmerik-van Oortmerssen, K., Smid, G., Smit, F., de Haan, L. and 
Schoevers, R. (2014). The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-
regression exploring prevalence rates. Schizophrenia Research, 152(2-3), pp.458-468.  
Szatmari, P., Paterson, A., Zwaigenbaum, L., Roberts, W., Brian, J., Liu, X., & Vincent, J. et al. 
(2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature 
Genetics, 39(3), 319-328.  
Tager-Flusberg, H., & Joseph, R. (2003). Identifying neurocognitive phenotypes in autism. 
Philosophical Transactions of the Royal Society B: Biological Sciences, 358(1430), 303-314. 
Talkowski, M., Rosenfeld, J., Blumenthal, I., Pillalamarri, V., Chiang, C., Heilbut, A., & Ernst, C. et 
al. (2012). Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer 
Risk across Diagnostic Boundaries. Cell, 149(3), 525-537.  
Tandon, R. (2012). The Nosology of Schizophrenia. Psychiatric Clinics of North America, 35(3), 557-
569. 
Tandon, R., & Maj, M. (2008). Nosological status and definition of schizophrenia: Some 
considerations for DSM-V and ICD-11. Asian Journal of Psychiatry, 1(2), 22-27. 
Tandon, R., Gaebel, W., Barch, D., Bustillo, J., Gur, R., Heckers, S., & Malaspina, D. et al. (2013). 
Definition and description of schizophrenia in the DSM-5. Schizophrenia Research, 150(1), 3-10. 
Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F., Xiong, L., Piton, A., & Spiegelman, D. et al. (2011). 
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and 
schizophrenia. Translational Psychiatry, 1(11), e55. 
Tarpey, P., Smith, R., Pleasance, E., Whibley, A., Edkins, S., Hardy, C., & O'Meara, S., et al. (2009). 
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. 
Nature Genetics, 41(5), pp.535-543. 
Taylor, L., Swerdfeger, A., & Eslick, G. (2014). Vaccines are not associated with autism: An 
evidence-based meta-analysis of case-control and cohort studies. Vaccine, 32(29), 3623-3629. 
 131 
Temmingh, H. & Stein, D. (2015). Anxiety in Patients with Schizophrenia: Epidemiology and 
Management. CNS Drugs, 29(10), 819-832.  
Ten Kate, L. P. (2012). Genetic risk. Journal of Community Genetics, 3(3), 159–166.  
Thirion-Marissiaux, A.F., & Nader-Gosbois, N. (2008). Theory of mind ‘‘beliefs’’, developmental 
characteristics and social under- standing in children and adolescents with intellectual disabilities. 
Research in Developmental Disabilities, 29, 547–566.  
Thoma, P., & Daum, I. (2013). Comorbid substance use disorder in schizophrenia: A selective 
overview of neurobiological and cognitive underpinnings. Psychiatry Clin Neurosci, 67(6), 367-383.  
Tibbo, P., Swainson, J., Chue, P., & LeMelledo, J. (2003). Prevalence and relationship to delusions 
and hallucinations of anxiety disorders in schizophrenia. Depression and Anxiety, 17(2), 65-72.  
Toal, F., Bloemen, O., Deeley, Q., Tunstall, N., Daly, E., Page, L., & Brammer, M. et al. (2009). 
Psychosis and autism: magnetic resonance imaging study of brain anatomy. The British Journal of 
Psychiatry, 194(5), 418-425.  
Tomasulo, D.  J  .,  &  Razza,  N.  J.  (2007).  Posttraumatic  Stress  Disorder.  In:  Fletcher,  R., 
Loschen,  E.,  Stavrakaki,  C.,  &  First,  M.  (Eds.).  Diagnostic  Manual-Intellectual  Disability (DM-
ID):  A  Textbook  of  Diagnosis  of  Mental  Disorders  in  Persons  with  Intellectual Disability (pp. 
365-78). Kingston, NY: NADD Press.  
Torres, F., Barbosa, M., & Maciel, P. (2015). Recurrent copy number variations as risk factors for 
neurodevelopmental disorders: critical overview and analysis of clinical implications. Journal of 
Medical Genetics. 
Towbin, K.E. (2005). Pervasive developmental disorder not otherwise specified. In: Volkmar FR, Paul 
R, Klin A, Cohen D, Hoboken NJ (ed). Handbook of Autism and Pervasive Developmental Disorders. 
John Wiley & Sons. 
Trivedi, J. K. (2006). Cognitive deficits in psychiatric disorders: Current status. Indian Journal of 
Psychiatry, 48(1), 10–20.  
Tsai, J., & Rosenheck, R. (2013). Psychiatric comorbidity among adults with schizophrenia: A latent 
class analysis. Psychiatry Research, 210(1), 16-20.  
Tsuang, M. (2000). Schizophrenia: genes and environment. Biological Psychiatry, 47(3), 210-220.  
Turner, K. C., Frost, L., Linsenbardt, D., McIlroy, J. R., & Muller, R. A. (2006). Atypically diffuse 
functional connectivity between caudate nuclei and cerebral cortex in autism. Behavioral and Brain 
Functions, 2, 34. 
Turner, T. (1989). Schizophrenia and mental handicap: A historical review, with implications for 
further research. Psychological Medicine, 19, 301–314. 
Tzschach, A., & Ropers, H.H. (2007). Genetics of mental retardation. Dtsch Arztebl., 104:A, 1400–
1405. 
U.S. Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators; 
Centers for Disease Control and Prevention (CDC). (2009). Prevalence of autism spectrum disorders - 
Autism and Developmental Disabilities Monitoring Network. United States, 2006. MMWR Surveill 
Summ, 58 (NoSS-10). 
U.S. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; 
Centers for Disease Control and Prevention (CDC). (2014). Prevalence of autism spectrum disorder 
among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, 
United States, 2010. MMWR Surveill Summ, 28,63(2), 1-21. 
 132 
Underwood, L., McCarthy, J., & Tsakanikos, E. (2010). Mental health of adults with autism spectrum 
disorders and intellectual disability. Current Opinion in Psychiatry, 23(5), 421-426.  
Underwood, L., McCarthy, J., Chaplin, E., & Bertelli, M. (2015). Assessment and diagnosis of 
psychiatric disorder in adults with autism spectrum disorder. Advances in Mental Health and 
Intellectual Disabilities, 9(5), 222-229. 
Unenge Hallerbäck, M., Lugnegård, T., & Gillberg, C. (2012). Is autism spectrum disorder common in 
schizophrenia?. Psychiatry Research, 198(1), 12-17.  
Uzunova, G., Pallanti, S., & Hollander, E. (2015). Excitatory/inhibitory imbalance in autism spectrum 
disorders: Implications for interventions and therapeutics. The World Journal of Biological Psychiatry, 
1-13.  
van Impelen, A., Merckelbach, H., Jelicic, M., & Merten, T. (2014). The Structured Inventory of 
Malingered Symptomatology (SIMS): A Systematic Review and Meta-Analysis. The Clinical 
Neuropsychologist, 28(8), 1336-1365. 
van Kooten, I., Palmen, S., von Cappeln, P., Steinbusch, H., Korr, H., Heinsen, H., & Hof, P. et al. 
(2008). Neurons in the fusiform gyrus are fewer and smaller in autism. Brain, 131(4), 987-999.  
Van Os, J. & Kapur, S. (2009). Schizophrenia. The Lancet, 374 (9690), 635–645. 
Van't Wout, M., van Rijn, S., Jellema, T., Kahn, R.S., & Aleman, A. (2009). Deficits in implicit 
attention to social signals in schizophrenia and high risk groups: behavioural evidence from a new 
illusion. PLoS ONE, 4(5), e5581. 
Vanstraelen, M., & Tyrer, S. (2001). Review: Rapid cycling bipolar affective disorder in people with 
intellectual disability: a systematic review. Journal of Intellectual Disability Research, 43(5), 349-359.  
Varcin, K.J., Bailey, P.E., & Henry, J.D. (2010). Empathic deficits in schizophrenia: the potential role 
of rapid facial mimicry. Journal of the International Neuropsychological Society, 16, 621–629. 
Venables, P., Liu, J., Raine, A., & Mednick, S. (2007). Prenatal Influenza Exposure and Delivery 
Complications. Family & Community Health, 30(2), 151-159.  
Vissers, L., de Vries, B., & Veltman, J. (2009). Genomic microarrays in mental retardation: from copy 
number variation to gene, from research to diagnosis. Journal of Medical Genetics, 47(5), 289-297. 
Voineskos, A., Foussias, G., Lerch, J., Felsky, D., Remington, G., Rajji, T., & Lobaugh, N. et al. 
(2013). Neuroimaging Evidence for the Deficit Subtype of Schizophrenia. JAMA Psychiatry, 70(5), 
472.  
Volkmar, F.R. & Pauls, D. (2003). Autism. Lancet, 362, 1133-1141.  
Volkow, N. D. (2009). Substance Use Disorders in Schizophrenia—Clinical Implications of 
Comorbidity. Schizophrenia Bulletin, 35(3), 469–472.  
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., & Berelowitz, M. et al. 
(1998). RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive 
developmental disorder in children. The Lancet, 351(9103), 637-641. The Editors of The Lancet,. 
(2010). Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive 
developmental disorder in children. The Lancet, 375(9713), 445. 
Waltereit, R., Banaschewski, T., Meyer-Lindenberg, A., & Poustka, L. (2013). Interaction of 
neurodevelopmental pathways and synaptic plasticity in mental retardation, autism spectrum disorder 
and schizophrenia: implications for psychiatry. World Journal of Biological Psychiatry, 15(7), 507-
516. 
 133 
Warburg, M. (2001). Visual impairment in adult people with intellectual disability: Literature review. 
Journal of Intellectual Disability Research, 45(5), 424-438.  
Watts, T. J. (2008). The Pathogenesis of Autism. Clinical Medicine. Pathology, 1, 99–103. 
Wechsler, D. (1955), WAIS. Scala d’Intelligenza Wechsler per Adulti. Tr. it. O.S. Organizzazioni 
Speciali, Firenze 1974. 
Wechsler, D. (1981), WAIS-R. Scala d’Intelligenza Wechsler per Adulti-Riveduta. Tr. it. O.S. 
Organizzazioni Speciali, Firenze 1997. 
Wehring, H., & Carpenter, W. (2011). Violence and Schizophrenia. Schizophrenia Bulletin, 37(5), 
877-878.  
Weiss, R., Rosenfeld, B., & Farkas, M. (2011). The Utility of the Structured Interview of Reported 
Symptoms in a Sample of Individuals With Intellectual Disabilities. Assessment, 18(3), 284-290.  
Werner, S. & Stawski, M. (2012). Mental health: knowledge, attitudes and training of professionals on 
dual diagnosis of intellectual disability and psychiatric disorder. Journal of Intellectual Disability 
Research, 56(3), 291-304. 
Wicks, S., Hjern, A., Gunnell, D., Lewis, G., & Dalman, C. (2005). Social Adversity in Childhood and 
the Risk of Developing Psychosis: A National Cohort Study. American Journal of Psychiatry, 162(9), 
1652-1657.  
Wieland, J., Wardenaar, K., Van den Brink, A., & Zitman, F. (2013). 870 – The prevalence of 
personality disorders in psychiatric outpatients with an intellectual disability. European Psychiatry, 
28, 1. 
Wilkins, J., & Matson, J.L. (2009). A comparison of social skills profiles in intellectually disabled 
adults with and without ASD. Behavior Modification, 33, 143–155. 
Wilson, K., Mills, E., Ross, C., McGowan, J., & Jadad, A. (2003). Association of Autistic Spectrum 
Disorder and the Measles, Mumps, and Rubella Vaccine. A Systematic Review of Current 
Epidemiological Evidence. Archives of Pediatric and Adolescence Medicine, 157(7), 628-634. 
Wilson, S. R. (2001) A four stage model for management of borderline personality disorder in people 
with mental retardation. Mental Health Aspects of Developmental Disabilities, 4, 68-76. 
Wing, J. & Nixon J. (1975). Discriminating symptoms in schizophrenia. A report from the 
international pilot study of schizophrenia.  Archives of General Psychiatry, 32(7), 853-9. 
Wing, L. (2001). The Autistic Spectrum: A Parent’s Guide to Understanding and Helping Your Child, 
Ulysses Press, Berkeley, CA. 
Wing, L. & Potter, D. (2002). The epidemiology of autistic spectrum disorders: is the prevalence 
rising?. Mental Retardation and Developmental Disabilities Research Reviews, 8(3), pp.151-161.. 
Wing, L., & Shah, A. (2006). A systematic examination of catatonia-like clinical pictures in autism 
spectrum disorders. International Review of Neurobiology, 72, 21–39. 
Wing, L., Gould, J. & Gillberg, C. (2011). Autism spectrum disorders in the DSM-V: Better or worse 
than the DSM-IV?. Research in Developmental Disabilities, 32(2), pp.768-773. 
Winklbaur, B., Ebner, N., Sachs, G., Thau, K., & Fischer, G. (2006). Substance abuse in patients with 
schizophrenia. Dialogues in Clinical Neuroscience, 8(1), 37–43. 
Winter, S., Autry, A., Boyle, C., & Yeargin-Allsopp, M. (2002). Trends in the Prevalence of Cerebral 
Palsy in a Population-Based Study. Pediatrics, 110(6), 1220-1225. 
 134 
Woodberry, K., Giuliano, A., & Seidman, L. (2008). Premorbid IQ in Schizophrenia: A Meta-Analytic 
Review. American Journal of Psychiatry, 165(5), 579-587.  
Woods, R., Vallero, R., Golub, M., Suarez, J., Ta, T., Yasui, D., & Chi, L. et al. (2012). Long-lived 
epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Human Molecular 
Genetics, 21(11), 2399-2411. 
World Health Organisation. (1980). The ICD-9 Classification of Mental and Behavioural Disorders: 
Clinical Descriptions and Diagnostic Guidelines , World Health Organisation, Geneva. 
World Health Organisation. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: 
Clinical Descriptions and Diagnostic Guidelines , World Health Organisation, Geneva. 
World Health Organization. (2007). Atlas: global resources for persons with intellectual disabilities. 
World Health Organization, Geneva. 
Wykes, T., & Spaulding, W. (2011). Thinking About the Future Cognitive Remediation Therapy--
What Works and Could We Do Better?. Schizophrenia Bulletin, 37(suppl 2), S80-S90. 
Yalon-Chamovitz, S., & Weiss, P.L. (2008). Virtual reality as a leisure activity for young adults with 
physical and intellectual disabilities. Research in Developmental Disabilities, 29, 273–287. 
Yu, C., Li, J., Liu, Y., Qin, W., Li, Y., Shu, N., & Jiang, T. et al. (2008). White matter tract integrity 
and intelligence in patients with mental retardation and healthy adults. NeuroImage, 40(4), 1533-1541.  
Zahir, F., & Brown, C. (2011). Epigenetic Impacts on Neurodevelopment: Pathophysiological 
Mechanisms and Genetic Modes of Action. Pediatric Research, 69(5 Part 2), 92R-100R. 
Zayac, R.M., & Johnston, J.M. (2008). Contriving establishing operations: Responses of individuals 
with developmental disabilities during a learning task. Research in Developmental Disabilities, 29, 
202–216. 
Zheng, W., Wang, H., Zeng, Z., Lin, J., Little, P., Srivastava, L., & Quirion, R. (2012). The possible 
role of the Akt signaling pathway in schizophrenia. Brain Research, 1470, 145-158. 
Zhubi, A., Cook, E., Guidotti, A., & Grayson, D. (2014). Epigenetic Mechanisms in Autism Spectrum 
Disorder. International Review of Neurobiology, 203-244. 
Zipursky, R., Reilly, T., & Murray, R. (2012). The Myth of Schizophrenia as a Progressive Brain 
Disease. Schizophrenia Bulletin, 39(6), 1363-1372.  
 
 
 
